0001075415-22-000025.txt : 20220803 0001075415-22-000025.hdr.sgml : 20220803 20220803162949 ACCESSION NUMBER: 0001075415-22-000025 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 63 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220803 DATE AS OF CHANGE: 20220803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DIVERSIFIED HEALTHCARE TRUST CENTRAL INDEX KEY: 0001075415 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 043445278 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-15319 FILM NUMBER: 221133076 BUSINESS ADDRESS: STREET 1: C/O THE RMR GROUP STREET 2: TWO NEWTON PL., 255 WASH. ST., STE. 300 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: (617) 796-8350 MAIL ADDRESS: STREET 1: C/O THE RMR GROUP STREET 2: TWO NEWTON PL., 255 WASH. ST., STE. 300 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: SENIOR HOUSING PROPERTIES TRUST DATE OF NAME CHANGE: 19981217 10-Q 1 dhc-20220630.htm 10-Q dhc-20220630
0001075415false12/312022Q2http://fasb.org/us-gaap/2022#OtherAssetshttp://fasb.org/us-gaap/2022#OtherAssetshttp://fasb.org/us-gaap/2022#OtherLiabilitieshttp://fasb.org/us-gaap/2022#OtherLiabilities238,197238,197237,871237,871238,173238,173237,853237,853238,197238,197237,871238,173237,85300010754152022-01-012022-06-300001075415dhc:SeniorNotesDue2042Member2022-01-012022-06-300001075415dhc:SeniorNotesDue2046Member2022-01-012022-06-3000010754152022-07-29xbrli:shares00010754152022-06-30iso4217:USD00010754152021-12-31iso4217:USDxbrli:shares0001075415dhc:RentalIncomeMember2022-04-012022-06-300001075415dhc:RentalIncomeMember2021-04-012021-06-300001075415dhc:RentalIncomeMember2022-01-012022-06-300001075415dhc:RentalIncomeMember2021-01-012021-06-300001075415dhc:ResidentFeesAndServicesMember2022-04-012022-06-300001075415dhc:ResidentFeesAndServicesMember2021-04-012021-06-300001075415dhc:ResidentFeesAndServicesMember2022-01-012022-06-300001075415dhc:ResidentFeesAndServicesMember2021-01-012021-06-3000010754152022-04-012022-06-3000010754152021-04-012021-06-3000010754152021-01-012021-06-300001075415srt:AffiliatedEntityMember2022-04-012022-06-300001075415srt:AffiliatedEntityMember2021-04-012021-06-300001075415srt:AffiliatedEntityMember2022-01-012022-06-300001075415srt:AffiliatedEntityMember2021-01-012021-06-300001075415us-gaap:CommonStockMember2021-12-310001075415us-gaap:AdditionalPaidInCapitalMember2021-12-310001075415us-gaap:RetainedEarningsMember2021-12-310001075415dhc:CumulativeCommonDistributionsMember2021-12-310001075415us-gaap:ParentMember2021-12-310001075415us-gaap:NoncontrollingInterestMember2021-12-310001075415us-gaap:RetainedEarningsMember2022-01-012022-03-310001075415us-gaap:ParentMember2022-01-012022-03-3100010754152022-01-012022-03-310001075415dhc:CumulativeCommonDistributionsMember2022-01-012022-03-310001075415us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001075415us-gaap:CommonStockMember2022-01-012022-03-310001075415us-gaap:CommonStockMember2022-03-310001075415us-gaap:AdditionalPaidInCapitalMember2022-03-310001075415us-gaap:RetainedEarningsMember2022-03-310001075415dhc:CumulativeCommonDistributionsMember2022-03-310001075415us-gaap:ParentMember2022-03-310001075415us-gaap:NoncontrollingInterestMember2022-03-3100010754152022-03-310001075415us-gaap:RetainedEarningsMember2022-04-012022-06-300001075415us-gaap:ParentMember2022-04-012022-06-300001075415dhc:CumulativeCommonDistributionsMember2022-04-012022-06-300001075415us-gaap:CommonStockMember2022-04-012022-06-300001075415us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001075415us-gaap:CommonStockMember2022-06-300001075415us-gaap:AdditionalPaidInCapitalMember2022-06-300001075415us-gaap:RetainedEarningsMember2022-06-300001075415dhc:CumulativeCommonDistributionsMember2022-06-300001075415us-gaap:ParentMember2022-06-300001075415us-gaap:NoncontrollingInterestMember2022-06-300001075415us-gaap:CommonStockMember2020-12-310001075415us-gaap:AdditionalPaidInCapitalMember2020-12-310001075415us-gaap:RetainedEarningsMember2020-12-310001075415dhc:CumulativeCommonDistributionsMember2020-12-310001075415us-gaap:ParentMember2020-12-310001075415us-gaap:NoncontrollingInterestMember2020-12-3100010754152020-12-310001075415us-gaap:RetainedEarningsMember2021-01-012021-03-310001075415us-gaap:ParentMember2021-01-012021-03-310001075415us-gaap:NoncontrollingInterestMember2021-01-012021-03-3100010754152021-01-012021-03-310001075415dhc:CumulativeCommonDistributionsMember2021-01-012021-03-310001075415us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001075415us-gaap:CommonStockMember2021-03-310001075415us-gaap:AdditionalPaidInCapitalMember2021-03-310001075415us-gaap:RetainedEarningsMember2021-03-310001075415dhc:CumulativeCommonDistributionsMember2021-03-310001075415us-gaap:ParentMember2021-03-310001075415us-gaap:NoncontrollingInterestMember2021-03-3100010754152021-03-310001075415us-gaap:RetainedEarningsMember2021-04-012021-06-300001075415us-gaap:ParentMember2021-04-012021-06-300001075415us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001075415dhc:CumulativeCommonDistributionsMember2021-04-012021-06-300001075415us-gaap:CommonStockMember2021-04-012021-06-300001075415us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001075415us-gaap:CommonStockMember2021-06-300001075415us-gaap:AdditionalPaidInCapitalMember2021-06-300001075415us-gaap:RetainedEarningsMember2021-06-300001075415dhc:CumulativeCommonDistributionsMember2021-06-300001075415us-gaap:ParentMember2021-06-300001075415us-gaap:NoncontrollingInterestMember2021-06-3000010754152021-06-300001075415dhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2022-06-012022-06-30xbrli:puredhc:propertydhc:state0001075415dhc:JointVentureMember2022-06-30dhc:jointVenture0001075415us-gaap:CorporateJointVentureMember2022-06-30utr:sqft0001075415dhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:TheLSMDFundREITLLCMemberus-gaap:CorporateJointVentureMember2022-06-300001075415stpr:MAdhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2022-06-300001075415stpr:CAdhc:TheLSMDFundREITLLCMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:SeaportInnovationLLCMember2021-12-31dhc:option0001075415stpr:CAdhc:TheLSMDFundREITLLCMemberus-gaap:CorporateJointVentureMember2022-01-012022-06-300001075415stpr:CAus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberdhc:TheLSMDFundREITLLCMemberus-gaap:CorporateJointVentureMember2022-01-012022-06-300001075415us-gaap:InterestRateCapMemberstpr:CAus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberdhc:TheLSMDFundREITLLCMemberus-gaap:CorporateJointVentureMember2022-01-012022-06-300001075415dhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2021-12-012021-12-310001075415dhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2021-12-300001075415dhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2022-06-280001075415dhc:SeniorLivingCommunitiesMemberdhc:SkilledNursingBedLicenseMember2022-06-012022-06-300001075415dhc:MedicalOfficeBuildingandLifeScienceBuildingMemberdhc:SeaportInnovationLLCMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:SeaportInnovationLLCMember2022-06-300001075415dhc:MedicalOfficeBuildingandLifeScienceBuildingMemberus-gaap:CorporateJointVentureMember2022-01-012022-01-31dhc:investor0001075415dhc:SeniorLivingCommunitiesMemberdhc:SkilledNursingBedLicenseMember2022-01-012022-01-310001075415dhc:MedicalOfficeBuildingandLifeScienceBuildingMemberdhc:DiversifiedHealthcareTrustsMemberus-gaap:CorporateJointVentureMemberdhc:UnrelatedInvestorOneMember2022-01-310001075415dhc:MedicalOfficeBuildingandLifeScienceBuildingMemberdhc:DiversifiedHealthcareTrustsMemberdhc:UnrelatedInvestorTwoMemberus-gaap:CorporateJointVentureMember2022-01-310001075415dhc:MedicalOfficeBuildingandLifeScienceBuildingMemberdhc:DiversifiedHealthcareTrustsMemberus-gaap:CorporateJointVentureMember2022-01-310001075415us-gaap:CorporateJointVentureMember2022-01-310001075415dhc:LifeScienceBuildingLocatedInCaliforniaMemberus-gaap:SubsequentEventMember2022-07-31dhc:trustee0001075415dhc:LifeScienceBuildingLocatedInCaliforniaMemberus-gaap:SubsequentEventMember2022-07-012022-07-310001075415us-gaap:LineOfCreditMember2022-06-300001075415us-gaap:UnsecuredDebtMember2022-06-300001075415us-gaap:MortgagesMember2022-06-300001075415dhc:FinanceLeasedPropertiesMember2022-06-300001075415dhc:FinanceLeasedPropertiesMember2021-12-310001075415us-gaap:LineOfCreditMember2022-01-012022-06-300001075415us-gaap:LineOfCreditMember2022-04-012022-06-300001075415us-gaap:LineOfCreditMember2021-04-012021-06-300001075415us-gaap:LineOfCreditMember2021-01-012021-06-300001075415us-gaap:LineOfCreditMember2022-01-310001075415us-gaap:LineOfCreditMember2022-02-280001075415us-gaap:LineOfCreditMember2022-02-012022-02-280001075415us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:LineOfCreditMember2022-02-012022-02-280001075415srt:ScenarioForecastMemberus-gaap:LineOfCreditMember2023-01-310001075415dhc:MedicalOfficeAndLifeScienceMemberus-gaap:LineOfCreditMember2022-06-300001075415dhc:MedicalOfficeBuildingMemberdhc:Mortgages628PercentDueJuly2022Member2022-04-300001075415dhc:MedicalOfficeBuildingMemberdhc:Mortgages628PercentDueJuly2022Member2022-04-012022-04-300001075415dhc:SeniorUnsecuredNoteDue2025Member2022-06-300001075415dhc:SeniorUnsecuredNoteDue2025Member2022-06-012022-06-300001075415dhc:SeniorUnsecuredNoteDue2025Member2022-01-012022-06-300001075415dhc:SeniorLivingCommunitiesMemberus-gaap:SubsequentEventMemberdhc:Mortgages628PercentDueJuly2022Member2022-07-310001075415dhc:SeniorLivingCommunitiesMemberus-gaap:SubsequentEventMemberdhc:Mortgages628PercentDueJuly2022Member2022-07-012022-07-310001075415dhc:AlerisLifeIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415dhc:AlerisLifeIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415dhc:AlerisLifeIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415dhc:AlerisLifeIncMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415dhc:LifeSciencePropertyMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-06-300001075415dhc:LifeSciencePropertyMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-06-300001075415dhc:LifeSciencePropertyMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001075415dhc:LifeSciencePropertyMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:FairValueMeasurementsRecurringMemberdhc:JointVentureMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel3Member2021-12-310001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMemberus-gaap:MeasurementInputDiscountRateMember2022-06-300001075415dhc:LifeSciencePropertyMemberdhc:MeasurementInputMarketCapitalizationRateMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2022-01-012022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:CorporateJointVentureMember2022-01-012022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberus-gaap:CorporateJointVentureMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMembersrt:MaximumMemberus-gaap:CorporateJointVentureMemberus-gaap:MeasurementInputDiscountRateMember2022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberdhc:MeasurementInputMarketCapitalizationRateMemberus-gaap:CorporateJointVentureMembersrt:MinimumMember2022-06-300001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberdhc:MeasurementInputMarketCapitalizationRateMembersrt:MaximumMemberus-gaap:CorporateJointVentureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2024Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2024Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotes975PercentDue2025Member2022-06-300001075415dhc:SeniorUnsecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotes975PercentDue2025Member2022-06-300001075415dhc:SeniorUnsecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberdhc:SeniorUnsecuredNotes975PercentDue2025Member2021-12-310001075415dhc:SeniorUnsecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberdhc:SeniorUnsecuredNotes975PercentDue2025Member2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes4.75PercentDue2028Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotes4375PercentDue2031Memberdhc:SeniorUnsecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotes4375PercentDue2031Memberdhc:SeniorUnsecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotes4375PercentDue2031Memberdhc:SeniorUnsecuredNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotes4375PercentDue2031Memberdhc:SeniorUnsecuredNotesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes5625PercentDue2042Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415dhc:SeniorUnsecuredNotesMemberdhc:SeniorUnsecuredNotes625PercentDue2046Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415us-gaap:SecuredDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415us-gaap:SecuredDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415us-gaap:SecuredDebtMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415us-gaap:SecuredDebtMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-06-300001075415us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-06-300001075415us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310001075415us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310001075415us-gaap:FairValueInputsLevel1Member2022-06-30dhc:security0001075415us-gaap:FairValueInputsLevel1Member2021-12-310001075415us-gaap:FairValueInputsLevel2Member2021-12-310001075415us-gaap:FairValueInputsLevel2Member2022-06-300001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMemberdhc:ThirdPartyInvestorMember2017-03-310001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2017-03-310001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2021-12-012021-12-310001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2021-12-310001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2022-06-012022-06-300001075415dhc:LifeSciencePropertyMemberus-gaap:CorporateJointVentureMember2022-06-280001075415dhc:TrusteeMemberdhc:ShareAwardPlansMemberdhc:ReitManagementAndResearchMember2022-06-022022-06-020001075415dhc:TrusteeMemberdhc:ShareAwardPlansMemberdhc:ReitManagementAndResearchMember2022-06-020001075415dhc:FormerEmployeesOfRMRLLCMemberus-gaap:CommonStockMember2022-01-012022-06-3000010754152022-02-172022-02-1700010754152022-05-192022-05-190001075415us-gaap:SubsequentEventMember2022-07-142022-07-14dhc:segment0001075415dhc:OfficePortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:RentalIncomeMember2022-04-012022-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:ResidentFeesAndServicesMember2022-04-012022-06-300001075415dhc:OfficePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-04-012022-06-300001075415us-gaap:CorporateNonSegmentMember2022-04-012022-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:RentalIncomeMember2022-01-012022-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:ResidentFeesAndServicesMember2022-01-012022-06-300001075415dhc:OfficePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-06-300001075415us-gaap:CorporateNonSegmentMember2022-01-012022-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001075415dhc:OfficePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2022-06-300001075415us-gaap:CorporateNonSegmentMember2022-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:RentalIncomeMember2021-04-012021-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:ResidentFeesAndServicesMember2021-04-012021-06-300001075415dhc:OfficePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-04-012021-06-300001075415us-gaap:CorporateNonSegmentMember2021-04-012021-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberdhc:RentalIncomeMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:RentalIncomeMember2021-01-012021-06-300001075415dhc:OfficePortfolioSegmentMemberdhc:ResidentFeesAndServicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001075415us-gaap:CorporateNonSegmentMemberdhc:ResidentFeesAndServicesMember2021-01-012021-06-300001075415dhc:OfficePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-06-300001075415us-gaap:CorporateNonSegmentMember2021-01-012021-06-300001075415dhc:OfficePortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310001075415dhc:SeniorHousingOperatingPortfolioSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310001075415us-gaap:CorporateNonSegmentMember2021-12-310001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2021-06-09dhc:communitydhc:unit0001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2021-06-092021-06-090001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMember2021-06-090001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2021-06-090001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMember2021-06-092021-06-090001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2021-12-310001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2021-12-310001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2022-04-012022-06-300001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2021-04-012021-06-300001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2022-01-012022-06-300001075415dhc:SeniorLivingCommunityMemberdhc:FiveStarQualityCareIncMemberus-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember2021-01-012021-06-300001075415dhc:FiveStarQualityCareIncMemberdhc:SeniorLivingCommunityMembersrt:AffiliatedEntityMember2022-01-012022-06-300001075415dhc:FiveStarQualityCareIncMemberdhc:SeniorLivingCommunityMembersrt:AffiliatedEntityMember2021-01-012021-06-300001075415dhc:FiveStarQualityCareIncMember2022-04-012022-06-300001075415dhc:FiveStarQualityCareIncMember2021-04-012021-06-300001075415dhc:FiveStarQualityCareIncMember2022-01-012022-06-300001075415dhc:FiveStarQualityCareIncMember2021-01-012021-06-300001075415dhc:FiveStarQualityCareIncMemberus-gaap:OperatingExpenseMember2022-04-012022-06-300001075415dhc:FiveStarQualityCareIncMemberus-gaap:OperatingExpenseMember2021-04-012021-06-300001075415dhc:FiveStarQualityCareIncMemberus-gaap:OperatingExpenseMember2022-01-012022-06-300001075415dhc:FiveStarQualityCareIncMemberus-gaap:OperatingExpenseMember2021-01-012021-06-300001075415dhc:RehabilitationServicesMemberdhc:FiveStarQualityCareIncMember2022-04-012022-06-300001075415dhc:RehabilitationServicesMemberdhc:FiveStarQualityCareIncMember2021-04-012021-06-300001075415dhc:RehabilitationServicesMemberdhc:FiveStarQualityCareIncMember2022-01-012022-06-300001075415dhc:RehabilitationServicesMemberdhc:FiveStarQualityCareIncMember2021-01-012021-06-300001075415srt:AffiliatedEntityMember2022-04-012022-06-300001075415srt:AffiliatedEntityMember2021-04-012021-06-300001075415srt:AffiliatedEntityMember2022-01-012022-06-300001075415srt:AffiliatedEntityMember2021-01-012021-06-300001075415dhc:FiveStarQualityCareIncMemberdhc:ThirdPartyInvestorMember2022-04-012022-06-300001075415dhc:FiveStarQualityCareIncMemberdhc:ThirdPartyInvestorMember2022-01-012022-06-300001075415dhc:BasicHousingAndSupportServicesMemberdhc:ResidentFeesAndServicesMember2022-04-012022-06-300001075415dhc:BasicHousingAndSupportServicesMemberdhc:ResidentFeesAndServicesMember2021-04-012021-06-300001075415dhc:BasicHousingAndSupportServicesMemberdhc:ResidentFeesAndServicesMember2022-01-012022-06-300001075415dhc:BasicHousingAndSupportServicesMemberdhc:ResidentFeesAndServicesMember2021-01-012021-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:MedicareAndMedicaidProgramsMember2022-04-012022-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:MedicareAndMedicaidProgramsMember2021-04-012021-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:MedicareAndMedicaidProgramsMember2022-01-012022-06-300001075415dhc:ResidentFeesAndServicesMemberdhc:MedicareAndMedicaidProgramsMember2021-01-012021-06-300001075415dhc:PrivatePayAndOtherThirdPartyPayerServicesMemberdhc:ResidentFeesAndServicesMember2022-04-012022-06-300001075415dhc:PrivatePayAndOtherThirdPartyPayerServicesMemberdhc:ResidentFeesAndServicesMember2021-04-012021-06-300001075415dhc:PrivatePayAndOtherThirdPartyPayerServicesMemberdhc:ResidentFeesAndServicesMember2022-01-012022-06-300001075415dhc:PrivatePayAndOtherThirdPartyPayerServicesMemberdhc:ResidentFeesAndServicesMember2021-01-012021-06-30dhc:employee0001075415dhc:SeniorLivingCommunityMemberdhc:ReitManagementAndResearchMember2022-01-012022-06-30dhc:agreement0001075415dhc:ReitManagementAndResearchMember2022-04-012022-06-300001075415dhc:ReitManagementAndResearchMember2021-04-012021-06-300001075415dhc:ReitManagementAndResearchMember2022-01-012022-06-300001075415dhc:ReitManagementAndResearchMember2021-01-012021-06-300001075415dhc:ReitManagementAndResearchMember2022-06-300001075415dhc:AlerisLifeIncMember2022-06-300001075415dhc:AlerisLifeIncMemberdhc:AlerisLifeIncMember2022-06-30dhc:jointVenture_arrangement0001075415dhc:MedicalOfficeAndLifeSciencePropertiesMemberdhc:ReitManagementAndResearchMember2022-06-300001075415dhc:ReitManagementAndResearchMember2022-01-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549 
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
For the quarterly period ended June 30, 2022
OR 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 
Commission File Number 1-15319 
DIVERSIFIED HEALTHCARE TRUST
(Exact Name of Registrant as Specified in Its Charter) 
Maryland 04-3445278
(State or Other Jurisdiction of Incorporation or
Organization)
 (IRS Employer Identification No.)
 Two Newton Place, 255 Washington Street, Suite 300, Newton, MA 02458-1634
(Address of Principal Executive Offices) (Zip Code) 
617 - 796 - 8350
(Registrant's Telephone Number, Including Area Code)

Securities registered pursuant to Section 12(b) of the Act:
Title Of Each ClassTrading Symbol(s)Name Of Each Exchange On Which Registered
Common Shares of Beneficial InterestDHCThe Nasdaq Stock Market LLC
5.625% Senior Notes due 2042DHCNIThe Nasdaq Stock Market LLC
6.25% Senior Notes due 2046DHCNLThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act. 
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   No 
Number of registrant's common shares outstanding as of July 29, 2022: 239,123,496


DIVERSIFIED HEALTHCARE TRUST
FORM 10-Q
 
June 30, 2022
 
INDEX
  Page
 
   
   
 
   
 
   
 
   
 
   
   
   
   
 
   
 
   
   
   
 
 
References in this Quarterly Report on Form 10-Q to the Company, we, us or our include Diversified Healthcare Trust and its consolidated subsidiaries unless otherwise expressly stated or the context indicates otherwise.



PART I.  Financial Information
 
Item 1.  Financial Statements.
 
DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in thousands, except share data)
(unaudited)
 June 30,December 31,
 20222021
Assets  
Real estate properties:  
Land$652,655 $741,501 
Buildings and improvements5,819,802 6,072,055 
Total real estate properties, gross6,472,457 6,813,556 
Accumulated depreciation(1,738,379)(1,737,807)
Total real estate properties, net4,734,078 5,075,749 
Investments in unconsolidated joint ventures158,759 215,127 
Cash and cash equivalents705,160 634,848 
Restricted cash163,242 382,097 
Acquired real estate leases and other intangible assets, net37,359 48,746 
Other assets, net347,266 266,947 
Total assets$6,145,864 $6,623,514 
Liabilities and Shareholders' Equity  
Revolving credit facility$700,000 $800,000 
Senior unsecured notes, net2,315,286 2,806,811 
Secured debt and finance leases, net57,006 69,713 
Accrued interest27,639 29,845 
Assumed real estate lease obligations, net1,293 2,556 
Other liabilities255,015 252,199 
Total liabilities3,356,239 3,961,124 
Commitments and contingencies
Shareholders' equity:  
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 239,123,496 and 238,994,894 shares issued and outstanding, respectively
2,391 2,390 
Additional paid in capital4,616,449 4,615,475 
Cumulative net income2,218,664 2,087,624 
Cumulative distributions(4,047,879)(4,043,099)
Total shareholders' equity2,789,625 2,662,390 
Total liabilities and shareholders' equity$6,145,864 $6,623,514 
 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
1

DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(amounts in thousands, except per share data)
(unaudited)
 Three Months Ended June 30,Six Months Ended June 30,
 2022202120222021
Revenues:    
Rental income$62,522 $102,394 $127,807 $205,152 
Residents fees and services250,506 243,947 495,954 503,913 
Total revenues313,028 346,341 623,761 709,065 
Expenses:    
Property operating expenses266,066 264,632 534,808 552,023 
Depreciation and amortization58,261 67,888 115,520 134,041 
General and administrative7,207 9,126 14,492 16,668 
Acquisition and certain other transaction related costs609 12,071 1,537 12,071 
Impairment of assets   (174)
Total expenses332,143 353,717 666,357 714,629 
(Loss) gain on sale of properties(686)30,760 327,108 30,638 
Losses on equity securities, net(10,157)(3,849)(18,710)(12,188)
Interest and other income2,266 16,038 2,661 18,873 
Interest expense (including net amortization of debt premiums, discounts and issuance costs of $2,318, $3,017, $4,790 and $5,829, respectively)
(55,975)(67,657)(113,106)(127,748)
Loss on modification or early extinguishment of debt(29,560)(370)(30,043)(2,410)
(Loss) income from continuing operations before income tax benefit (expense) and equity in earnings of investees(113,227)(32,454)125,314 (98,399)
Income tax benefit (expense)640 (191)(832)(429)
Equity in earnings of investees3,204  6,558  
Net (loss) income(109,383)(32,645)131,040 (98,828)
Net income attributable to noncontrolling interest (1,577) (2,899)
Net (loss) income attributable to common shareholders$(109,383)$(34,222)$131,040 $(101,727)
Weighted average common shares outstanding (basic and diluted)238,197 237,871 238,173 237,853 
Per common share amounts (basic and diluted):    
Net (loss) income attributable to common shareholders$(0.46)$(0.14)$0.55 $(0.43)
 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2

DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
(dollars in thousands)
(unaudited)
Number of
Shares
Common
Shares
Additional
Paid In
Capital
Cumulative
Net Income
Cumulative DistributionsTotal Equity Attributable to Common ShareholdersTotal Equity Attributable to Noncontrolling
Interest
Total Equity
Balance at December 31, 2021:238,994,894 $2,390 $4,615,475 $2,087,624 $(4,043,099)$2,662,390 $ $2,662,390 
Net income— — — 240,423 — 240,423 — 240,423 
Distributions— — — — (2,390)(2,390)— (2,390)
Share grants— — 318 — — 318 — 318 
Share repurchases(1,698)— (5)— — (5)— (5)
Share forfeitures(4,900)— (3)— — (3)— (3)
Balance at March 31, 2022:238,988,296 2,390 4,615,785 2,328,047 (4,045,489)2,900,733  2,900,733 
Net loss— — — (109,383)— (109,383)— (109,383)
Distributions— — — — (2,390)(2,390)— (2,390)
Share grants140,000 1 668 — — 669 — 669 
Share forfeitures(4,800)— (4)— — (4)— (4)
Balance at June 30, 2022:239,123,496 $2,391 $4,616,449 $2,218,664 $(4,047,879)$2,789,625 $ $2,789,625 
Balance at December 31, 2020:238,268,478 $2,383 $4,613,904 $1,913,109 $(4,033,559)$2,495,837 $123,385 $2,619,222 
Net (loss) income— — — (67,505)— (67,505)1,322 (66,183)
Distributions— — — — (2,383)(2,383)— (2,383)
Share grants— — 228 — — 228 — 228 
Distributions to noncontrolling interest— — — — — — (5,694)(5,694)
Balance at March 31, 2021:238,268,478 2,383 4,614,132 1,845,604 (4,035,942)2,426,177 119,013 2,545,190 
Net (loss) income— — — (34,222)— (34,222)1,577 (32,645)
Distributions— — — — (2,383)(2,383)— (2,383)
Share grants120,000 1 675 — — 676 — 676 
Share repurchases(13,906)— (59)— — (59)— (59)
Distributions to noncontrolling interest— — — — — — (5,630)(5,630)
Balance at June 30, 2021:238,374,572 $2,384 $4,614,748 $1,811,382 $(4,038,325)$2,390,189 $114,960 $2,505,149 
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3

DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(dollars in thousands)
(unaudited)
 Six Months Ended June 30,
 20222021
Cash flows from operating activities:  
Net income (loss)$131,040 $(98,828)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:  
Depreciation and amortization115,520 134,041 
Net amortization of debt premiums, discounts and issuance costs4,790 5,829 
Straight line rental income(4,455)(2,125)
Amortization of acquired real estate leases162 (3,715)
Loss on modification or early extinguishment of debt30,043 2,410 
Impairment of assets (174)
Gain on sale of properties(327,108)(30,638)
Losses on equity securities, net18,710 12,188 
Other non-cash adjustments, net(905)(982)
Unconsolidated joint venture distributions5,660  
Equity in earnings of investees(6,558) 
Change in assets and liabilities:  
Deferred leasing costs, net(4,968)(8,258)
Other assets25,922 (7,937)
Accrued interest(2,206)8,918 
Other liabilities(17,503)16,317 
Net cash (used in) provided by operating activities(31,856)27,046 
Cash flows from investing activities:  
Real estate improvements(116,640)(83,468)
Proceeds from sale of properties, net792 103,057 
Proceeds from sale of properties to joint venture, net643,892  
Proceeds from sale of interest in joint venture, net(330) 
Net cash provided by investing activities527,714 19,589 
Cash flows from financing activities:  
Proceeds from issuance of senior unsecured notes, net 492,500 
Proceeds from borrowings on revolving credit facility 800,000 
Repayments of borrowings on revolving credit facility(100,000) 
Redemption of senior unsecured notes(500,000)(300,000)
Repayment of term loan (200,000)
Repayment of other debt(12,421)(1,558)
Loss on early extinguishment of debt settled in cash(24,375) 
Payment of debt issuance costs(2,820)(4,188)
Repurchase of common shares(5)(59)
Distributions to noncontrolling interest (11,324)
Distributions to shareholders(4,780)(4,766)
Net cash (used in) provided by financing activities(644,401)770,605 
(Decrease) increase in cash and cash equivalents and restricted cash(148,543)817,240 
Cash and cash equivalents and restricted cash at beginning of period1,016,945 90,849 
Cash and cash equivalents and restricted cash at end of period$868,402 $908,089 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4

DIVERSIFIED HEALTHCARE TRUST
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
(dollars in thousands)
(unaudited)
Six Months Ended June 30,
20222021
Supplemental cash flow information:  
Interest paid$110,522 $113,933 
Income taxes paid$895 $1,880 
Non-cash investing activities:
Decrease in assets resulting from the deconsolidation of investments that were previously consolidated:
   Real estate, net$(355,669)$ 
Change in assets resulting from the sale of interest in joint venture:
   Investments in unconsolidated joint ventures$(108,246)$ 
   Other assets, net$108,956 $ 
Real estate improvements accrued, not paid$24,325 $20,860 
Capitalized interest$ $932 
Supplemental disclosure of cash and cash equivalents and restricted cash:
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within our condensed consolidated balance sheets to the amount shown in our condensed consolidated statements of cash flows:
As of June 30,
20222021
Cash and cash equivalents$705,160 $849,079 
Restricted cash (1)
163,242 59,010 
Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows$868,402 $908,089 
(1) As of June 30, 2022, restricted cash consists of proceeds from the sale of joint venture interests and proceeds from the sale of properties to joint ventures held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties. Prior to the deconsolidation of the joint venture that owns a life science property located in Boston, Massachusetts, or our Boston life science property joint venture, restricted cash also consisted of cash held for the operations of this joint venture. As of June 30, 2021, restricted cash also included amounts from dispositions held as collateral pursuant to our credit agreement. In June 2022, we sold an additional 10% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022, which will be included in restricted cash in our condensed consolidated balance sheet.

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


5

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 
Note 1.  Basis of Presentation
The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or we, us, or our, are unaudited. Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for complete financial statements have been condensed or omitted. We believe the disclosures made are adequate to make the information presented not misleading. However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2021, or our Annual Report.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.
We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings arising in the ordinary course of our business, some of which may involve material amounts. Also, the defense and resolution of these claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings may require us to incur significant expense. We account for claims and litigation losses in accordance with the Financial Accounting Standards Board Accounting Standards Codification Topic 450, Contingencies, or ASC 450. Under ASC 450, loss contingency provisions are recorded for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the estimated minimum loss amount, which could be zero, is recorded; and then, as information becomes known, the minimum loss amount is updated, as appropriate. A minimum or best estimate amount may be increased or decreased when events result in a changed expectation.

Note 2.  Real Estate Investments
As of June 30, 2022, we wholly owned 378 properties located in 36 states and Washington, D.C. and we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet.
Joint Venture Activities:
As of June 30, 2022, we had equity investments in joint ventures as follows:
Joint VentureDHC Ownership
DHC Carrying Value of Investment at June 30, 2022
Number of PropertiesLocationSquare Feet
Seaport Innovation LLC10%$108,286 1MA1,134,479 
The LSMD Fund REIT LLC20%50,473 10CA, MA, NY, TX, WA1,068,763 
$158,759 112,203,242 
6

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
The following table provides a summary of the mortgage debts of these joint ventures:
Joint VentureCoupon RateMaturity Date
Principal Balance at June 30, 2022 (1)
Mortgage Notes Payable (secured by one property in Massachusetts) (2)
3.53%8/6/2026$620,000 
Mortgage Notes Payable (secured by nine properties in five states)3.46%2/11/2032189,800 
Mortgage Notes Payable (secured by one property in California) (3)
3.18%2/9/2024266,825 
3.43%$1,076,625 
(1)Amounts are not adjusted for our minority equity interest.
(2)Following the deconsolidation in December 2021 of the net assets of our Boston life science property joint venture, we no longer include this $620,000 of secured debt financing in our condensed consolidated balance sheet; however, we continue to provide certain guaranties on this debt.
(3)The maturity date of February 9, 2024 is subject to three, one year extension options and requires interest to be paid at an annual rate based on the secured overnight financing rate, or SOFR, plus a premium of 1.90%. The interest rate is as of June 30, 2022. This joint venture has also purchased an interest rate cap through February 2024 with a SOFR strike rate equal to 4.00%.

In December 2021, we sold an additional 35% equity interest from our then remaining 55% equity interest in our Boston life science property joint venture to another third party institutional investor for $378,000, before closing costs and other adjustments. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. Prior to the deconsolidation of the net assets of this joint venture, the joint venture investor's interest in this consolidated entity was reflected as noncontrolling interest in our consolidated financial statements. In June 2022, we sold an additional 10% equity interest from our then remaining 20% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022. We recognized a net loss on sale of $1,226 related to this transaction, which is included in (loss) gain on sale of properties in our condensed consolidated statements of comprehensive income (loss). After giving effect to these sales, we continue to own a 10% equity interest in this joint venture. Our investment amount was based on a property valuation of $1,700,000, less $620,000 of existing mortgage debts on the property that this joint venture assumed. See Note 5 for more information regarding the valuation of our investment in this joint venture.
In January 2022, we entered into a joint venture with two unrelated third party institutional investors for 10 medical office and life science properties we owned, or our 10 medical office and life science properties joint venture. We sold equity interests in this joint venture to those investors for aggregate proceeds, before closing costs and other adjustments, of approximately $653,300. We deconsolidated the net assets of these properties effective as of the date of the sale and recognized a net gain on sale of $327,542 related to this transaction, which is included in (loss) gain on sale of properties in our condensed consolidated statements of comprehensive income (loss). The equity interests that the investors acquired from us equaled 41% and 39%, respectively, of the total equity interests in the joint venture and we retained a 20% equity interest in the joint venture. Following the sale, we account for this joint venture using the equity method of accounting under the fair value option. The investment amounts are based upon a property valuation of approximately $702,500, less approximately $456,600 of secured debt on the properties incurred by this joint venture. See Note 5 for more information regarding the valuation of our investment in this joint venture.
Acquisitions and Dispositions:
In July 2022, we acquired one life science property located in California with approximately 89,000 square feet for a purchase price of approximately $82,000, excluding closing costs. We did not acquire or dispose of any properties during the six months ended June 30, 2022.
Impairment:
We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value. No
7

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
material impairment charges were recorded on held and used properties during the three or six months ended June 30, 2022 or 2021.

Note 3.  Leases
We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.
Certain of our leases provide for base rent payments and in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term.
We increased rental income to record revenue on a straight line basis by $2,710 and $1,321 for the three months ended June 30, 2022 and 2021, respectively, and $4,455 and $2,125 for the six months ended June 30, 2022 and 2021, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $71,902 and $82,131 of straight line rent receivables at June 30, 2022 and December 31, 2021, respectively, and are included in other assets, net in our condensed consolidated balance sheets.
We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $10,430 and $18,476 for the three months ended June 30, 2022 and 2021, respectively, of which tenant reimbursements totaled $10,350 and $18,440, respectively, and $21,138 and $36,704 for the six months ended June 30, 2022 and 2021, respectively, of which tenant reimbursements totaled $21,013 and $36,620, respectively.
Right of Use Asset and Lease Liability. For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use assets and related liabilities representing our future obligation under the respective lease arrangements for which we are the lessee were $28,003 and $28,382, respectively, as of June 30, 2022, and $4,153 and $4,352, respectively, as of December 31, 2021. The right of use assets and related lease liabilities are included within other assets, net and other liabilities, respectively, within our condensed consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our condensed consolidated balance sheets.

Note 4.  Indebtedness
Our principal debt obligations, excluding any debt obligations of our joint ventures, at June 30, 2022 were: (1) outstanding borrowings under our $700,000 revolving credit facility; (2) $2,350,000 outstanding principal amount of senior unsecured notes; and (3) $50,715 aggregate principal amount of mortgage notes secured by five properties. These five mortgaged properties had a gross book value of $87,870 at June 30, 2022. We also had two properties subject to finance leases with lease obligations totaling $5,999 at June 30, 2022; these two properties had gross book value and accumulated depreciation of $37,630 and $18,632, respectively, at June 30, 2022, and $36,730 and $18,203, respectively, at December 31, 2021, and the finance leases expire in 2026.
We have a $700,000 revolving credit facility that is used for general business purposes. The maturity date of our revolving credit facility is January 2024. Our revolving credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. As of June 30, 2022, our revolving credit facility required interest to be paid on borrowings at the annual rate of 4.2%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility.
8

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
The weighted average annual interest rates for borrowings under our revolving credit facility were 3.3% and 2.9% for the three months ended June 30, 2022 and 2021, respectively, and 3.1% and 2.9% for the six months ended June 30, 2022 and 2021, respectively. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. As of June 30, 2022 and July 29, 2022, we were fully drawn under our revolving credit facility.
In February 2022, we and our lenders amended our credit agreement. Pursuant to the amendment:
the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022, or the Amendment Period;
the revolving credit facility commitments have been reduced from $800,000 to $700,000 following our repayment of $100,000, and as a result of the reduction in commitments, we recorded a loss on modification or early extinguishment of debt of $483 for the six months ended June 30, 2022;
we have the ability to fund $400,000 of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;
the interest rate premium under our revolving credit facility increased by 15 basis points; and
certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period.
Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586,373 in January 2023 and as such, further repayment of our revolving credit facility will be required by that time.
Pursuant to our credit agreement, we pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement and agreed to provide, and as of September 2021 had provided, first mortgage liens on 61 medical office and life science properties with an aggregate gross book value of real estate assets of $996,709 as of June 30, 2022 to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things.
In April 2022, we prepaid a mortgage note secured by one of our medical office properties with an outstanding principal balance of approximately $10,934, a maturity date in July 2022 and an annual interest rate of 6.28%, using cash on hand.
In June 2022, we redeemed $500,000 of our outstanding 9.75% senior notes due 2025 for a redemption price equal to 104.875% of the $500,000 principal amount of the notes being redeemed plus accrued and unpaid interest of $1,083, using restricted cash on hand. As a result of this redemption, we recorded a loss on early extinguishment of debt of $29,576 for the six months ended June 30, 2022.
In July 2022, we prepaid a mortgage note secured by two of our senior living communities with an outstanding principal balance of approximately $15,273, a maturity date in October 2022 and an annual interest rate of 5.75%, using cash on hand.
Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a change of control of us, as defined, which includes The RMR Group LLC, or RMR, ceasing to act as our business and property manager. Our credit agreement and our senior unsecured notes indentures and their supplements also contain covenants, including covenants that restrict our ability to incur debts, and generally require us to maintain certain financial ratios, and our credit agreement restricts our ability to make distributions under certain circumstances. As of June 30, 2022, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are unable to incur additional debt until this ratio is at or above 1.5x on a pro forma basis. We believe we were in compliance with the remaining terms and conditions of the respective covenants under our credit agreement and our senior unsecured notes indentures and their supplements at June 30, 2022, subject to the waivers noted above. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the
9

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
economy or the industries in which our properties and businesses operate may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants.

Note 5.  Fair Value of Assets and Liabilities
The following table presents certain of our assets that are measured at fair value at June 30, 2022 and December 31, 2021, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.
As of June 30, 2022As of December 31, 2021
DescriptionCarrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
Recurring Fair Value Measurements Assets:    
Investment in AlerisLife (Level 1) (1)
$12,830 $12,830 $31,540 $31,540 
Investment in unconsolidated joint venture (Level 3) (2)
$108,286 $108,286 $215,127 $215,127 
Investment in unconsolidated joint venture (Level 3) (3)
$50,473 $50,473 $ $ 
(1)Our 10,691,658 shares of common stock of AlerisLife Inc., or AlerisLife, are included in other assets, net in our condensed consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs). During the three months ended June 30, 2022 and 2021, we recorded unrealized losses of $10,157 and $3,849, respectively, and during the six months ended June 30, 2022 and 2021, we recorded unrealized losses of $18,710 and $12,188, respectively, which are included in losses on equity securities, net in our condensed consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Note 11 for further information about our investment in AlerisLife.
(2)The 10% equity interest we own in our Boston life science property joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 5.58%, an exit capitalization rate of 5.25%, a holding period of approximately 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.
(3)The 20% equity interest we own in our 10 medical office and life science properties joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 5.67% and 8.93%, exit capitalization rates of between 4.75% and 6.00%, holding periods of approximately 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.
In addition to the assets described in the table above, our financial instruments at June 30, 2022 and December 31, 2021 included cash and cash equivalents, restricted cash, other assets, our revolving credit facility, senior unsecured notes, secured debt and finance leases and other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:
10

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 As of June 30, 2022As of December 31, 2021
Description
Carrying Amount (1)
Estimated Fair Value
Carrying Amount (1)
Estimated Fair Value
Senior unsecured notes, 4.750% coupon rate, due 2024
$249,488 $224,353 $249,348 $257,695 
Senior unsecured notes, 9.750% coupon rate, due 2025
494,838 493,125 987,903 1,081,990 
Senior unsecured notes, 4.750% coupon rate, due 2028
492,836 368,125 492,199 491,480 
Senior unsecured notes, 4.375% coupon rate, due 2031
492,557 340,000 492,127 480,763 
Senior unsecured notes, 5.625% coupon rate, due 2042
342,374 227,850 342,183 309,260 
Senior unsecured notes, 6.250% coupon rate, due 2046
243,193 170,700 243,051 226,500 
Secured debts (2)
57,006 56,161 69,713 71,963 
 $2,372,292 $1,880,314 $2,876,524 $2,919,651 
(1)Includes unamortized net debt issuance costs, premiums and discounts.
(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.
We estimated the fair value of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on Nasdaq (Level 1 input) as of June 30, 2022 and December 31, 2021, respectively. We estimated the fair values of our four issuances of senior unsecured notes due 2024, 2025, 2028 and 2031 using an average of the bid and ask price on Nasdaq on or about June 30, 2022 and December 31, 2021 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.

Note 6. Noncontrolling Interest
In March 2017, we entered into our Boston life science property joint venture. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a variable interest entity, or VIE, and that we controlled the activities that most significantly impacted the economic performance of this entity; we therefore consolidated the results of this joint venture in our financial statements. In December 2021, we sold an additional 35% equity interest in our Boston life science property joint venture to another third party institutional investor. After giving effect to the sale, we owned a 20% equity interest in this joint venture, but determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated these properties and accounted for this joint venture using the equity method of accounting under the fair value option. In June 2022, we sold an additional 10% equity interest from our then remaining 20% equity interest in this joint venture to an existing joint venture investor and continue to account for this joint venture using the equity method of accounting under the fair value option. The portion of the joint venture's net income and comprehensive income not attributable to us, or $1,577 and $2,899 for the three and six months ended June 30, 2021, respectively, is reported as a noncontrolling interest in our condensed consolidated statements of comprehensive income (loss). This joint venture made aggregate cash distributions to the other joint venture investor of $5,630 and $11,324 for the three and six months ended June 30, 2021, respectively, which are reflected as a decrease in total equity attributable to noncontrolling interest in our condensed consolidated statement of shareholders' equity.

Note 7.  Shareholders' Equity
Common Share Awards:
On June 2, 2022, in accordance with our Trustee compensation arrangements, we awarded to each of our seven Trustees 20,000 of our common shares, valued at $2.14 per share, the closing price of our common shares on Nasdaq on that day.
11

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
Common Share Repurchases:
During the six months ended June 30, 2022, we purchased 1,698 of our common shares, valued at $3.20 per common share, from a former employee of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of prior awards of our common shares.
Distributions:
During the six months ended June 30, 2022, we declared and paid quarterly distributions to common shareholders as follows:
Declaration DateRecord DatePayment DateDistribution Per ShareTotal Distributions
January 13, 2022January 24, 2022February 17, 2022$0.01 $2,390 
April 14, 2022April 25, 2022May 19, 20220.01 2,390 
$0.02 $4,780 
On July 14, 2022, we declared a quarterly distribution to common shareholders of record on July 25, 2022 of $0.01 per share, or approximately $2,391. We expect to pay this distribution on or about August 18, 2022.

Note 8.  Segment Reporting
We operate in, and report financial information for, the following two segments: Office Portfolio and senior housing operating portfolio, or SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities.
We also report “non-segment” operations, consisting of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
12

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 For the Three Months Ended June 30, 2022
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$52,610 $ $9,912 $62,522 
Residents fees and services 250,506  250,506 
Total revenues52,610 250,506 9,912 313,028 
Expenses:    
Property operating expenses22,026 244,040  266,066 
Depreciation and amortization17,997 37,369 2,895 58,261 
General and administrative  7,207 7,207 
Acquisition and certain other transaction related costs
  609 609 
Total expenses40,023 281,409 10,711 332,143 
(Loss) gain on sale of properties(1,226)540  (686)
Losses on equity securities, net  (10,157)(10,157)
Interest and other income 760 1,506 2,266 
Interest expense(216)(491)(55,268)(55,975)
Gain (loss) on modification or early extinguishment of debt16  (29,576)(29,560)
Income (loss) from continuing operations before income tax benefit and equity in earnings of investees11,161 (30,094)(94,294)(113,227)
Income tax benefit  640 640 
Equity in earnings of investees3,204   3,204 
Net income (loss)$14,365 $(30,094)$(93,654)$(109,383)
13

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 For the Six Months Ended June 30, 2022
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$107,607 $ $20,200 $127,807 
Residents fees and services 495,954  495,954 
Total revenues107,607 495,954 20,200 623,761 
Expenses:    
Property operating expenses45,473 489,335  534,808 
Depreciation and amortization36,387 73,352 5,781 115,520 
General and administrative  14,492 14,492 
Acquisition and certain other transaction related costs
  1,537 1,537 
Total expenses81,860 562,687 21,810 666,357 
Gain on sale of properties326,316 792  327,108 
Losses on equity securities, net  (18,710)(18,710)
Interest and other income 959 1,702 2,661 
Interest expense(581)(985)(111,540)(113,106)
Gain (loss) on modification or early extinguishment of debt16  (30,059)(30,043)
Income (loss) from continuing operations before income tax expense and equity in earnings of investees351,498 (65,967)(160,217)125,314 
Income tax expense  (832)(832)
Equity in earnings of investees6,558   6,558 
Net income (loss)$358,056 $(65,967)$(161,049)$131,040 
Under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the U.S. Department of Health and Human Services, or HHS, established a Provider Relief Fund. Retention and use of the funds received under the CARES Act are subject to certain terms and conditions. The terms and conditions require that the funds be utilized to compensate for lost revenues that are attributable to the COVID-19 pandemic and for eligible costs to prevent, prepare for and respond to the COVID-19 pandemic that are not covered by other sources. Further, fund recipients are required to be participating in Medicare at the time of distribution and are subject to certain other terms and conditions, including quarterly reporting requirements. In addition, fund recipients are required to have billed Medicare during 2019 and to continue to provide care after January 31, 2020 for diagnosis, testing or care for individuals with possible or actual COVID-19 cases. Any funds not used in accordance with the terms and conditions must be returned to HHS. We recognize income from government grants on a systematic and rational basis over the period in which we recognize the related expenses or loss of revenues for which the grants are intended to compensate when there is reasonable assurance that we will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. We have recognized $959 and $18,181 as other income in our condensed consolidated statements of comprehensive income (loss) with respect to our SHOP segment for the six months ended June 30, 2022 and 2021, respectively.
 As of June 30, 2022
 Office PortfolioSHOP Non-SegmentConsolidated
Total assets$1,892,417 $3,001,413 $1,252,034 $6,145,864 

14

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 For the Three Months Ended June 30, 2021
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$92,804 $ $9,590 $102,394 
Residents fees and services 243,947  243,947 
Total revenues92,804 243,947 9,590 346,341 
Expenses:    
Property operating expenses31,321 233,311  264,632 
Depreciation and amortization32,497 32,538 2,853 67,888 
General and administrative  9,126 9,126 
Acquisition and certain other transaction related costs
  12,071 12,071 
Total expenses63,818 265,849 24,050 353,717 
Gain on sale of properties30,760   30,760 
Losses on equity securities, net  (3,849)(3,849)
Interest and other income 15,748 290 16,038 
Interest expense(5,992)(525)(61,140)(67,657)
Loss on modification or early extinguishment of debt  (370)(370)
Income (loss) from continuing operations before income tax expense53,754 (6,679)(79,529)(32,454)
Income tax expense  (191)(191)
Net income (loss)53,754 (6,679)(79,720)(32,645)
Net income attributable to noncontrolling interest
(1,577)  (1,577)
Net income (loss) attributable to common shareholders
$52,177 $(6,679)$(79,720)$(34,222)
15

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
 For the Six Months Ended June 30, 2021
 Office PortfolioSHOP Non-SegmentConsolidated
Revenues:    
Rental income$186,127 $ $19,025 $205,152 
Residents fees and services 503,913  503,913 
Total revenues186,127 503,913 19,025 709,065 
Expenses:    
Property operating expenses62,614 489,409  552,023 
Depreciation and amortization64,435 63,899 5,707 134,041 
General and administrative  16,668 16,668 
Acquisition and certain other transaction related costs
  12,071 12,071 
Impairment of assets (174) (174)
Total expenses127,049 553,134 34,446 714,629 
Gain on sale of properties30,638   30,638 
Losses on equity securities, net  (12,188)(12,188)
Interest and other income 18,181 692 18,873 
Interest expense(11,931)(1,053)(114,764)(127,748)
Loss on modification or early extinguishment of debt  (2,410)(2,410)
Income (loss) from continuing operations before income tax expense77,785 (32,093)(144,091)(98,399)
Income tax expense  (429)(429)
Net income (loss)77,785 (32,093)(144,520)(98,828)
Net income attributable to noncontrolling interest
(2,899)  (2,899)
Net income (loss) attributable to common shareholders
$74,886 $(32,093)$(144,520)$(101,727)
 As of December 31, 2021
Office PortfolioSHOP Non-SegmentConsolidated
Total assets$2,282,652 $2,995,819 $1,345,043 $6,623,514 


Note 9. Senior Living Community Management Agreements
Our managed senior living communities are operated by third parties pursuant to management agreements. Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, manages certain of our SHOP communities.
2021 Amendments to our Management Arrangements with Five Star. On June 9, 2021, we amended our management arrangements with Five Star. The principal changes to the management arrangements included:
that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;
that we no longer have the right to sell up to an additional $682,000 of senior living communities currently managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star upon sale;
that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, were closed and are being evaluated and repositioned;
16

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target earnings before interest, taxes, depreciation and amortization for the applicable period;
that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;
that RMR will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and
that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.
Pursuant to these changes, we and Five Star entered into an amended and restated master management agreement, or the Master Management Agreement, for the senior living communities that Five Star is continuing to manage and interim management agreements for the senior living communities that we and Five Star agreed to transition to new third party managers. These agreements replaced our prior master leases and management and pooling agreements with Five Star. In addition, AlerisLife delivered to us a related amended and restated guaranty agreement pursuant to which AlerisLife is continuing to guarantee the payment and performance of its subsidiaries' obligations under the applicable management agreements.
As of December 31, 2021, we had transitioned 107 of the 108 senior living communities, containing 7,340 living units, from Five Star to new third party managers. The remaining senior living community was closed in February 2022 and we are assessing opportunities to redevelop that property. We continue to lease our senior living communities that have been transitioned to new managers to our taxable REIT subsidiaries, or TRSs. We incurred costs related to retention and other transition costs for these communities. We recorded $517 and $11,914 for the three months ended June 30, 2022 and 2021, respectively, and $1,445 and $11,914 for the six months ended June 30, 2022 and 2021, respectively, of these costs to acquisition and certain other transaction related costs in our condensed consolidated statements of comprehensive income (loss).
Our Senior Living Communities Managed by Five Star. Five Star managed 120 and 235 of our senior living communities as of June 30, 2022 and 2021, respectively. We lease our senior living communities that are managed by Five Star to our TRSs.
We incurred management fees payable to Five Star of $8,971 and $12,927 for the three months ended June 30, 2022 and 2021, respectively, and $17,903 and $26,777 for the six months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, $8,274 and $12,212, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $697 and $715, respectively, were capitalized in our condensed consolidated balance sheets. For the six months ended June 30, 2022 and 2021, $16,416 and $25,228, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,487 and $1,549, respectively, were capitalized in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We incurred fees of $1,736 and $2,630 for the three months ended June 30, 2022 and 2021, respectively, and $3,652 and $8,071 for the six months ended June 30, 2022 and 2021, respectively, with respect to rehabilitation services Five Star provided at our senior living communities that are payable by us. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).
We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services. We recorded $379 and $398 for the three months ended June 30, 2022 and 2021, respectively, and $767 and $795 for the six months ended June 30, 2022 and 2021, respectively, with respect to these leases.
Our Senior Living Communities Managed by Other Third Party Managers. We incurred management fees payable to our other third party managers of $5,218 and $10,326 for the three and six months ended June 30, 2022, respectively. These amounts are included in property operating expenses in our condensed consolidated financial statements.
17

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:
Three Months Ended June 30,Six Months Ended June 30,
Revenue from contracts with customers:2022202120222021
Basic housing and support services$196,999 $188,169 $389,873 $376,198 
Medicare and Medicaid programs18,966 24,907 38,783 60,855 
Private pay and other third party payer SNF services 34,541 30,871 67,298 66,860 
Total residents fees and services$250,506 $243,947 $495,954 $503,913 

Note 10. Business and Property Management Agreements with RMR
We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally; and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. See Note 11 for further information regarding our relationship, agreements and transactions with RMR.
We recognized net business management fees of $4,506 and $6,324 for the three months ended June 30, 2022 and 2021, respectively, and $9,319 and $11,641 for the six months ended June 30, 2022 and 2021, respectively. Based on our common share total return, as defined in our business management agreement, as of each of June 30, 2022 and 2021, no estimated incentive fees are included in the net business management fees we recognized for the three or six months ended June 30, 2022 or 2021. The actual amount of annual incentive fees for 2022, if any, will be based on our common share total return as defined in our business management agreement, for the three-year period ending December 31, 2022, and will be payable in January 2023. We did not incur any incentive fee payable for the year ended December 31, 2021. We recognize business management and incentive fees in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss). RMR provides management services to our joint ventures. See Note 11 for further information regarding our joint ventures' management arrangements with RMR and the related impact on our management fees payable to RMR.
We and RMR amended our business management agreement effective August 1, 2021 to provide that (i) for periods beginning on and after August 1, 2021, the MSCI U.S. REIT/Health Care REIT Index will be used to calculate benchmark returns per share for purposes of determining any incentive management fee payable by us to RMR, and (ii) for periods prior to August 1, 2021, the SNL U.S. REIT Healthcare Index will continue to be used. This change of index was due to S&P Global ceasing to publish the SNL U.S. REIT Healthcare Index.
We recognized aggregate net property management and construction supervision fees of $2,518 and $3,191 for the three months ended June 30, 2022 and 2021, respectively, and $4,909 and $6,345 for the six months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, $1,272 and $2,465, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,246 and $726, respectively, were capitalized as building improvements in our condensed consolidated balance sheets. For the six months ended June 30, 2022 and 2021, $2,621 and $4,950, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $2,288 and $1,395, respectively, were capitalized as building improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR's centralized accounting personnel, our share of RMR's costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $3,111 and $3,202 for these expenses and costs for the three months ended June 30,
18

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
2022 and 2021, respectively, and $6,075 and $6,499 for the six months ended June 30, 2022 and 2021, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss) for these periods.
On June 9, 2021, we and RMR amended our property management agreement to, among other things, provide for RMR's oversight of any major capital projects and repositionings at our senior living communities, including our senior living communities which Five Star is continuing to manage, and that RMR receives the same fee previously paid to Five Star for such services, which is equal to 3% of the cost of any such major capital project or repositioning.

Note 11. Related Person Transactions
We have relationships and historical and continuing transactions with RMR, The RMR Group Inc., or RMR Inc., AlerisLife (including Five Star) and others related to them, including other companies to which RMR or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the managing member of RMR. The Chair of our Board and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., the chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and the chair of the board of directors and a managing director of AlerisLife. Jennifer F. Francis, our other Managing Trustee and our President and Chief Executive Officer, and our Chief Financial Officer and Treasurer are also employees and officers of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust and a managing director and the secretary of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR. Some of our Independent Trustees also serve as independent trustees or independent directors of other public companies to which RMR or its subsidiaries provide management services. Adam Portnoy serves as the chair of the board and as a managing director or managing trustee of these companies. Other officers of RMR, including Ms. Clark and certain of our officers, serve as managing trustees, managing directors or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR or its subsidiaries provide management services.
AlerisLife. We are currently AlerisLife's largest stockholder. As of June 30, 2022, we owned approximately 32.8% of AlerisLife's outstanding common shares. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own pursuant to the Master Management Agreement. RMR provides management services to both us and AlerisLife. See Note 9 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star) and Note 5 for further information regarding our investment in AlerisLife.
As of June 30, 2022, ABP Acquisition LLC, a subsidiary of ABP Trust, the controlling shareholder of RMR Inc., together with ABP Trust, owned approximately 6.2% of AlerisLife's outstanding common shares.
Our Joint Ventures. We have two separate joint venture arrangements with two third party institutional investors, our Boston life science property joint venture and our 10 medical office and life science properties joint venture. We own a 10% equity interest in our Boston life science property joint venture and a 20% equity interest in our 10 medical office and life science properties joint venture; from January 2022 until June 28, 2022, we owned a 20% equity interest in our Boston life science property joint venture. We initially entered into our Boston life science property joint venture prior to January 1, 2021, and we entered into our 10 medical office and life science properties joint venture in January 2022. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures. Prior to December 23, 2021, our Boston life science property joint venture was our consolidated subsidiary and, as such, we were previously obligated to pay management fees to RMR under our management agreements with RMR for the services it provided regarding that joint venture; however, that joint venture paid management fees directly to RMR, and any such fees paid by that joint venture were credited against the fees payable by us to RMR. In addition, we wholly owned the 10 medical office and life science properties until the contribution of these properties to the applicable joint venture in January 2022 and we paid management fees to RMR for the management services it provided to us for those properties up until that time. As of June 30, 2022, in connection with the closing of our 10 medical office and life science properties joint venture in January 2022, we paid mortgage escrow amounts and closing costs of $11,113 that were payable by that joint venture. Those costs are presented as other assets, net, in our condensed consolidated balance sheet.
19

DIVERSIFIED HEALTHCARE TRUST
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
(dollar amounts in thousands, except per share data or as otherwise stated)
Our Manager, RMR. We have two agreements with RMR to provide management services to us. See Note 10 for further information regarding our management agreements with RMR.
For further information about these and other such relationships and certain other related person transactions, see our Annual Report.

Note 12.  Income Taxes
We have elected to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, and, as such, are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT. Our current income tax expense (or benefit) fluctuates from period to period based primarily on the timing of our income, including gains on the disposition of properties or losses in a particular quarter. For the three months ended June 30, 2022 and 2021, we recognized income tax benefit of $640 and expense of $191, respectively, and for the six months ended June 30, 2022 and 2021, we recognized income tax expense of $832 and $429, respectively.

Note 13. Weighted Average Common Shares (share amounts in thousands)
We calculate basic earnings per common share using the two class method. We calculate diluted earnings per share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares, together with the related impact on earnings, are considered when calculating diluted earnings per share. For purposes of calculating diluted earnings per share, we did not include 833 and 837 of unvested share awards for the three and six months ended June 30, 2022, respectively, because to do so would have been antidilutive.
20

Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion should be read in conjunction with our condensed consolidated financial statements and notes thereto included in this Quarterly Report on Form 10-Q and with our Annual Report.
OVERVIEW
We are a REIT that is organized under Maryland law and which owns medical office and life science properties, senior living communities and other healthcare related properties throughout the United States. As of June 30, 2022, we wholly owned 378 properties, including eight closed senior living communities, located in 36 states and Washington, D.C. At June 30, 2022, the gross book value of our real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, was $6.9 billion.
As of June 30, 2022, we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet that was 98% leased with an average (by annualized rental income) remaining lease term of 6.5 years.
Our business is focused on healthcare related properties, including medical office and life science properties, senior living communities, wellness centers and other medical and healthcare related properties. We believe that the healthcare sector and many of our tenants, managers and operators provide essential services across the United States. Due to restrictions intended to prevent the spread of the virus that causes COVID-19, certain of our medical office and wellness center tenants, which include physician practices that had discontinued non-essential surgeries and procedures and fitness centers that had been ordered closed by state executive orders, experienced disruptions to their businesses. Our senior living community operators also experienced disruptions, including limitations on in-person tours and new admissions, and experienced challenges in attracting new residents to their communities in addition to experiencing increased expenses due to increased labor costs, including higher health benefits costs, and increased costs and consumption of supplies, including personal protective equipment.
We are closely monitoring the impacts of the COVID-19 pandemic and the current inflationary market conditions on all aspects of our business, including, but not limited to, labor availability, wage inflation and cost pressures from supply chain disruptions and commodity price inflation in our SHOP segment. We expect to continue to have elevated labor costs on a per resident basis.
The U.S. Federal Reserve has recently raised interest rates in an effort to combat high inflation, which could result in negative consequences in the U.S. economy, and concerns about a potential recession are becoming more pronounced. It is unclear whether the U.S. economy will be able to withstand such challenges and realize continued sustained growth. A recession could adversely affect our financial condition and that of our managers, operators and tenants, could adversely impact the ability of our managers, tenants or residents to pay the contractual amounts of returns, rents or other obligations due to us, could impair our ability to effectively deploy our capital or realize upon investments on favorable terms and may cause the values of our properties and other investments and of our securities to decline. We could also be affected by any overall weakening of, or disruptions in, the financial markets, including an adverse impact on our ability to raise capital and the cost thereof.
We believe that we are well positioned to weather the present disruptions facing the real estate industry and, in particular, the real estate healthcare industry, including senior living. However, it is unclear whether the number of COVID-19 infections will further increase or amplify in the United States or elsewhere and, if so, what the impact of that would be on human health and safety, the economy, or our managers', operators' and tenants' businesses. It is also uncertain what the impact of changing market and economic conditions would be on our and our managers', operators' and tenants' businesses. As a result of these uncertainties, we are unable to determine what the ultimate impacts will be on our, our tenants', our managers', our operators' and other stakeholders' businesses, operations, financial results and financial position. For further information and risks relating to the COVID-19 pandemic and its aftermath on us and our business, see Part I, Item 1, "Business" and Part I, Item 1A, "Risk Factors" in our Annual Report.
21

PORTFOLIO OVERVIEW
The following tables present an overview of our portfolio (dollars in thousands, except investment per square foot or unit data):
As of June 30, 2022Number
of Properties
Square Feet or Number of Units 
Gross Book Value of Real Estate Assets(1)
% of Total Gross Book Value of Real Estate Assets
Investment per Square Foot or Unit(2)
Q2 2022 Revenues% of
Q2 2022 Revenues
Q2 2022 NOI (3)
% of Q2 2022 NOI
Office Portfolio (4)
104 8,722,866 sq. ft.$2,193,695 32.0 %$251 $52,610 16.8 %$30,584 65.1 %
SHOP234 25,075 units4,226,840 61.7 %$168,568 250,506 80.0 %6,466 13.8 %
Triple net leased senior living communities30 2,327 units252,961 3.7 %$108,707 6,114 2.0 %6,114 13.0 %
Wellness centers10 812,000 sq. ft.178,110 2.6 %$219 3,798 1.2 %3,798 8.1 %
Total378  $6,851,606 100.0 %$313,028 100.0 %$46,962 100.0 %
 Occupancy
As of and For the Three Months Ended June 30,
 20222021
Office Portfolio (5)
88.1 %91.0 %
SHOP73.6 %70.9 %
Triple net leased senior living communities (6)(7)
79.8 %74.3 %
Wellness centers (7)
100.0 %100.0 %
(1)Represents gross book value of real estate assets at cost plus certain acquisition costs, before depreciation and purchase price allocations and less impairment write downs, if any.
(2)Represents gross book value of real estate assets divided by number of rentable square feet or living units, as applicable, at June 30, 2022.
(3)We calculate our NOI on a consolidated basis and by reportable segment. Our definition of NOI and our reconciliation of net income (loss) to NOI are included below under the heading “Non-GAAP Financial Measures”.
(4)Our medical office and life science property leases include some triple net leases where, in addition to paying fixed rents, the tenants assume the obligation to operate and maintain the properties at their expense, and some net and modified gross leases where we are responsible for the operation and maintenance of the properties and we charge tenants for some or all of the property operating costs. A small percentage of our medical office and life science property leases are full-service leases where we receive fixed rent from our tenants and no reimbursement for our property operating costs.
(5)Medical office and life science property occupancy data is as of June 30, 2022 and 2021 and includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants and (iii) space being fitted out for occupancy.
(6)Excludes data for periods prior to our ownership of certain properties, data for properties sold or classified as held for sale, if any, and data for which there was a transfer of operations during the periods presented.
(7)Operating data for triple net leased senior living communities leased to third party operators and wellness centers are presented based upon the operating results provided by our tenants for the three months ended March 31, 2022 and 2021, or the most recent prior period for which tenant operating results are made available to us. We have not independently verified tenant operating data.
22

During the three and six months ended June 30, 2022, we entered into new and renewal leases at our medical office and life science properties in our Office Portfolio segment as summarized in the following tables (dollars and square feet in thousands, except per square foot amounts):
Three Months Ended June 30, 2022
 New LeasesRenewalsTotal
Square feet leased during the quarter52 211 263 
Weighted average rental rate change (by rentable square feet)14.9 %6.8 %9.1 %
Weighted average lease term (years) (1)
5.8 5.4 5.5 
Total leasing costs and concession commitments (2)
$2,986 $2,350 $5,336 
Total leasing costs and concession commitments per square foot (2)
$57.47 $11.13 $20.28 
Total leasing costs and concession commitments per square foot per year (2)
$9.91 $2.07 $3.69 
Six Months Ended June 30, 2022
 New LeasesRenewalsTotal
Square feet leased during the period172 292 464 
Weighted average rental rate change (by rentable square feet)15.0 %4.5 %8.7 %
Weighted average lease term (years) (1)
8.4 4.9 6.4 
Total leasing costs and concession commitments (2)
$14,316 $3,558 $17,874 
Total leasing costs and concession commitments per square foot (2)
$83.21 $12.18 $38.50 
Total leasing costs and concession commitments per square foot per year (2)
$9.92 $2.47 $6.02 
(1)Weighted based on annualized rental income pursuant to existing leases as of June 30, 2022, including straight line rent adjustments and estimated recurring expense reimbursements, and excluding lease value amortization.
(2)Includes commitments made for leasing expenditures and concessions, such as tenant improvements, leasing commissions, tenant reimbursements and free rent.
Lease Expiration Schedules
As of June 30, 2022, lease expirations at our medical office and life science properties in our Office Portfolio segment are as follows (dollars in thousands):
YearNumber of TenantsSquare Feet LeasedPercent of TotalCumulative Percent of Total
Annualized  Rental Income(1)
Percent of TotalCumulative Percent of Total
202254418,778 5.4 %5.4 %$11,660 5.3 %5.3 %
202346658,901 8.6 %14.0 %18,229 8.3 %13.6 %
202472971,967 12.6 %26.6 %26,335 12.0 %25.6 %
202574713,422 9.3 %35.9 %16,923 7.7 %33.3 %
202664796,376 10.4 %46.3 %23,932 10.9 %44.2 %
202757809,691 10.5 %56.8 %19,400 8.8 %53.0 %
202833874,257 11.4 %68.2 %22,809 10.4 %63.4 %
202937390,787 5.1 %73.3 %11,259 5.1 %68.5 %
203018388,369 5.1 %78.4 %7,693 3.5 %72.0 %
2031 and thereafter501,665,116 21.6 %100.0 %60,998 28.0 %100.0 %
Total5057,687,664 100.0 %$219,238 100.0 %
Weighted average remaining lease term (in years)5.3 5.7 
(1)Annualized rental income is based on rents pursuant to existing leases as of June 30, 2022, including straight line rent adjustments and estimated recurring expense reimbursements for certain net and modified gross leases and excluding lease value amortization at certain of our medical office and life science properties.
Lease expiration data for our triple net leased senior living communities leased to third party operators and wellness centers has not been provided because there were no changes to the lease expiration schedules from those reported in our Annual Report.
23


RESULTS OF OPERATIONS (dollars and square feet in thousands, unless otherwise noted)
We operate in, and report financial information for, the following two segments: Office Portfolio and SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities.
We also report “non-segment” operations, consisting of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
The following table summarizes the results of operations of each of our segments for the three and six months ended June 30, 2022 and 2021:
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Revenues:  
Office Portfolio$52,610 $92,804 $107,607 $186,127 
SHOP250,506 243,947 495,954 503,913 
Non-Segment9,912 9,590 20,200 19,025 
Total revenues$313,028 $346,341 $623,761 $709,065 
Net income (loss) attributable to common shareholders:
Office Portfolio$14,365 $52,177 $358,056 $74,886 
SHOP(30,094)(6,679)(65,967)(32,093)
Non-Segment(93,654)(79,720)(161,049)(144,520)
Net income (loss) attributable to common shareholders$(109,383)$(34,222)$131,040 $(101,727)
The following sections analyze and discuss the results of operations of each of our segments for the periods presented.
24


Three Months Ended June 30, 2022 Compared to Three Months Ended June 30, 2021 (dollars and square feet in thousands, except average monthly rate):
Unless otherwise indicated, references in this section to changes or comparisons of results, income or expenses refer to comparisons of the results for the three months ended June 30, 2022 to the three months ended June 30, 2021. Our definition of NOI and our reconciliation of net income (loss) to NOI and a description of why we believe NOI is an appropriate supplemental measure are included below under the heading “Non-GAAP Financial Measures.”
Three Months Ended June 30,
20222021$ Change% Change
NOI by segment:
Office Portfolio$30,584 $61,483 $(30,899)(50.3)%
SHOP6,466 10,636 (4,170)(39.2)%
Non-Segment9,912 9,590 322 3.4 %
Total NOI46,962 81,709 (34,747)(42.5)%
Depreciation and amortization58,261 67,888 (9,627)(14.2)%
General and administrative7,207 9,126 (1,919)(21.0)%
Acquisition and certain other transaction related costs609 12,071 (11,462)(95.0)%
(Loss) gain on sale of properties(686)30,760 (31,446)(102.2)%
Losses on equity securities, net(10,157)(3,849)(6,308)163.9 %
Interest and other income2,266 16,038 (13,772)(85.9)%
Interest expense
(55,975)(67,657)11,682 (17.3)%
Loss on modification or early extinguishment of debt(29,560)(370)(29,190)nm
Loss from continuing operations before income tax benefit (expense) and equity in earnings of investees(113,227)(32,454)(80,773)248.9 %
Income tax benefit (expense)640 (191)831 nm
Equity in earnings of investees3,204 — 3,204 nm
Net loss(109,383)(32,645)(76,738)235.1 %
Net income attributable to noncontrolling interest— (1,577)1,577 (100.0)%
Net loss attributable to common shareholders$(109,383)$(34,222)$(75,161)219.6 %
    nm - not meaningful
Office Portfolio:
 
Comparable Properties (1)
All Properties
 As of June 30,As of June 30,
 2022202120222021
Total buildings95 95 104 118 
Total square feet (2)
8,019 8,020 8,723 10,927 
Occupancy (3)
91.2 %91.8 %88.1 %91.0 %
(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since April 1, 2021; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and medical office and life science properties owned by unconsolidated joint ventures in each of which we own an equity interest.
(2)Prior periods exclude space remeasurements made subsequent to those periods.
(3)All property occupancy for medical office and life science properties includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants, and (iii) space being fitted out for occupancy. Comparable property occupancy excludes out of service assets undergoing redevelopment and medical office and life science properties owned by unconsolidated joint ventures in each of which we own an equity interest.
25


Three Months Ended June 30,
Comparable (1)
Non-Comparable
 Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20222021ChangeChange2022202120222021ChangeChange
Rental income$48,679 $48,213 $466 1.0 %$3,931 $44,591 $52,610 $92,804 $(40,194)(43.3)%
Property operating expenses(19,825)(19,165)660 3.4 %(2,201)(12,156)(22,026)(31,321)(9,295)(29.7)%
NOI$28,854 $29,048 $(194)(0.7)%$1,730 $32,435 $30,584 $61,483 $(30,899)(50.3)%
(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since April 1, 2021; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and medical office and life science properties owned by unconsolidated joint ventures in each of which we own an equity interest.
Rental income. Rental income decreased primarily due to the deconsolidation of 11 medical office and life science properties currently owned by two unconsolidated joint ventures in each of which we own an equity interest and our disposition of four properties since April 1, 2021, partially offset by an increase in rental income at our comparable properties. Rental income increased at our comparable properties primarily due to higher average rents achieved from our new and renewal leasing activity and increased parking revenue at certain of our comparable properties as certain states and municipalities have eased restrictions related to the COVID-19 pandemic, tenants' employees have increasingly returned to the office and commercial activity has increased, partially offset by decreases in tax escalation income and other property operating expense reimbursements at certain of our comparable properties.
Property operating expenses. Property operating expenses consist of real estate taxes, utility expenses, insurance, management fees, salaries and benefit costs of property level personnel, repairs and maintenance expense, cleaning expense and other direct costs of operating these properties. The decrease in property operating expenses is primarily due to the deconsolidation of 11 medical office and life science properties currently owned by two unconsolidated joint ventures in each of which we own an equity interest and our disposition of four properties since April 1, 2021, partially offset by an increase in property operating expenses at our comparable properties, which increased primarily due to increases in real estate taxes and other direct costs at certain of our comparable properties.
Net operating income. The change in NOI reflects the net changes in rental income and property operating expenses described above.
SHOP:
 
Comparable Properties (1)
All Properties
 As of and For the Three MonthsAs of and For the Three Months
 Ended June 30,Ended June 30,
 2022202120222021
Total properties120 120 234 235 
Number of units17,886 17,886 25,075 25,423 
Occupancy74.1 %72.9 %73.6 %70.9 %
Average monthly rate (2)
$4,109 $4,018 $4,480 $4,307 
(1)Consists of senior living communities that we have owned and which have been operated by the same operator continuously since April 1, 2021; excludes communities classified as held for sale or closed, if any.
(2)Average monthly rate is calculated by taking the average daily rate, which is defined as total residents fees and services divided by occupied units during the period, and multiplying it by 30 days.
Three Months Ended June 30,
Comparable (1)
Non-Comparable
Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20222021ChangeChange2022202120222021ChangeChange
Residents fees and services$165,182 $168,655 $(3,473)(2.1)%$85,324 $75,292 $250,506 $243,947 $6,559 2.7 %
Property operating expenses(152,304)(156,191)(3,887)(2.5)%(91,736)(77,120)(244,040)(233,311)10,729 4.6 %
NOI$12,878 $12,464 $414 3.3 %$(6,412)$(1,828)$6,466 $10,636 $(4,170)(39.2)%
(1)Consists of senior living communities that we have owned and which have been operated by the same operator continuously since April 1, 2021; excludes communities classified as held for sale or closed, if any.
26


Residents fees and services. Residents fees and services are the revenues earned at our managed senior living communities. We recognize these revenues as services are provided and related fees are accrued. Residents fees and services increased primarily due to increases in occupancy and average monthly rate at both comparable and non-comparable properties, partially offset by our closure of one property since April 1, 2021. Residents fees and services at our comparable properties decreased due to the closure of skilled nursing units during the three months ended June 30, 2021.
Property operating expenses. Property operating expenses consist of real estate taxes, utility expenses, insurance, salaries and benefit costs of property level personnel, repairs and maintenance expense, management fees, cleaning expense and other direct costs of operating these communities. Property operating expenses increased primarily due to increases in labor costs, variable costs resulting from higher occupancy at certain of our properties and increases to our insurance premiums for certain of our properties. These increases were partially offset by the closure of skilled nursing units at certain of our comparable properties during the three months ended June 30, 2021 and our closure of one property since April 1, 2021.
Net operating income. The change in NOI reflects the net changes in residents fees and services and property operating expenses described above.
Non-Segment(1):
 
Comparable Properties (2)
All Properties
 As of and For the Three Months Ended June 30,As of and For the Three Months Ended June 30,
 2022202120222021
Total properties:
Triple net leased senior living communities29 29 30 29 
Wellness centers10 10 10 10 
Rent coverage:
Triple net leased senior living communities (3)
1.18 x1.38 x1.18 x1.38 x
Wellness centers (3)
1.34 x0.94 x1.34 x0.94 x
(1)Non-segment operations consists of all of our other operations, including certain senior living communities leased to third party operators and wellness centers, which segment we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
(2)Comparable properties consists of properties that we have owned and which have been leased to the same operator continuously since April 1, 2021; excludes properties classified as held for sale, if any.
(3)All tenant operating data presented is based upon the operating results provided by our tenants for the 12 months ended March 31, 2022 and 2021 or the most recent prior period for which tenant operating results are available to us. Rent coverage is calculated using the operating cash flows from our triple net lease tenants' operations of our properties, before subordinated charges, if any, divided by triple net lease minimum rents payable to us. We have not independently verified tenant operating data. Excludes data for historical periods prior to our ownership of certain properties, as well as data for properties sold or classified as held for sale, if any, or for which there was a transfer of operations during the periods presented.
Three Months Ended June 30,
Comparable (1)
Non-Comparable
Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20222021ChangeChange2022202120222021ChangeChange
Rental income$10,107 $9,590 $517 5.4 %$(195)$— $9,912 $9,590 $322 3.4 %
NOI$10,107 $9,590 $517 5.4 %$(195)$— $9,912 $9,590 $322 3.4 %
(1)Consists of properties that we have owned and which have been leased to the same operator continuously since April 1, 2021; excludes properties classified as held for sale, if any.
Rental income. Rental income increased primarily due to an increase in rental income at our comparable properties and as a result of our purchase of improvements at our comparable properties since April 1, 2021. Rental income increased at our comparable properties primarily due to higher cash rents received during the three months ended June 30, 2022 from a tenant that previously defaulted under leases for six of our wellness centers. We have elected to recognize rental income from this previously defaulted tenant as rent payments are received. In February 2022, the leases for these six wellness centers were amended and a portion of the rent due to us was deferred. Increases in rental income were partially offset by rents being reserved for a defaulted tenant at one of our senior living communities.
Net operating income. The change in NOI reflects the net changes in rental income described above.
27


Consolidated:
Depreciation and amortization expense. Depreciation and amortization expense decreased primarily due to the deconsolidation of 11 medical office and life science properties owned by two unconsolidated joint ventures in each of which we own an equity interest, our disposition of four properties and certain depreciable assets becoming fully depreciated since April 1, 2021. Decreases to depreciation and amortization expense were partially offset by the purchase of capital improvements at certain of our properties since April 1, 2021.
General and administrative expense. General and administrative expense consists of fees paid to RMR under our business management agreement, legal and accounting fees, fees and expenses of our Trustees, equity compensation expense and other costs relating to our status as a publicly traded company. General and administrative expense decreased primarily due to a decrease in our base business management fees expense as a result of lower consolidated indebtedness and lower trading prices for our common shares during the three months ended June 30, 2022 compared to the three months ended June 30, 2021.
Acquisition and certain other transaction related costs. For the three months ended June 30, 2022 and 2021, acquisition and certain other transaction related costs primarily represent costs related to the transition of certain senior living communities to new third party managers.
(Loss) gain on sale of properties. (Loss) gain on sale of properties is the net result of our sale of certain of our properties and joint venture equity interests during the three months ended June 30, 2022 and 2021. The loss on sale of properties during the three months ended June 30, 2022 reflects our sale of a 10% equity interest in our Boston life science property joint venture. For further information regarding (loss) gain on sale of properties, see Note 2 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q and Note 3 to our consolidated financial statements included in Part IV, Item 15 of our Annual Report.
Losses on equity securities, net. Losses on equity securities, net, represent the net unrealized losses to adjust our investment in AlerisLife to its fair value. For further information regarding our investment in AlerisLife, see Note 5 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Interest and other income. The decrease in interest and other income is primarily due to $760 of funds we received from the U.S. government pursuant to the CARES Act during the three months ended June 30, 2022 compared to $15,748 received during the three months ended June 30, 2021.
Interest expense. Interest expense decreased primarily due to the deconsolidation of the debt secured by one life science property owned by our Boston life science property joint venture. Additionally, interest expense decreased due to our redemption in June 2021 of all $300,000 of our 6.75% senior notes due 2021, our redemption in June 2022 of $500,000 of our 9.75% senior notes due 2025 and a decrease in average borrowings under our revolving credit facility. These decreases were partially offset by an increase in interest rates under our revolving credit facility during the 2022 period.
Loss on modification or early extinguishment of debt. During the three months ended June 30, 2022, we recorded a loss on early extinguishment of debt in connection with our redemption of $500,000 of our 9.75% senior notes due 2025, partially offset by a gain on early extinguishment of debt in connection with our prepayment of a mortgage note. We also recorded a loss in connection with our redemption of all $300,000 of our 6.75% senior notes due 2021 during the three months ended June 30, 2021.
Income tax benefit (expense). Income tax benefit (expense) is the result of operating income we earned in certain jurisdictions where we are subject to state income taxes.
Equity in earnings of investees. Equity in earnings of investees is the change in the fair value of our investments in our joint ventures.
28


Six Months Ended June 30, 2022 Compared to Six Months Ended June 30, 2021 (dollars and square feet in thousands, except average monthly rate):
Unless otherwise indicated, references in this section to changes or comparisons of results, income or expenses refer to comparisons of the results for the six months ended June 30, 2022 to the six months ended June 30, 2021. Our definition of NOI and our reconciliation of net income (loss) to NOI and a description of why we believe NOI is an appropriate supplemental measure are included below under the heading “Non-GAAP Financial Measures.”
Six Months Ended June 30,
20222021$ Change% Change
NOI by segment:
Office Portfolio$62,134 $123,513 $(61,379)(49.7)%
SHOP6,619 14,504 (7,885)(54.4)%
Non-Segment20,200 19,025 1,175 6.2 %
Total NOI88,953 157,042 (68,089)(43.4)%
Depreciation and amortization115,520 134,041 (18,521)(13.8)%
General and administrative14,492 16,668 (2,176)(13.1)%
Acquisition and certain other transaction related costs1,537 12,071 (10,534)(87.3)%
Impairment of assets— (174)174 (100.0)%
Gain on sale of properties327,108 30,638 296,470 nm
Losses on equity securities, net(18,710)(12,188)(6,522)53.5 %
Interest and other income2,661 18,873 (16,212)(85.9)%
Interest expense
(113,106)(127,748)14,642 (11.5)%
Loss on modification or early extinguishment of debt(30,043)(2,410)(27,633)nm
Income (loss) from continuing operations before income tax expense and equity in earnings of investees125,314 (98,399)223,713 nm
Income tax expense(832)(429)(403)93.9 %
Equity in earnings of investees6,558 — 6,558 nm
Net income (loss)131,040 (98,828)229,868 nm
Net income attributable to noncontrolling interest— (2,899)2,899 (100.0)%
Net income (loss) attributable to common shareholders$131,040 $(101,727)$232,767 nm
    nm - not meaningful
Office Portfolio:
 
Comparable Properties (1)
All Properties
 As of June 30,As of June 30,
 2022202120222021
Total buildings95 95 104 118 
Total square feet (2)
8,019 8,020 8,723 10,927 
Occupancy (3)
91.2 %91.8 %88.1 %91.0 %
(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since January 1, 2021; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and medical office and life science properties owned by unconsolidated joint ventures in each of which we own an equity interest.
(2)Prior periods exclude space remeasurements made subsequent to those periods.
(3)All property occupancy for medical office and life science properties includes (i) out of service assets undergoing redevelopment, (ii) space which is leased but is not occupied or is being offered for sublease by tenants, and (iii) space being fitted out for occupancy. Comparable property occupancy excludes out of service assets undergoing redevelopment and medical office and life science properties owned by unconsolidated joint ventures in each of which we own an equity interest.
29


Six Months Ended June 30,
Comparable (1)
Non-Comparable
Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20222021ChangeChange2022202120222021ChangeChange
Rental income$97,107 $96,336 $771 0.8 %$10,500 $89,791 $107,607 $186,127 $(78,520)(42.2)%
Property operating expenses(39,692)(38,339)1,353 3.5 %(5,781)(24,275)(45,473)(62,614)(17,141)(27.4)%
NOI$57,415 $57,997 $(582)(1.0)%$4,719 $65,516 $62,134 $123,513 $(61,379)(49.7)%
(1)Consists of medical office and life science properties that we have owned and which have been in service continuously since January 1, 2021; excludes properties classified as held for sale or out of service undergoing redevelopment, if any, and medical office and life science properties owned by unconsolidated joint ventures in each of which we own an equity interest.
Rental income. Rental income decreased primarily due to the deconsolidation of 11 medical office and life science properties currently owned by two unconsolidated joint ventures in each of which we own an equity interest and our disposition of five properties since January 1, 2021, partially offset by an increase in rental income at our comparable properties. Rental income increased at our comparable properties primarily due to higher average rents achieved from our new and renewal leasing activity and increased parking revenue at certain of our comparable properties as certain states and municipalities have eased restrictions related to the COVID-19 pandemic, tenants' employees have increasingly returned to the office and commercial activity has increased, partially offset by decreases in tax escalation income and other property operating expense reimbursements at certain of our comparable properties.
Property operating expenses. The decrease in property operating expenses is primarily due to the deconsolidation of 11 medical office and life science properties currently owned by two unconsolidated joint ventures in each of which we own an equity interest and our disposition of five properties since January 1, 2021, partially offset by an increase in property operating expenses at our comparable properties, which increased primarily due to increases in utility expenses, landscaping expenses and other direct costs at certain of our comparable properties.
Net operating income. The change in NOI reflects the net changes in rental income and property operating expenses described above.
SHOP:
 
Comparable Properties (1)
All Properties
 As of and For the Six Months Ended June 30,As of and For the Six Months Ended June 30,
 2022202120222021
Total properties120 120 234 235 
Number of units17,886 17,886 25,075 25,423 
Occupancy74.1 %72.8 %73.3 %70.2 %
Average monthly rate (2)
$4,096 $4,035 $4,476 $4,467 
(1)Consists of senior living communities that we have owned and which have been operated by the same operator continuously since January 1, 2021; excludes communities classified as held for sale or closed, if any.
(2)Average monthly rate is calculated by taking the average daily rate, which is defined as total residents fees and services divided by occupied units during the period, and multiplying it by 30 days.
Six Months Ended June 30,
Comparable (1)
Non-Comparable
 Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20222021ChangeChange2022202120222021ChangeChange
Residents fees and services$327,721 $353,972 $(26,251)(7.4)%$168,233 $149,941 $495,954 $503,913 $(7,959)(1.6)%
Property operating expenses(305,358)(331,150)(25,792)(7.8)%(183,977)(158,259)(489,335)(489,409)(74)0.0 %
NOI$22,363 $22,822 $(459)(2.0)%$(15,744)$(8,318)$6,619 $14,504 $(7,885)(54.4)%
(1)Consists of senior living communities that we have owned and which have been operated by the same operator continuously since January 1, 2021; excludes communities classified as held for sale or closed, if any.
30


Residents fees and services. Residents fees and services decreased primarily due to the closure of skilled nursing units at certain of our comparable properties during the six months ended June 30, 2021 and our closure of one property since January 1, 2021. Decreases to residents fees and services were partially offset by increases in occupancy and average monthly rate at both comparable and non-comparable properties.
Property operating expenses. Property operating expenses decreased primarily due to the closure of skilled nursing units at certain of our comparable properties during the six months ended June 30, 2021. Additionally, property operating expenses decreased due to our closure of one property since January 1, 2021. Decreases to property operating expenses were partially offset by increased labor costs on a per resident basis. Additionally, property operating expenses increased due to increases to our insurance premiums for certain of our properties.
Net operating income. The change in NOI reflects the net changes in residents fees and services and property operating expenses described above.
Non-Segment(1):
 
Comparable Properties (2)
All Properties
 As of and For the Six Months Ended June 30,As of and For the Six Months Ended June 30,
 2022202120222021
Total properties:
Triple net leased senior living communities29 29 30 29 
Wellness centers10 10 10 10 
Rent coverage:
Triple net leased senior living communities (3)
1.18 x1.38 x1.18 x1.38 x
Wellness centers (3)
1.34 x0.94 x1.34 x0.94 x
(1)Non-segment operations consists of all of our other operations, including certain senior living communities leased to third party operators and wellness centers, which segment we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
(2)Comparable properties consists of properties that we have owned and which have been leased to the same operator continuously since January 1, 2021; excludes properties classified as held for sale, if any.
(3)All tenant operating data presented is based upon the operating results provided by our tenants for the 12 months ended March 31, 2022 and 2021 or the most recent prior period for which tenant operating results are available to us. Rent coverage is calculated using the operating cash flows from our triple net lease tenants' operations of our properties, before subordinated charges, if any, divided by triple net lease minimum rents payable to us. We have not independently verified tenant operating data. Excludes data for historical periods prior to our ownership of certain properties, as well as data for properties sold or classified as held for sale, if any, or for which there was a transfer of operations during the periods presented.
Six Months Ended June 30,
Comparable (1)
Non-Comparable
Properties ResultsProperties ResultsConsolidated Properties Results
$%$%
 20222021ChangeChange2022202120222021ChangeChange
Rental income$20,200 $19,025 $1,175 6.2 %$— $— $20,200 $19,025 $1,175 6.2 %
NOI$20,200 $19,025 $1,175 6.2 %$— $— $20,200 $19,025 $1,175 6.2 %
(1)Consists of properties that we have owned and which have been leased to the same operator continuously since January 1, 2021; excludes properties classified as held for sale, if any.
Rental income. Rental income increased primarily due to an increase in rental income at our comparable properties as a result of our purchase of improvements and increased rents resulting from our purchase of improvements at our comparable properties since January 1, 2021. Rental income increased at our comparable properties primarily due to higher cash rents received during the six months ended June 30, 2022 from a tenant that previously defaulted under leases for six of our wellness centers. We have elected to recognize rental income from this previously defaulted tenant as rent payments are received. In February 2022, the leases for these six wellness centers were amended and a portion of the rent due to us was deferred.
Net operating income. The change in NOI reflects the net changes in rental income described above.
31



Consolidated:
Depreciation and amortization expense. Depreciation and amortization expense decreased primarily due to the deconsolidation of 11 medical office and life science properties owned by two unconsolidated joint ventures in each of which we own an equity interest, our disposition of five properties and certain depreciable assets becoming fully depreciated since January 1, 2021. Decreases to depreciation and amortization expense were partially offset by the purchase of capital improvements at certain of our properties since January 1, 2021.
General and administrative expense. General and administrative expense decreased primarily due to a decrease in our base business management fees expense as a result of lower trading prices for our common shares and lower consolidated indebtedness during the six months ended June 30, 2022 compared to the six months ended June 30, 2021.
Acquisition and certain other transaction related costs. For the six months ended June 30, 2022 and 2021, acquisition and certain other transaction related costs primarily represent costs related to the transition of certain senior living communities to new third party managers.
Impairment of assets. For information about our asset impairment charges, see Note 3 to our consolidated financial statements included in Part IV, Item 15 of our Annual Report.
Gain on sale of properties. Gain on sale of properties is the net result of our sale of certain of our properties and joint venture equity interests during the six months ended June 30, 2022 and 2021. The gain on sale of properties during the six months ended June 30, 2022 reflects our sale of 10 medical office and life science properties to our 10 medical office and life science properties joint venture in which we retained a 20% equity interest and our sale of a 10% equity interest in our Boston life science property joint venture. For further information regarding gain on sale of properties, see Note 2 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q and Note 3 to our consolidated financial statements included in Part IV, Item 15 of our Annual Report.
Losses on equity securities, net. Losses on equity securities, net, represent the net unrealized losses to adjust our investment in AlerisLife to its fair value. For further information regarding our investment in AlerisLife, see Note 5 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Interest and other income. The decrease in interest and other income is primarily due to $959 of funds we received from the U.S. government pursuant to the CARES Act during the six months ended June 30, 2022 compared to $18,181 received during the six months ended June 30, 2021.
Interest expense. Interest expense decreased primarily due to the deconsolidation of the debt secured by one life science property owned by our Boston life science property joint venture. Additionally, interest expense decreased due to our prepayment in February 2021 of our $200,000 term loan, our redemption in June 2021 of all $300,000 of our 6.75% senior notes due 2021 and our redemption in June 2022 of $500,000 of our 9.75% senior notes due 2025. These decreases were partially offset by an increase in average borrowings under our revolving credit facility and our issuance in February 2021 of $500,000 aggregate principal amount of our 4.375% senior notes due 2031 and an increase in interest rates under our revolving credit facility during the 2022 period.
Loss on modification or early extinguishment of debt. During the six months ended June 30, 2022, we recorded a loss on modification or early extinguishment of debt in connection with the amendment to our credit agreement and our redemption of $500,000 of our 9.75% senior notes due 2025, partially offset by a gain on early extinguishment of debt in connection with our prepayment of a mortgage note. We also recorded a loss in connection with the amendments to our credit agreement and the agreement governing our previously existing $200,000 term loan, our prepayment of our $200,000 term loan and our redemption of all $300,000 of our 6.75% senior notes due 2021 during the six months ended June 30, 2021.
Income tax expense. Income tax expense is the result of operating income we earned in certain jurisdictions where we are subject to state income taxes.
Equity in earnings of investees. Equity in earnings of investees is the change in the fair value of our investments in our joint ventures.
32


Non-GAAP Financial Measures (dollars in thousands, except per share amounts)
We present certain "non-GAAP financial measures" within the meaning of applicable rules of the Securities and Exchange Commission, or SEC, including funds from operations attributable to common shareholders, or FFO attributable to common shareholders, normalized funds from operations attributable to common shareholders, or Normalized FFO attributable to common shareholders, and NOI for the three and six months ended June 30, 2022 and 2021. These measures do not represent cash generated by operating activities in accordance with GAAP and should not be considered alternatives to net income (loss) or net income (loss) attributable to common shareholders as indicators of our operating performance or as measures of our liquidity. These measures should be considered in conjunction with net income (loss) and net income (loss) attributable to common shareholders as presented in our condensed consolidated statements of comprehensive income (loss). We consider these non-GAAP measures to be appropriate supplemental measures of operating performance for a REIT, along with net income (loss) and net income (loss) attributable to common shareholders. We believe these measures provide useful information to investors because by excluding the effects of certain historical amounts, such as depreciation and amortization, they may facilitate a comparison of our operating performance between periods and with other REITs and, in the case of NOI, reflecting only those income and expense items that are generated and incurred at the property level may help both investors and management to understand the operations of our properties.
Funds From Operations and Normalized Funds From Operations Attributable to Common Shareholders
We calculate FFO attributable to common shareholders and Normalized FFO attributable to common shareholders as shown below. FFO attributable to common shareholders is calculated on the basis defined by the National Association of Real Estate Investment Trusts, which is net income (loss) attributable to common shareholders, calculated in accordance with GAAP, excluding any gain or loss on sale of properties, equity in earnings or losses of unconsolidated joint ventures, loss on impairment of real estate assets, gains or losses on equity securities, net, if any, including adjustments to reflect our proportionate share of FFO of our equity method investment in AlerisLife and our proportionate share of FFO from our unconsolidated joint ventures, plus real estate depreciation and amortization of consolidated properties and minus FFO adjustments attributable to noncontrolling interest, as well as certain other adjustments currently not applicable to us. In calculating Normalized FFO attributable to common shareholders, we adjust for the items shown below including similar adjustments for our unconsolidated joint ventures, if any. FFO attributable to common shareholders and Normalized FFO attributable to common shareholders are among the factors considered by our Board of Trustees when determining the amount of distributions to our shareholders. Other factors include, but are not limited to, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance, and our expected needs for and availability of cash to pay our obligations. Other real estate companies and REITs may calculate FFO attributable to common shareholders and Normalized FFO attributable to common shareholders differently than we do.
Our calculations of FFO attributable to common shareholders and Normalized FFO attributable to common shareholders for the three and six months ended June 30, 2022 and 2021 and reconciliations of net income (loss) attributable to common shareholders, the most directly comparable financial measure under GAAP reported in our condensed consolidated financial statements, to FFO attributable to common shareholders and Normalized FFO attributable to common shareholders appear in the following table. This table also provides a comparison of distributions to shareholders, FFO attributable to common shareholders and Normalized FFO attributable to common shareholders and net income (loss) attributable to common shareholders per share for these periods.
33


 Three Months Ended June 30,Six Months Ended June 30,
 2022202120222021
Net (loss) income attributable to common shareholders$(109,383)$(34,222)$131,040 $(101,727)
Depreciation and amortization58,261 67,888 115,520 134,041 
Loss (gain) on sale of properties686 (30,760)(327,108)(30,638)
Impairment of assets— — — (174)
Losses on equity securities, net10,157 3,849 18,710 12,188 
FFO adjustments attributable to noncontrolling interest— (5,275)— (10,548)
Equity in earnings of unconsolidated joint ventures(3,204)— (6,558)— 
Share of FFO from unconsolidated joint ventures3,704 — 7,379 — 
Adjustments to reflect our share of FFO attributable to an equity method investment(1,466)(3,005)(3,398)(969)
FFO attributable to common shareholders(41,245)(1,525)(64,415)2,173 
Acquisition and certain other transaction related costs609 12,071 1,537 12,071 
Loss on modification or early extinguishment of debt29,560 370 30,043 2,410 
Adjustments to reflect our share of Normalized FFO attributable to an equity method investment681 1,299 539 1,384 
Normalized FFO attributable to common shareholders$(10,395)$12,215 $(32,296)$18,038 
Weighted average common shares outstanding (basic and diluted)238,197 237,871 238,173 237,853 
Per common share data (basic and diluted):
Net (loss) income attributable to common shareholders$(0.46)$(0.14)$0.55 $(0.43)
FFO attributable to common shareholders$(0.17)$(0.01)$(0.27)$0.01 
Normalized FFO attributable to common shareholders$(0.04)$0.05 $(0.14)$0.08 
Distributions declared $0.01 $0.01 $0.02 $0.02 
Property Net Operating Income (NOI)
We calculate NOI as shown below. The calculation of NOI excludes certain components of net income (loss) in order to provide results that are more closely related to our property level results of operations. We define NOI as income from our real estate less our property operating expenses. NOI excludes amortization of capitalized tenant improvement costs and leasing commissions that we record as depreciation and amortization. We use NOI to evaluate individual and company-wide property level performance. Other real estate companies and REITs may calculate NOI differently than we do.
34


The calculation of NOI by reportable segment is included above in this Item 2. The following table includes the reconciliation of net income (loss) to NOI for the three and six months ended June 30, 2022 and 2021.
Three Months Ended June 30,Six Months Ended June 30,
2022202120222021
Reconciliation of Net Income (Loss) to NOI:    
Net (loss) income$(109,383)$(32,645)$131,040 $(98,828)
Equity in earnings of investees(3,204)— (6,558)— 
Income tax (benefit) expense(640)191 832 429 
(Loss) income from continuing operations before income tax benefit (expense) and equity in earnings of investees(113,227)(32,454)125,314 (98,399)
Loss on modification or early extinguishment of debt29,560 370 30,043 2,410 
Interest expense55,975 67,657 113,106 127,748 
Interest and other income(2,266)(16,038)(2,661)(18,873)
Losses on equity securities, net10,157 3,849 18,710 12,188 
Loss (gain) on sale of properties686 (30,760)(327,108)(30,638)
Impairment of assets— — — (174)
Acquisition and certain other transaction related costs609 12,071 1,537 12,071 
General and administrative7,207 9,126 14,492 16,668 
Depreciation and amortization58,261 67,888 115,520 134,041 
Total NOI$46,962 $81,709 $88,953 $157,042 
Office Portfolio NOI$30,584 $61,483 $62,134 $123,513 
SHOP NOI6,466 10,636 6,619 14,504 
Non-Segment NOI9,912 9,590 20,200 19,025 
Total NOI$46,962 $81,709 $88,953 $157,042 

LIQUIDITY AND CAPITAL RESOURCES
Our principal sources of cash to meet operating and capital expenses, pay debt service obligations and make distributions to our shareholders are the operating cash flows we generate as rental income from our leased properties, residents fees and services revenues from our managed communities, borrowings under our revolving credit facility and proceeds from the disposition of certain properties. We believe that these sources will be sufficient to meet our operating and capital expenses, pay debt service obligations and make distributions to our shareholders for the next 12 months and for the foreseeable future thereafter. Our future cash flows from operating activities will depend primarily upon:
our ability to receive rents from our tenants, including in light of the COVID-19 pandemic and its impact on our tenants' businesses;
our ability to maintain or increase the occupancy of, and the rental rates at, our properties, particularly at our senior living communities;
our and our managers' abilities to control operating expenses and capital expenses at our properties, including increased operating expenses that we may incur in response to inflation, supply chain challenges or in response to the COVID-19 pandemic; and
our managers' abilities to maintain or increase our returns from our managed senior living communities.
In March 2021, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility in light of continued uncertainties related to the COVID-19 pandemic. In February 2022, we repaid $100.0 million of this borrowing and reduced the borrowing capacity under our revolving credit
35

facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement. In addition, in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586.4 million in January 2023 and as such, further repayment of our revolving credit facility will be required by that time. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic, inflation, increasing interest rates, a possible recession or other economic, market or industry conditions may cause further increased pressure on our ability to satisfy financial and other covenants. We may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants. As of June 30, 2022, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are unable to incur additional debt until this ratio is at or above 1.5x on a pro forma basis. For additional responses and measures taken relating to the COVID-19 pandemic, see Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources" in our Annual Report.
In January 2022, we entered into a joint venture with two unrelated third party institutional investors for 10 medical office and life science properties we owned for aggregate proceeds, before closing costs and other adjustments, of $653.3 million. The equity interests that the investors acquired from us equaled 41% and 39%, respectively, of the total equity interests in the joint venture and we retained a 20% equity interest in the joint venture. Following the sale, we account for this joint venture using the equity method of accounting under the fair value option. The investment amounts are based upon a property valuation of approximately $702.5 million, less approximately $456.6 million of secured debt on the properties incurred by this joint venture.
In June 2022, we sold an additional 10% equity interest in our Boston life science property joint venture to an existing joint venture investor. The net proceeds of $109.0 million, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022. After giving effect to this sale, we continue to own a 10% equity interest in this joint venture. Our investment amount was based on a property valuation of $1.7 billion, less $620.0 million of existing mortgage debts on the property that this joint venture assumed.
The measures we have taken to enhance our ability to maintain sufficient liquidity may not sufficiently offset the decrease in cash flows from operations as a result of the properties we have sold, operating losses we may experience and capital investments we make, in which case our liquidity would be negatively impacted.
The following is a summary of our sources and uses of cash flows for the periods presented, as reflected in our condensed consolidated statements of cash flows (dollars in thousands):
 Six Months Ended June 30,
 20222021
Cash and cash equivalents and restricted cash at beginning of period$1,016,945 $90,849 
Net cash provided by (used in):
Operating activities(31,856)27,046 
Investing activities527,714 19,589 
Financing activities(644,401)770,605 
Cash and cash equivalents and restricted cash at end of period$868,402 $908,089 
Our Operating Liquidity and Resources
We generally receive minimum rents from our tenants monthly or quarterly, we receive residents fees and services revenues, net of expenses, from our managed senior living communities monthly and we receive percentage rents from certain of our senior living community tenants monthly, quarterly or annually.
The change in cash (used in) provided by operating activities for the six months ended June 30, 2022 compared to the prior period was primarily due to the continued impact of the COVID-19 pandemic and wage inflation in the senior living communities in our SHOP segment, along with reduced NOI as a result of the deconsolidation of joint venture properties during 2021 and 2022 and dispositions of properties during 2021. These decreases were partially offset by the cash distributions we received from our unconsolidated joint venture interests. As noted elsewhere in this Quarterly Report on Form 10-Q, the transition of the management of the 107 senior living communities from Five Star to other third party managers was completed
36

as of December 31, 2021 and we have closed the remaining senior living community that we and Five Star agreed to transition and are assessing opportunities to redevelop that property.
Specifically as it relates to our SHOP segment, we face and may continue to face issues with labor availability and wage inflation along with cost pressures from supply chain disruptions and commodity price inflation.
Our Investing Liquidity and Resources
The increase in cash provided by investing activities for the six months ended June 30, 2022 compared to the prior period was primarily due to proceeds from our sale of 10 medical office and life science properties to our 10 medical office and life science properties joint venture in which we retained a 20% equity interest, partially offset by less proceeds from the sale of real estate properties and an increase in real estate improvements in the 2022 period compared to the 2021 period.
The following is a summary of capital expenditures, development, redevelopment and other activities for the periods presented (dollars in thousands):
 Three Months Ended June 30,Six Months Ended June 30,
 2022202120222021
Office Portfolio segment capital expenditures:
   Lease related costs (1)
$4,633 $10,044 $11,392 $18,402 
   Building improvements (2)
3,319 4,437 3,904 6,613 
SHOP segment fixed assets and capital improvements25,059 19,283 45,387 41,813 
Recurring capital expenditures$33,011 $33,764 $60,683 $66,828 
Development, redevelopment and other activities - Office Portfolio segment (3)
$17,593 $9,689 $34,210 $22,407 
Development, redevelopment and other activities - SHOP segment (3)
14,282 5,345 30,396 11,437 
Total development, redevelopment and other activities$31,875 $15,034 $64,606 $33,844 
(1)Office Portfolio segment lease related costs generally include capital expenditures to improve tenants' space or amounts paid directly to tenants to improve their space and other leasing related costs, such as brokerage commissions and tenant inducements.
(2)Office Portfolio segment building improvements generally include expenditures to replace obsolete building components that extend the useful life of existing assets or other improvements to increase the marketability of the property.
(3)Development, redevelopment and other activities generally include capital expenditures that reposition a property or result in new sources of revenue.
We plan to continue investing capital in our properties, including redevelopment projects, to better position these properties in their respective markets in order to increase our returns in future years. In 2022, we expect to incur capital expenditures in excess of 2021 levels, up to the $400.0 million limit allowed pursuant to our credit agreement. We also expect to purchase additional properties that we believe will enhance our portfolio and provide future returns.
As of June 30, 2022, we had estimated unspent leasing related obligations at our triple net leased senior living communities and our medical office and life science properties of approximately $53.6 million, of which we expect to spend approximately $36.8 million during the next 12 months. We expect to fund these obligations using operating cash flows we generate as rental income from our leased properties, residents fees and services revenues from our managed communities, cash on hand, proceeds related to contributions we may make of properties we own to joint ventures and proceeds from the disposition of certain properties.
We are currently in the process of redeveloping five properties in our Office Portfolio. Our redevelopments in Lexington, MA, Decatur, GA and Tempe, AZ are currently expected to be completed in the second half of 2022. Our redevelopments at our properties in Irving, TX and Washington, D.C. are expected to be completed in 2023 and 2025, respectively. We have entered into a new ten year lease for the entire building at the Lexington, MA property at a rental rate that is 46% higher than the prior rental rate for the same space. Additionally, in January 2022, we entered into a new 11 year lease for the entire building at the Tempe, AZ property at a rental rate that is 20% higher than the prior rental rate for the same space. We are also currently reviewing strategic alternatives at a property in our Office Portfolio located in Silver Springs, MD, including
37

opportunities to redevelop this property. We continue to assess opportunities to redevelop other properties in our portfolio. These redevelopment projects may require significant capital expenditures and time to complete.
In July 2022, we acquired one life science property located in California with approximately 89,000 square feet for a purchase price of approximately $82.0 million, excluding closing costs.
As noted above, our ability to make capital investments is currently limited pursuant to our credit agreement. Additionally, due to supply chain disruptions and inflation, the capital investments we plan to make may be delayed or cost more than we expect. For further information regarding our acquisitions and dispositions, see Note 2 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Our Financing Liquidity and Resources
The change in cash (used in) provided by financing activities for the six months ended June 30, 2022 compared to the prior period was primarily due to repayments of borrowings under our revolving credit facility in the 2022 period compared to our full drawdown of our revolving credit facility in the 2021 period, net proceeds from our issuance in February 2021 of $500.0 million aggregate principal amount of our 4.375% senior notes in the 2021 period, increased senior unsecured notes redemption amounts in the 2022 period compared to the 2021 period and a prepayment premium paid in the 2022 period for the redemption of $500.0 million of our outstanding 9.75% senior notes due 2025, partially offset by our repayment in February 2021 of our $200.0 million term loan. Additionally, our Boston life science property joint venture did not pay distributions during the 2022 period related to our noncontrolling interest that we deconsolidated in 2021.
As of June 30, 2022, we had $705.2 million of cash and cash equivalents and were fully drawn under our revolving credit facility. We typically use cash balances, borrowings under our revolving credit facility, net proceeds from offerings of debt or equity securities, net proceeds from the disposition of assets and the cash flows from our operations to fund our operations, debt repayments, distributions, property acquisitions, investments, capital expenditures and other general business purposes.
In order to fund investments and to meet cash needs that may result from timing differences between our receipt of rents and our desire or need to make distributions or pay operating or capital expenses, we maintain a revolving credit facility. The maturity date of our revolving credit facility is January 15, 2024. Our revolving credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. At June 30, 2022, our revolving credit facility required interest to be paid on borrowings at the annual rate of 4.2%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. On March 31, 2021, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility in light of continued uncertainties related to the COVID-19 pandemic. In February 2022, we repaid $100.0 million of this borrowing and reduced the borrowing capacity under our revolving credit facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586.4 million in January 2023 and as such, further repayment of our revolving credit facility will be required by that time. Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. As of June 30, 2022 and July 29, 2022, we were fully drawn under our revolving credit facility.
In February 2022, we and our lenders amended our credit agreement. Pursuant to the amendment:
the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022;
the revolving credit facility commitments have been reduced from $800.0 million to $700.0 million;
we have the ability to fund $400.0 million of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;
the interest rate premium under our revolving credit facility increased by 15 basis points; and
certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200.0 million will remain in place during the Amendment Period.
38

Generally, when significant amounts are outstanding under our revolving credit facility, or as the maturities of our indebtedness approach, we intend to explore refinancing alternatives. Such alternatives may include incurring additional debt, selling certain properties and issuing new equity securities. In addition, we may also seek to expand our existing joint venture arrangements or to participate in additional joint ventures or other arrangements that may provide us additional sources of financing. We currently have an effective shelf registration statement that allows us to issue public securities on an expedited basis, but it does not assure that there will be buyers for such securities. We may also assume debt in connection with our acquisitions of properties or place new debt on properties we own.
During the six months ended June 30, 2022, we paid quarterly cash distributions to our shareholders totaling approximately $4.8 million using existing cash balances. On July 14, 2022, we declared a quarterly distribution payable to common shareholders of record on July 25, 2022 in the amount of $0.01 per share, or approximately $2.4 million. We expect to pay this distribution on or about August 18, 2022 using cash on hand. For further information regarding the distribution we paid during 2022, see Note 7 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
We believe we will have access to various types of financings, including debt or equity offerings, to fund our future acquisitions and to pay our debts and other obligations as they become due, subject to limitations on debt offerings in agreements governing our debt. Our ability to complete, and the costs associated with, future debt or equity transactions depends primarily upon credit market conditions and our then creditworthiness. We have no control over market conditions. Our credit and debt ratings, which were most recently downgraded in February 2022, depend upon evaluations by credit rating agencies of our business practices and plans, including our ability to maintain our earnings, to stagger our debt maturities and to balance our use of debt and equity capital so that our financial performance and leverage ratios afford us flexibility to withstand any reasonably anticipated adverse changes. Similarly, our ability to raise equity capital in the future will depend primarily upon equity capital market conditions and our ability to conduct our business to maintain and grow our operating cash flows. We intend to conduct our business activities in a manner which will afford us reasonable access to capital for investment and financing activities, but we cannot be sure that we will be able to successfully carry out that intention. It is uncertain what the duration and severity of the COVID-19 pandemic and its economic impact will be. A protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic, inflation or other economic, market or industry conditions, including a possible recession, may have various negative consequences including a decline in financing availability and increased costs for financing. Further, those conditions could also disrupt capital markets and limit our access to financing from public sources, particularly if the global financial markets experience significant disruptions.
In April 2022, we prepaid a mortgage note secured by one of our medical office properties with an outstanding principal balance of approximately $10.9 million, a maturity date in July 2022 and an annual interest rate of 6.28%, using cash on hand.
In June 2022, we redeemed $500.0 million of our outstanding 9.75% senior notes due 2025 for a redemption price equal to 104.875% of the $500.0 million principal amount of the notes being redeemed plus accrued and unpaid interest of $1.1 million, using restricted cash on hand.
In July 2022, we prepaid a mortgage note secured by two of our senior living communities with an outstanding principal balance of approximately $15.3 million, a maturity date in October 2022 and an annual interest rate of 5.75%, using cash on hand.
Our next significant debt maturity does not occur until our revolving credit facility becomes due in January 2024.
In February 2022, Moody's Investors Service downgraded our senior unsecured debt rating from B1 to B3, our 9.75% senior notes due 2025 rating from Ba3 to B2 and our 4.375% senior notes due 2031 rating from Ba3 to B2.
For further information regarding our outstanding debt, see Note 4 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Except for the limitations in the amendments to our credit agreement described above, our strategy related to property acquisitions and dispositions is materially unchanged from that disclosed in our Annual Report. Our plans for particular properties and other strategic considerations may cause us to change our acquisition and disposition strategies, and we may do so at any time and without shareholder approval. Further, those plans may be further impacted by the COVID-19 pandemic, inflation or other economic, market or industry conditions.
39

Debt Covenants
Our principal debt obligations at June 30, 2022 were: (1) outstanding borrowings under our $700.0 million revolving credit facility; (2) $2.4 billion outstanding principal amount of senior unsecured notes; and (3) $50.7 million aggregate principal amount of mortgage notes (excluding premiums, discounts and net debt issuance costs) secured by five properties. For further information regarding our indebtedness, see Note 4 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Our senior unsecured notes are governed by our senior unsecured notes indentures and their supplements. Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts outstanding upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a change of control of us, as defined, which includes RMR ceasing to act as our business and property manager. Our senior unsecured notes indentures and their supplements and our credit agreement also contain covenants that restrict our ability to incur debts, including debts secured by mortgages on our properties, in excess of calculated amounts and require us to maintain various financial ratios, and our credit agreement contains covenants that restrict our ability to make distributions to our shareholders in certain circumstances. As of June 30, 2022, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic, inflation and other economic, market or industry conditions continued to adversely impact our operations. We are unable to incur additional debt until this ratio is at or above 1.5x on a pro forma basis, and as such, prior to falling below the 1.5x incurrence requirement, we borrowed $800.0 million under our revolving credit facility as a precautionary measure to increase our cash position and preserve financial flexibility. The proceeds from this borrowing may be used for general business purposes. In February 2022, we repaid $100.0 million of this borrowing and reduced the borrowing capacity under our revolving credit facility to $700.0 million pursuant to the February 2022 amendment to our credit agreement. As of June 30, 2022, we believe we were in compliance with all of the other covenants under our senior unsecured notes indentures and their supplements, our credit agreement and our other debt obligations, subject to the waivers noted above. Although we have taken steps to enhance our ability to maintain sufficient liquidity, as noted elsewhere in this Quarterly Report on Form 10-Q, a protracted negative impact on the economy or the industries in which our properties and businesses operate resulting from the COVID-19 pandemic, inflation and other economic, market or industry conditions, including a possible recession, may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by the economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants. Further, if we believe we will not be able to satisfy our financial or other covenants, we will seek waivers, amendments, or in the case of our public debt covenants, borrow any undrawn amounts which may become available under our revolving credit facility prior to any covenant violation, consistent with our approach in March 2021, which may lead to increased costs and interest rates, additional restrictive covenants or other lender protections. We cannot assure that we would be able to obtain these waivers or amendments or repay the related debt facilities when due, or that there will be any amounts available to borrow under our revolving credit facility, which may result in an event of default under the agreements governing our debt or the potential acceleration of our outstanding debt.
Neither our senior unsecured notes indentures and their supplements, nor our credit agreement, contain provisions for acceleration which could be triggered by our debt ratings. However, under our credit agreement, our senior unsecured debt ratings are used to determine the fees and interest rates we pay. Accordingly, following our debt ratings downgrades, our interest expense and related costs under our credit agreement has increased. See "—Our Financing Liquidity and Resources" above for information regarding recent downgrades of our issuer credit rating and senior unsecured debt rating that resulted in a change in the interest rate premiums under our revolving credit facility.
Our senior unsecured notes indentures and their supplements contain cross default provisions to any other debts of more than $20.0 million ($50.0 million or more in the case of our senior unsecured notes indentures and supplements entered in February 2016, February 2018, June 2020 and February 2021). Similarly, our credit agreement has cross default provisions to other indebtedness that is recourse of $25.0 million or more and indebtedness that is non-recourse of $75.0 million or more.
The loan agreements governing the aggregate $620.0 million secured debt financing related to our Boston life science property joint venture contain customary covenants and provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default. We no longer include this $620.0 million of secured debt financing in our condensed consolidated balance sheet following the deconsolidation of the net assets of this joint venture; however, we continue to provide certain guaranties on this debt. The debt secured by the properties included in our 10 medical office and life science properties joint venture in which we own a 20% equity interest is guaranteed by this joint venture.
40

Supplemental Guarantor Information
On May 28, 2020, we issued $1.0 billion of our 9.75% senior notes due 2025. We subsequently redeemed $500.0 million of this debt in June 2022, with $500.0 million outstanding. On February 3, 2021, we issued $500.0 million of our 4.375% senior notes due 2031. As of June 30, 2022, all $500.0 million of our 9.75% senior notes due 2025 and all $500.0 million of our 4.375% senior notes due 2031 were fully and unconditionally guaranteed, on a joint and several basis and on a senior unsecured basis, by all of our subsidiaries, except for certain excluded subsidiaries, including pledged subsidiaries under our credit agreement. The notes and the guarantees are effectively subordinated to all of our and the subsidiary guarantors' secured indebtedness, respectively, to the extent of the value of the collateral securing such secured indebtedness, and are structurally subordinated to all indebtedness and other liabilities and any preferred equity of any of our subsidiaries that do not guarantee the notes. Our remaining $1.35 billion of senior unsecured notes do not have the benefit of any guarantees as of June 30, 2022.
A subsidiary guarantor's guarantee of our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, as applicable, and all other obligations of such subsidiary guarantor under the indenture governing the notes will automatically terminate and such subsidiary guarantor will automatically be released from all of its obligations under such subsidiary guarantee and the indenture under certain circumstances, including on or after the date (a) the notes have an investment grade rating from two rating agencies and one of such investment grade ratings is a mid-BBB investment grade rating and (b) no default or event of default has occurred and is continuing under the indenture. Our non-guarantor subsidiaries are separate and distinct legal entities and have no obligation, contingent or otherwise, to pay any amounts due on our 9.75% senior notes due 2025 or our 4.375% senior notes due 2031 or the respective guarantees, or to make any funds available therefor, whether by dividend, distribution, loan or other payments. The rights of holders of our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, as applicable, to benefit from any of the assets of our non-guarantor subsidiaries are subject to the prior satisfaction of claims of those subsidiaries' creditors and any preferred equity holders. As a result, our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031 and the respective guarantees are structurally subordinated to all indebtedness, guarantees and other liabilities of our subsidiaries that do not guarantee our 9.75% senior notes due 2025 and our 4.375% senior notes due 2031, including guarantees of other indebtedness of ours, payment obligations under lease agreements, trade payables and preferred equity.
The following tables present summarized financial information for guarantor entities and issuer, on a combined basis after eliminating (i) intercompany transactions and balances among the guarantor entities and (ii) equity in earnings from, and any investments in, any subsidiary that is a non-guarantor (dollars in thousands):
June 30, 2022December 31, 2021
Real estate properties, net$3,870,445 $3,846,072 
Other assets, net1,323,757 1,426,726 
Total assets$5,194,202 $5,272,798 
Indebtedness, net$3,021,285 $3,624,615 
Other liabilities264,616 260,377 
Total liabilities$3,285,901 $3,884,992 
Six Months Ended June 30, 2022
Revenues$550,551 
Expenses616,208 
Loss from continuing operations(220,870)
Net loss(215,144)
Related Person Transactions
We have relationships and historical and continuing transactions with RMR, RMR Inc., AlerisLife (including Five Star) and others related to them. For further information about these and other such relationships and related person transactions, see Notes 9, 10 and 11 to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on
41

Form 10-Q, our Annual Report, our definitive Proxy Statement for our 2022 Annual Meeting of Shareholders and our other filings with the SEC. In addition, see the section captioned “Risk Factors” of our Annual Report for a description of risks that may arise as a result of these and other related person transactions and relationships. We may engage in additional transactions with related persons, including businesses to which RMR or its subsidiaries provide management services.
Critical Accounting Estimates
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.
A discussion of our critical accounting estimates is included in our Annual Report. There have been no significant changes in our critical accounting estimates since the year ended December 31, 2021.
Impact of Government Reimbursement
For the six months ended June 30, 2022, substantially all of our NOI was generated from properties where a majority of the revenues are derived from our tenants' and residents' private resources, and a small amount of our NOI was generated from properties where a majority of the revenues are derived from Medicare and Medicaid payments. Nonetheless, we own, and our tenants, managers and operators operate, facilities in many states that participate in federal and state healthcare payment programs, including the federal Medicare and state Medicaid programs and other federal and state healthcare payment programs. Also, some of our medical office and life science property tenants participate in federal Medicare and state Medicaid programs and other government healthcare payment programs.
During the six months ended June 30, 2022 and 2021, we recognized $1.0 million and $18.2 million, respectively, in interest and other income in our condensed consolidated statements of comprehensive income (loss) related to funds received under the CARES Act.
For more information regarding the government healthcare funding and regulation of our business, please see the section captioned “Business—Government Regulation and Reimbursement” in our Annual Report and the section captioned “Management's Discussion and Analysis of Financial Condition and Results of Operations—Impact of Government Reimbursement” in our Annual Report.
Item 3.  Quantitative and Qualitative Disclosures About Market Risk.
We are exposed to risks associated with market changes in interest rates. We manage our exposure to this market risk by monitoring available financing alternatives. Our strategy to manage exposure to changes in interest rates has not materially changed since December 31, 2021. Other than as described below, we do not currently foresee any significant changes in our exposure to fluctuations in interest rates or in how we manage this exposure in the near future.
Although we have no present plans to do so, we may in the future enter into hedge arrangements or derivative contracts from time to time to mitigate our exposure to changes in interest rates.
42

Fixed Rate Debt
At June 30, 2022, our outstanding fixed rate debt included the following (dollars in thousands):
  AnnualAnnual  
 PrincipalInterestInterest Interest
Debt
Balance (1)
Rate (1)
ExpenseMaturityPayments Due
Senior unsecured notes$250,000 4.750 %$11,875 2024Semi-Annually
Senior unsecured notes500,000 9.750 %48,750 2025Semi-Annually
Senior unsecured notes500,000 4.750 %23,750 2028Semi-Annually
Senior unsecured notes500,000 4.375 %21,875 2031Semi-Annually
Senior unsecured notes350,000 5.625 %19,688 2042Quarterly
Senior unsecured notes250,000 6.250 %15,625 2046Quarterly
Mortgage note10,352 4.850 %502 2022Monthly
Mortgage note (2)
15,273 5.750 %878 2022Monthly
Mortgage note14,970 6.640 %994 2023Monthly
Mortgage note10,120 4.444 %450 2043Monthly
 $2,400,715 $144,387   
(1)The principal balances and interest rates are the amounts stated in the applicable contracts. In accordance with GAAP, our carrying values and recorded interest expense may differ from these amounts because of market conditions at the time we assumed certain of these debts. This table does not include obligations under finance leases.
(2)We prepaid this mortgage in July 2022.
No principal repayments are due under our unsecured notes until maturity. Our mortgage notes generally require principal and interest payments through maturity pursuant to amortization schedules. Because these debts require interest to be paid at a fixed rate, changes in market interest rates during the term of these debts will not affect our interest obligations. If these debts were refinanced at interest rates which are one percentage point higher or lower than shown above, our annual interest cost would increase or decrease by approximately $24.0 million.
Changes in market interest rates also would affect the fair value of our fixed rate debt obligations; increases in market interest rates decrease the fair value of our fixed rate debt, while decreases in market interest rates increase the fair value of our fixed rate debt. The U.S. Federal Reserve recently raised interest rates in an effort to combat high inflation and may continue to do so. Based on the balances outstanding at June 30, 2022, and discounted cash flows analyses through the respective maturity dates, and assuming no other changes in factors that may affect the fair value of our fixed rate debt obligations, a hypothetical immediate one percentage point increase in interest rates would change the fair value of those obligations by approximately $1.1 million.
Our senior unsecured notes and certain of our mortgages contain provisions that allow us to make repayments earlier than the stated maturity date. In some cases, we are not allowed to make early repayment prior to a cutoff date and we are generally allowed to make prepayments only at a premium equal to a make whole amount, as defined, which is generally designed to preserve a stated yield to the noteholder. In the past, we have repurchased and retired some of our outstanding debt and we may do so again in the future. These prepayment rights and our ability to repurchase and retire outstanding debt may afford us opportunities to mitigate the risk of refinancing our debts at maturity at higher rates by refinancing prior to maturity.
Floating Rate Debt
At June 30, 2022, our floating rate debt obligations consisted of $700.0 million outstanding under our revolving credit facility. Our revolving credit facility matures in January 2024. Generally, no principal repayments are required under our revolving credit facility prior to maturity, and we can borrow, repay and re-borrow funds available, subject to conditions, at any time without penalty.
Borrowings under our revolving credit facility are in U.S. dollars and interest is required to be paid at the rate of LIBOR plus a premium that is subject to adjustment based upon changes to our credit ratings. Accordingly, we are exposed to interest rate risk for changes in U.S. dollar based short term rates, specifically LIBOR, and to changes in our credit ratings. In addition, upon renewal or refinancing of our revolving credit facility, we are vulnerable to increases in interest rate premiums due to
43

market conditions or our perceived credit characteristics. Generally, a change in interest rates would not affect the value of our floating rate debt but would affect our operating results.
The following table presents the impact a one percentage point increase in interest rates would have on our annual floating rate interest expense as of June 30, 2022 (dollars in thousands except per share amounts):
 Impact of Changes in Interest Rates
  OutstandingTotal InterestAnnual Earnings
 
Interest Rate (1)
Floating Rate DebtExpense Per Year
Per Share Impact (2)
At June 30, 20224.17 %$700,000 $29,190 $0.12 
One percentage point increase5.17 %$700,000 $36,190 $0.15 
(1)Interest rate under our revolving credit facility as of June 30, 2022.
(2)Based on weighted average number of shares outstanding (diluted) for the six months ended June 30, 2022.
The foregoing table shows the impact of an immediate increase in floating interest rates. If interest rates were to increase gradually over time, the impact would be spread over time. Our exposure to fluctuations in floating interest rates will increase or decrease in the future with increases or decreases in the amount of our borrowings outstanding under our revolving credit facility or other floating rate debt.
LIBOR Phase Out

LIBOR has phased out for new contracts and it is currently expected to be phased out for pre-existing contracts by June 30, 2023. We are required to pay interest on borrowings under our revolving credit facility at floating rates based on LIBOR and interest we may pay on any future debt that we may incur may also require that we pay interest based upon LIBOR. In September 2021, we amended our credit agreement to set forth the mechanics for establishing a replacement benchmark rate under our revolving credit facility at such time as LIBOR is no longer available to calculate interest payable on amounts outstanding thereunder. Despite this amendment, we cannot be sure that any changes to the determination of interest under our agreement will approximate the current calculation in accordance with LIBOR. We cannot be sure what standard, if any, will replace LIBOR, and any alternative interest rate index that may replace LIBOR may result in our paying increased interest.

Item 4.  Controls and Procedures.
 
As of the end of the period covered by this Quarterly Report on Form 10-Q, our management carried out an evaluation, under the supervision and with the participation of our President and Chief Executive Officer and our Chief Financial Officer and Treasurer, of the effectiveness of our disclosure controls and procedures pursuant to Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934, as amended. Based upon that evaluation, our President and Chief Executive Officer and our Chief Financial Officer and Treasurer concluded that our disclosure controls and procedures are effective.
There have been no changes in our internal control over financial reporting during the quarter ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
44

Warning Concerning Forward-Looking Statements
This Quarterly Report on Form 10-Q contains statements that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Also, whenever we use words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these or similar expressions, we are making forward-looking statements. These forward-looking statements are based upon our present intent, beliefs or expectations, but forward-looking statements are not guaranteed to occur and may not occur. Forward-looking statements in this Quarterly Report on Form 10-Q relate to various aspects of our business, including:
The duration and severity of the COVID-19 pandemic and its impact on us and our managers' and other operators' and tenants' businesses,
The ability of our senior living community managers to minimize negative economic impacts, including the current inflationary conditions, supply chain challenges and possible recession, on our senior living communities and to manage them profitably and increase our returns,
Our belief that we are well positioned to weather the present disruptions facing the real estate industry and, in particular, the real estate healthcare industry, including the senior living industry,
Our belief that the healthcare sector and many of our tenants and managers and other operators provide essential services across the United States and the implication that our and our tenants' and managers' and other operators' businesses will remain open to provide such essential services,
Whether the aging U.S. population and increasing life spans of seniors will increase the demand for senior living communities and other medical and healthcare related properties and healthcare services,
Our ability to retain our existing tenants, attract new tenants and maintain or increase current rental rates on terms as favorable to us as our prior leases,
The credit qualities of our tenants,
Our ability to compete for tenancies and acquisitions effectively,
Our expectation regarding our plans to pursue and complete redevelopment projects at our properties, the cost and timing to complete those projects and the benefits we may realize from those projects,
Our capital expenditures and capital investing plans and our expectations of the benefits we will realize as a result,
Our acquisitions and sales of properties,
Our closures and repositioning of senior living communities,
The impact of increasing labor costs and shortages and commodity and other price inflation due to supply chain challenges or other market conditions,
Our ability to raise debt or equity capital,
Our ability to complete dispositions,
Our ability to maintain sufficient liquidity and satisfy financial covenants under our debt agreements,
The future availability of borrowings under our revolving credit facility,
Our policies and plans regarding investments, financings and dispositions,
Our ability to pay distributions to our shareholders and to sustain the amount of such distributions,
Whether we may contribute additional properties to our joint ventures and receive proceeds from the other investors in our joint ventures in connection with any such contributions or enter into new joint venture arrangements,
45

Our ability to pay interest on and principal of our debt,
Our ability to appropriately balance our use of debt and equity capital,
Our credit ratings,
Our expectation that we benefit from our relationships with RMR,
Our qualification for taxation as a REIT, and
Other matters.
Our actual results may differ materially from those contained in or implied by our forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, some of which are beyond our control. Risks, uncertainties and other factors that could have a material adverse effect on our forward-looking statements and upon our business, results of operations, financial condition, FFO attributable to common shareholders, Normalized FFO attributable to common shareholders, NOI, cash flows, liquidity and prospects include, but are not limited to:
The impacts of the COVID-19 pandemic on us and our managers and other operators and tenants,
The impacts of economic conditions, including increasing interest rates, inflation and a possible recession, and the capital markets on us and our managers and other operators and tenants,
Compliance with, and changes to, federal, state and local laws and regulations, accounting rules, tax laws and similar matters,
Limitations imposed on our business and our ability to satisfy complex rules in order for us to maintain our qualification for taxation as a REIT for U.S. federal income tax purposes,
Competition within the healthcare and real estate industries, particularly in those markets in which our properties are located,
Actual and potential conflicts of interest with our related parties, including our Managing Trustees, AlerisLife (including Five Star), RMR and others affiliated with them, and
Acts of terrorism, outbreaks of pandemics, including the COVID-19 pandemic, or other manmade or natural disasters beyond our control.
For example:
Under the current economic conditions for the industries in which our properties and businesses operate, our managers and other operators and tenants may not be able to profitably operate their businesses at our properties, our tenants may become unable or unwilling to pay their rent obligations to us, or our senior living community managers may be unable to generate our minimum returns for sustained periods as a result of the COVID-19 pandemic or otherwise. Additionally, if we default under our credit facility or other debt obligations, we may be required to repay our outstanding borrowings and other debt. Further, although we have taken steps to enhance our ability to maintain sufficient liquidity, unanticipated events may require us to expend amounts not currently planned,
Our senior living community managers and other operators may experience operating and financial challenges resulting from a number of factors, some of which are beyond their control, and which challenges impact our operating results, including, but not limited to:
Fluctuations in occupancy,
Competition within the senior living and other health and wellness related service businesses,
Older adults delaying or forgoing moving into senior living communities or purchasing health and wellness services,
46

Increased labor costs, decreased labor availability and staffing turnover at our senior living communities or increases in costs paid for goods and services, due in part to supply chain constraints and commodity price inflation,
The availability and increases in cost of general and professional liability insurance coverage,
Medicare or Medicaid policies and regulations, as well as federal, state, local, and industry-regulated licensure, certification and inspection laws, regulations and standards that could affect our senior living community managers' services or impose requirements, costs and administrative burdens that may reduce our managers' ability to profitably operate their businesses,
Imposition of civil, criminal and administrative penalties resulting from any noncompliance with healthcare laws and regulations at our senior living communities, including suspension of or non-payment for new admission or the loss or suspension of accreditation, licenses or certificates of need, among other things, and
Exposure to litigation and regulatory and government proceedings due to the nature of the senior living and other health and wellness related service businesses.
We own a significant number of AlerisLife common shares and we expect to own these shares for the foreseeable future. However, we may sell some or all of our AlerisLife common shares, or our ownership interest in AlerisLife may otherwise be diluted in the future,
Our current cash distribution rate to common shareholders is $0.01 per share per quarter, or $0.04 per share per year, due to the operating challenges and other economic impacts resulting from the COVID-19 pandemic. Our distribution rate may be set and reset from time to time by our Board of Trustees. Our Board of Trustees will consider many factors when setting or resetting our distribution rate, including our historical and projected net income, Normalized FFO, requirements to maintain our qualification for taxation as a REIT, limitations in the agreements governing our debt, the availability to us of debt and equity capital, our expectation of our future capital requirements and operating performance, our expected needs for and availability of cash to pay our obligations and other factors deemed relevant by our Board of Trustees in its discretion. Further, our projected cash available for distribution may change and may vary from our expectations. Accordingly, future distributions to our shareholders may be increased or decreased and we cannot be sure as to the rate at which future distributions will be paid,
Our ability to make future distributions to our shareholders and to make payments of principal and interest on our debt depends upon a number of factors, including our future earnings, the capital costs we incur to lease and operate our properties and our working capital requirements. We may be unable to pay our debt obligations when they become due or to maintain our current rate of distributions on our common shares and future distributions may be reduced or eliminated,
We intend to conduct our business activities in a manner that will afford us reasonable access to capital for investment and financing activities. However, we may not succeed in this regard and we may not have reasonable access to capital,
Subject to limitations on acquisitions in agreements governing our debt, we plan to selectively sell certain properties from time to time to fund future acquisitions, manage leverage and strategically update, rebalance and reposition our investment portfolio, which we refer to as our capital recycling program. We cannot be sure we will sell any of these properties or what the terms or timing of any such sales may be. In addition, any updating, rebalancing or repositioning of our portfolio may not result in the benefits we expect, and properties we may sell may be at prices that are less than expected and less than their carrying values,
Contingencies in our acquisition and sale agreements that we may enter may not be satisfied and any acquisitions and sales pursuant to such agreements and any related management arrangements we may expect to enter may not occur, may be delayed or the terms of such transactions or arrangements may change,
The capital investments we are making at our senior living communities and our plan to invest significant additional capital in our senior living communities to better position them in their respective markets in order to increase our future returns may not be successful and may not achieve our expected results. Our senior living communities may not be competitive, despite these capital investments, or these capital investments may be delayed or may cost more than expected due to supply chain disruptions, market inflation, labor shortages or other conditions,
47

Our redevelopment projects may not be successful and may cost more or take longer to complete than we currently expect. In addition, we may not realize the returns we expect from these projects and we may incur losses from these projects, and potential leasing arrangements related to our redevelopment projects may not materialize,
We may spend more for capital expenditures or redevelopment projects than we currently expect,
Our existing joint ventures and any additional joint ventures we may enter into in the future may not be successful,
Our tenants may experience losses and default on their rent obligations to us,
Some of our tenants may not renew expiring leases, and we may be unable to obtain new tenants to maintain or increase the historical occupancy rates of, or rents from, our properties. In addition, we may incur significant costs to reposition or re-lease a vacant property for a new operator and vacancies may reduce the value of the property,
Our ability to grow our business and maintain or increase our distributions to shareholders depends in large part upon our ability to buy properties and arrange for their profitable operation or lease them for rents, less their property operating expenses, that exceed our capital costs. We are currently generally limited in making acquisitions pursuant to our credit agreement. In addition, even after these restrictions expire, we may be unable to identify properties that we want to acquire, and we may fail to reach agreement with the sellers and complete the purchase of any properties we do want to acquire. In addition, we may not realize the returns we expect on any properties we acquire,
Rents that we receive from our properties may decline upon renewals or expirations of our leases because of changing market conditions or otherwise,
Although we have obtained a waiver from compliance with the fixed charge coverage ratio covenant included in our credit agreement through December 2022, if our operating results and financial condition are further adversely impacted by current economic conditions or otherwise, we may fail to comply with the terms of the waiver and other requirements under our credit agreement, and we may also fail to satisfy certain financial requirements under the agreements governing our public debt. For example, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our credit agreement and our public debt covenants as of June 30, 2022, and we cannot be certain how long this ratio will remain below 1.5x. We are unable to incur additional debt until this ratio is at or above 1.5x on a pro forma basis, but we are not required to repay outstanding debt as a result of failure to comply with this financial requirement. We are currently fully drawn under our revolving credit facility and could also be required to repay our outstanding debt in the event of non-compliance with certain other requirements of our credit agreement or the agreements governing our public debt. We may therefore experience future liquidity constraints, as we are currently unable to incur additional debt under our credit agreement or otherwise for failure to comply with the requirements of our credit agreement and the agreements governing our public debt, and we will be limited to our cash on hand or be forced to raise additional sources of capital or take other measures to maintain adequate liquidity,
Actual costs under our revolving credit facility or other floating rate debt will be higher than the stated rates because of fees and expenses associated with such debt,
The premiums used to determine the interest rate payable on our revolving credit facility and the facility fee payable on our revolving credit facility are based on our credit ratings, which are subject to change,
For the three months ended June 30, 2022, substantially all of our NOI was generated from properties where a majority of the revenues are derived from our tenants' and residents' private resources. This may imply that we will maintain or increase the percentage of our NOI generated from private resources at our senior living communities. However, our residents and patients may become unable to fund our charges with private resources and we may be required or may elect for business reasons to accept or pursue revenues from government sources, which could result in an increased part of our NOI and revenue being generated from government payments and our becoming more dependent on government payments. If the government fails to pay us or our managers or other operators amounts due to us or them because of government defaults, shutdowns, budgetary constraints or otherwise, we and they may be significantly negatively impacted,
Circumstances that adversely affect the ability of seniors or their families to pay for our managers' or other operators' services, such as economic downturns or a possible recession, weak housing market conditions, higher levels of unemployment among our residents' family members, lower levels of consumer confidence, inflation, increasing
48

interest rates, stock market volatility and/or changes in demographics generally could affect the profitability of our senior living communities,
It is difficult to accurately estimate tenant space preparation costs. Our unspent leasing related obligations may cost more or less and may take longer to complete than we currently expect, and we may incur increasing amounts for these and similar purposes in the future,
We expect that we will benefit from RMR's Environmental, Social and Governance, or ESG, program and initiatives. However, we may not realize the benefits we expect from such program and initiatives and we or RMR may not succeed in meeting existing or future standards regarding ESG,
We believe that our relationships with our related parties, including AlerisLife (including Five Star) and RMR and others affiliated with them may benefit us and provide us with competitive advantages in operating and growing our business. However, the advantages we believe we may realize from these relationships may not materialize, and
The business and property management agreements between us and RMR have continuing 20 year terms. However, those agreements permit early termination in certain circumstances. Accordingly, we cannot be sure that these agreements will remain in effect for continuing 20 year terms.
Currently unexpected results could occur due to many different circumstances, some of which are beyond our control, such as economic conditions, including increasing interest rates, high inflation and a possible recession, other changes in capital markets or the economy generally, the COVID-19 pandemic and its aftermath, new legislation or regulations affecting our business or the businesses of our managers or other operators or tenants, changes in our managers' or other operators' or tenants' revenues or costs, worsening or lack of improvement of the financial condition or changes in our managers' or other operators' or tenants' financial conditions, deficiencies in operations by a manager or other operator of one or more of our senior living communities, acts of terrorism, war or other hostilities, pandemics, natural disasters or climate change and climate related events.
The information contained elsewhere in this Quarterly Report on Form 10-Q or in our other filings with the SEC, including under the caption “Risk Factors”, or incorporated herein or therein, identifies other important factors that could cause differences from our forward-looking statements. Our other filings with the SEC are available on the SEC's website at www.sec.gov.
You should not place undue reliance upon our forward-looking statements.
Except as required by law, we do not intend to update or change any forward-looking statements as a result of new information, future events or otherwise.
Statement Concerning Limited Liability
The Amended and Restated Declaration of Trust establishing Diversified Healthcare Trust, dated September 20, 1999, as amended and supplemented, as filed with the State Department of Assessments and Taxation of Maryland, provides that no trustee, officer, shareholder, employee or agent of Diversified Healthcare Trust shall be held to any personal liability, jointly or severally, for any obligation of, or claim against, Diversified Healthcare Trust. All persons dealing with Diversified Healthcare Trust in any way shall look only to the assets of Diversified Healthcare Trust for the payment of any sum or the performance of any obligation.
49

PART II.   Other Information
 
Item 1A. Risk Factors.
There have been no material changes to risk factors from those we previously disclosed in our Annual Report.
Item 6. Exhibits.
Exhibit
Number
Description
3.1
3.2
3.3
3.4
3.5
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
4.10
4.11
4.12
10.1
50

10.2
22.1
31.1
31.2
32.1
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document. (Filed herewith.)
101.CALXBRL Taxonomy Extension Calculation Linkbase Document. (Filed herewith.)
101.DEFXBRL Taxonomy Extension Definition Linkbase Document. (Filed herewith.)
101.LABXBRL Taxonomy Extension Label Linkbase Document. (Filed herewith.)
101.PREXBRL Taxonomy Extension Presentation Linkbase Document. (Filed herewith.)
104Cover Page Interactive Data File. (Formatted as Inline XBRL and contained in Exhibit 101.)
51

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 DIVERSIFIED HEALTHCARE TRUST
  
  
 By:/s/ Jennifer F. Francis
  Jennifer F. Francis
  President and Chief Executive Officer
  
Dated: August 3, 2022 
  
  
 By:/s/ Richard W. Siedel, Jr.
  Richard W. Siedel, Jr.
  Chief Financial Officer and Treasurer
  (principal financial and accounting officer)
  
Dated: August 3, 2022 

52
EX-31.1 2 dhc_063022xexhibitx311.htm EX-31.1 Document

Exhibit 31.1
 
CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)
 
I, Jennifer F. Francis, certify that:
 
1.I have reviewed this Quarterly Report on Form 10-Q of Diversified Healthcare Trust;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
 
  
Date: August 3, 2022/s/ Jennifer F. Francis
 Jennifer F. Francis
 President and Chief Executive Officer


EX-31.2 3 dhc_063022xexhibitx312.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)
 
I, Richard W. Siedel, Jr., certify that:
 
1.I have reviewed this Quarterly Report on Form 10-Q of Diversified Healthcare Trust;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
 
  
Date: August 3, 2022/s/ Richard W. Siedel, Jr.
 Richard W. Siedel, Jr.
 Chief Financial Officer and Treasurer


EX-32.1 4 dhc_063022xexhibitx321.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION PURSUANT TO 18 U.S.C. SEC. 1350
 

 
    In connection with the filing by Diversified Healthcare Trust (the “Company”) of the Quarterly Report on Form 10-Q for the period ended June 30, 2022 (the “Report”), each of the undersigned hereby certifies, to the best of his or her knowledge:
 
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
      
 /s/ Jennifer F. Francis
 Jennifer F. Francis
 President and Chief Executive Officer
   
   
 /s/ Richard W. Siedel, Jr.
 Richard W. Siedel, Jr.
 Chief Financial Officer and Treasurer
 
Date: August 3, 2022


EX-101.SCH 5 dhc-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1008009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2102102 - Disclosure - Real Estate Investments link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Real Estate Investments (Tables) link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Real Estate Investments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Real Estate Investments - Equity Investment In Joint Venture (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Real Estate Investments - Mortgage Debt Joint Venture (Details) link:presentationLink link:calculationLink link:definitionLink 2107103 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2109104 - Disclosure - Indebtedness link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Indebtedness (Details) link:presentationLink link:calculationLink link:definitionLink 2111105 - Disclosure - Fair Value of Assets and Liabilities link:presentationLink link:calculationLink link:definitionLink 2312302 - Disclosure - Fair Value of Assets and Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2413406 - Disclosure - Fair Value of Assets and Liabilities - Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2414407 - Disclosure - Fair Value of Assets and Liabilities - Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2415408 - Disclosure - Fair Value of Assets and Liabilities - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2116106 - Disclosure - Noncontrolling Interest link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Noncontrolling Interest (Details) link:presentationLink link:calculationLink link:definitionLink 2118107 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 2319303 - Disclosure - Shareholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - Shareholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - Shareholders' Equity - Schedule of Dividends Declared and Paid (Details) link:presentationLink link:calculationLink link:definitionLink 2122108 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2323304 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2424412 - Disclosure - Segment Reporting - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2425413 - Disclosure - Segment Reporting - Income Statements (Details) link:presentationLink link:calculationLink link:definitionLink 2426414 - Disclosure - Segment Reporting - Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2127109 - Disclosure - Senior Living Community Management Agreements link:presentationLink link:calculationLink link:definitionLink 2328305 - Disclosure - Senior Living Community Management Agreements (Tables) link:presentationLink link:calculationLink link:definitionLink 2429415 - Disclosure - Senior Living Community Management Agreements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2430416 - Disclosure - Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2131110 - Disclosure - Business and Property Management Agreements with RMR link:presentationLink link:calculationLink link:definitionLink 2432417 - Disclosure - Business and Property Management Agreements with RMR (Details) link:presentationLink link:calculationLink link:definitionLink 2133111 - Disclosure - Related Person Transactions link:presentationLink link:calculationLink link:definitionLink 2434418 - Disclosure - Related Person Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 2135112 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2436419 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2137113 - Disclosure - Weighted Average Common Shares (shares amounts in thousands) link:presentationLink link:calculationLink link:definitionLink 2438420 - Disclosure - Weighted Average Common Shares (shares amounts in thousands) (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 dhc-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 7 dhc-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 8 dhc-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Net (loss) income Net (loss) income Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Related Party Transactions [Abstract] Related Party Transactions [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Area of real estate property Area of Real Estate Property Assumed real estate lease obligations, net Off-Market Lease, Unfavorable Debt Instrument [Axis] Debt Instrument [Axis] Finance lease obligations Finance Lease, Liability Distributions to shareholders Distributions to shareholders Total Distributions Payments of Ordinary Dividends, Common Stock Total real estate properties, gross Total real estate properties, gross Real Estate Investment Property, at Cost Number of management agreements Related Party, Management Agreements Related Party, Management Agreements Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Expenses from transactions with related party Related Party Transaction, Expenses from Transactions with Related Party Unsecured revolving credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Fair value disclosure Debt Instrument, Fair Value Disclosure Real Estate Investments Real Estate Disclosure [Text Block] Lease income Lease Income Property management and construction supervision fees Property Management and Construction Supervision Fees Represents the property management and construction supervision fees incurred pursuant to business and property management agreements with related parties. Fair Value Measurement [Domain] Fair Value Measurement [Domain] Basis points per annum (as a percent) Debt Instrument, Basis Spread on Variable Rate Statistical Measurement [Domain] Statistical Measurement [Domain] Depreciation and amortization Depreciation Coupon rate (percent) Debt Instrument, Interest Rate, Stated Percentage Additional paid in capital Additional Paid in Capital, Common Stock Investments in unconsolidated joint ventures Investments In Unconsolidated Joint Ventures Investments In Unconsolidated Joint Ventures Repayments of debt Repayments of Debt Other non-cash adjustments, net Other Noncash Income (Expense) Income taxes paid Income Taxes Paid Net (loss) income attributable to common shareholders Net Income (Loss) Attributable to Parent Measurement Input Type [Domain] Measurement Input Type [Domain] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Aggregate principal amount of mortgage debt Secured Debt Subsequent Event Type [Axis] Subsequent Event Type [Axis] Capitalized interest Interest Paid, Capitalized, Investing Activities Share forfeitures Shares Issued, Value, Share-Based Payment Arrangement, Forfeited Number of states in which properties are located Number of States in which Entity Operates Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Real estate, net Deconsolidation Of Previously Consolidated Investments, Real Estate Deconsolidation Of Previously Consolidated Investments, Real Estate Secured Debts Secured Debt [Member] Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Scenario [Axis] Scenario [Axis] Redemption price (as a percent) Debt Instrument, Redemption Price, Percentage Ownership [Axis] Ownership [Axis] Investment, Name [Domain] Investment, Name [Domain] Payment of debt issuance costs Payments of Financing Costs Related Party [Domain] Related Party [Domain] Plan Name [Axis] Plan Name [Axis] Debt instrument, amount redeemed Debt Instrument, Amount Redeemed Debt Instrument, Amount Redeemed Real Estate Real Estate [Line Items] Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Number of communities managed Number of Communities Managed by Related Party Represents the number of communities managed by a related party. Number of operating segments Number of Operating Segments SHOP Senior Housing Operating Portfolio Segment [Member] Senior Housing Operating Portfolio [Member] Noncontrolling Interest [Abstract] Plan Name [Domain] Plan Name [Domain] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Number of third party institutional investors Number Of Third Party Institutional Investors Number Of Third Party Institutional Investors Revolving credit facility Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Loss on modification or early extinguishment of debt Gain (Loss) On Early Extinguishment Of Debt Gain (Loss) On Early Extinguishment Of Debt Net cash (used in) provided by operating activities Net Cash Provided by (Used in) Operating Activities Related Party Transaction [Domain] Related Party Transaction [Domain] Other liabilities Other Liabilities Expenses: Expenses: Costs and Expenses [Abstract] Senior Unsecured Notes Senior Unsecured Notes [Member] Senior Unsecured Notes [Member] Amortization of acquired real estate leases Amortization of Acquired Real Estate Leases and Other Intangible Assets Represents the amortization of acquired real estate leases and other intangible assets during the period. Share forfeitures (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period RMR Reit Management And Research [Member] Represents details pertaining to Reit Management and Research LLC, or RMR. Legal Entity [Axis] Legal Entity [Axis] Per common share amounts (basic and diluted): Per Common Share Amounts, Basic and Diluted [Abstract] Per Common Share Amounts, Basic and Diluted Total liabilities Liabilities Share-based Compensation Arrangement by Share-based Payment Award Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Reimbursement revenue lease Reimbursement Revenue Lease Reimbursement Revenue Lease Geographical [Axis] Geographical [Axis] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Real Estate [Table] Real Estate [Table] Revolving Credit Facility Revolving Credit Facility [Member] Document Type Document Type SOFR Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Property management fee Property Management Fee Property Management Fee Segments [Axis] Segments [Axis] Indebtedness Debt Disclosure [Text Block] Total real estate properties, net Real Estate Investment Property, Net Proceeds from sale of interest in joint venture, net Proceeds from Divestiture Of Interest In Joint Venture, Net Proceeds from Divestiture Of Interest In Joint Venture, Net Period of actual amount of incentive fees Period Of Actual Amount Of Incentive Fees Period Of Actual Amount Of Incentive Fees Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Number of property units (units) Number of Units in Real Estate Property Business and Property Management Agreements with RMR LLC Business And Property Management Agreements [Text Block] Business And Property Management Agreements Concentration Risk [Table] Concentration Risk [Table] Diversified Healthcare Trusts Diversified Healthcare Trusts [Member] Diversified Healthcare Trusts Number joint venture arrangements Number Joint Venture Arrangements Number Joint Venture Arrangements Proceeds from sale of interest in joint venture, net Proceeds from Divestiture of Interest in Joint Venture Affiliated Entity Affiliated Entity [Member] Consolidation Items [Domain] Consolidation Items [Domain] Subsequent Event Subsequent Event [Member] Document Period End Date Document Period End Date Trustee Trustee [Member] Trustee Proceeds from sale of properties to joint venture, net Proceeds from Real Estate and Real Estate Joint Ventures Non-cash investing activities: Noncash Investing Activities [Abstract] Represents the information pertaining to the Non cash investing activities. Total assets Total assets Assets Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Schedule of Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Fair value measurement, number of debt securities Fair Value Measurement, Number Of Debt Securities Fair Value Measurement, Number Of Debt Securities Unsecured Debt Unsecured Debt [Member] Interest and other income Interest and other income Interest and Other Income Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Medical Office and Life Science Properties Medical Office and Life Science Properties [Member] Medical Office and Life Science Properties Unsecured Revolving Credit Facility Line of Credit [Member] (Loss) income from continuing operations before income tax benefit (expense) and equity in earnings of investees Income (loss) from continuing operations before income tax benefit (expense) and equity in earnings of investees Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Net amortization of debt premiums, discounts and issuance costs Amortization of Debt Issuance Costs and Discounts Weighted Average Common Shares (shares amounts in thousands) Earnings Per Share [Text Block] Noncontrolling Interest Noncontrolling Interest Disclosure [Text Block] 6.25% Senior Notes due 2046 Senior Notes Due 2046 [Member] Senior Notes Due 2046 [Member] Interest Rate Cap Interest Rate Cap [Member] Related person transactions Related Party Transaction [Line Items] Investments in unconsolidated joint ventures Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures Buildings and improvements Buildings and Improvements, Gross Loss on modification or early extinguishment of debt Gain (loss) on extinguishment of debt Gain (loss) on modification or early extinguishment of debt Gain (Loss) on Extinguishment of Debt Number of owned properties Number Of Owned Properties Number Of Owned Properties Derivative Contract [Domain] Derivative Contract [Domain] Entity Registrant Name Entity Registrant Name Property management agreement expense Related Party Transaction, Expenses from Property Management Agreement Transactions with Related Party Expenses recognized during the period resulting from property management transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period. Weighted average share price (in dollars per share) Stock Repurchased During Period, Weighted Average Price Stock Repurchased During Period, Weighted Average Price Mortgages Mortgages [Member] Proceeds from sale of properties, net Proceeds from Sale of Real Estate Held-for-investment Entity Address, City or Town Entity Address, City or Town Investment owned, percentage of total shares outstanding Investment Owned, Percentage of Total Shares Outstanding Represents the number of shares held as a percentage of the total shares outstanding at the end of the period. Leases [Abstract] Leases [Abstract] Total shareholders' equity Beginning balance Ending balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Number of medical office and life science properties Number Of Medical Office And Life Science Properties Number Of Medical Office And Life Science Properties Minimum Minimum [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common shares of beneficial interest, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Holding period Equity Securities, FV-NI, Holding Period Equity Securities, FV-NI, Holding Period Number of extension options Number Of Extension Options Number Of Extension Options Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Fair Value of Assets and Liabilities Fair Value Disclosures [Text Block] Investment, Name [Axis] Investment, Name [Axis] Share price (in dollars per share) Share Price Trading Symbol(s) Trading Symbol Entity File Number Entity File Number Disposal Group Classification [Axis] Disposal Group Classification [Axis] Repayment of term loan Repayments of Unsecured Debt Title of Individual [Axis] Title of Individual [Axis] Entity Information Entity Information [Line Items] Proceeds from borrowings on revolving credit facility Proceeds from Lines of Credit Debt ratio Consolidated Income Available To Debt Ratio Consolidated Income Available To Debt Ratio LIBOR London Interbank Offered Rate (LIBOR) [Member] Finance Leased Properties Finance Leased Properties [Member] Finance Leased Properties Income Taxes Income Tax Disclosure [Text Block] Loss on early extinguishment of debt settled in cash Payment for Debt Extinguishment or Debt Prepayment Cost Gain (loss) on sales of beds Gain (Loss) on Disposition of Other Assets Credit Facility [Domain] Credit Facility [Domain] Business management fees incurred Business Management Fees Represents the business management fees incurred pursuant to business management agreement with related parties. Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Property operating expenses Property operating expenses Operating Costs and Expenses Net (loss) income attributable to common shareholders - basic (in dollars per share) Earnings Per Share, Basic Real estate properties: Real Estate Investment Property, Net [Abstract] Senior Living Communities Senior Living Community [Member] Represents the information pertaining to senior living properties. Senior apartments are marketed to residents who are generally capable of caring for themselves. Residence is usually restricted on the basis of age. Purpose built properties may have special function rooms, concierge services, high levels of security and assistance call systems for emergency use. AlerisLife Inc AlerisLife Inc [Member] AlerisLife Inc Non-Segment Corporate, Non-Segment [Member] Distributions to noncontrolling interest Payments to Noncontrolling Interests Counterparty Name [Domain] Counterparty Name [Domain] 5.625% Senior Notes due 2042 Senior Notes Due 2042 [Member] Senior Notes Due 2042 [Member] Distributions Dividends, Common Stock Ownership [Domain] Ownership [Domain] Entity Interactive Data Current Entity Interactive Data Current Noncontrolling Interest Noncontrolling Interest [Line Items] Medical Office And Life Science Medical Office And Life Science [Member] Medical Office And Life Science Senior unsecured notes, 5.625% coupon rate, due 2042 Senior Unsecured Notes 5.625 Percent Due 2042 [Member] Senior Unsecured Notes 5.625 Percent Due 2042 Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Seaport Innovation LLC Seaport Innovation LLC [Member] Seaport Innovation LLC Change in assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Cumulative Net Income Retained Earnings [Member] Segment reporting Segment Reporting Information [Line Items] Common Shares Common Stock [Member] The LSMD Fund REIT LLC The LSMD Fund REIT LLC [Member] The LSMD Fund REIT LLC Repurchase of common shares Payments for Repurchase of Common Stock Statement [Table] Statement [Table] Document Quarterly Report Document Quarterly Report Closed Disposal Group, Held-for-sale, Not Discontinued Operations [Member] Related party transaction, closing cost Related Party Transaction, Closing Cost Related Party Transaction, Closing Cost Joint Venture Joint Venture [Member] Joint Venture [Member] Statistical Measurement [Axis] Statistical Measurement [Axis] Losses on equity securities, net Equity Securities, FV-NI, Realized Gain (Loss) Related Party Transaction [Axis] Related Party Transaction [Axis] Cumulative net income Retained Earnings (Accumulated Deficit) Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] Recurring Fair Value, Recurring [Member] Related Person Transactions Related Party Transactions Disclosure [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Five Star Five Star Quality Care Inc [Member] Represents the information pertaining to Five Star Quality Care, Inc. Statement Summarized financial information of significant tenant Statement [Line Items] Real estate improvements Payments for Capital Improvements Medical Office Building Medical Office Building [Member] Represents the information pertaining to medical office buildings. The MOBs are office or commercial buildings constructed for use or operated as medical office space for physicians and other health personnel, and other businesses in medical related fields, including clinics and laboratory uses. Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] California CALIFORNIA Senior unsecured notes, 6.250% coupon rate, due 2046 Senior Unsecured Notes 6.25 Percent Due 2046 [Member] Senior Unsecured Notes 6.25 Percent Due 2046 Operating lease, right-of-use asset Operating Lease, Right-of-Use Asset Share repurchases Stock Repurchased During Period, Value Document Transition Report Document Transition Report Rental income Rental Income [Member] Rental Income [Member] Local Phone Number Local Phone Number Beginning balance (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Purchase price Real Estate Aggregate Purchase Price Real Estate Aggregate Purchase Price Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Share repurchases (in shares) Number of shares (in shares) Stock Repurchased During Period, Shares Name of Property [Domain] Name of Property [Domain] Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Income Tax Expense (Benefit) Income tax benefit (expense) Income Tax Expense (Benefit) Geographical [Domain] Geographical [Domain] Income Statement [Abstract] Income Statement [Abstract] Additional Paid In Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Capital expenditure Capital Expenditure Funding Capacity Capital Expenditure Funding Capacity Cumulative Distributions Cumulative Common Distributions [Member] Represents cumulative distributions to common shareholders. Weighted average common shares outstanding (diluted) (in shares) Weighted Average Number of Shares Outstanding, Diluted Senior Living Community Management Agreements Concentration Risk Disclosure [Text Block] Life Science Building Located In California Life Science Building Located In California [Member] Life Science Building Located In California Basic housing and support services Basic Housing And Support Services [Member] Basic Housing And Support Services [Member] Distribution per share (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 239,123,496 and 238,994,894 shares issued and outstanding, respectively Common Stock, Value, Issued Carrying Amount Reported Value Measurement [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Residents fees and services Resident Fees And Services [Member] Resident Fees And Services [Member] Related party transaction capitalized amount Related Party Transaction Capitalized Amount Related Party Transaction Capitalized Amount Operating Segments Operating Segments [Member] Rehabilitation Services Rehabilitation Services [Member] Rehabilitation Services [Member] Cash and cash equivalents and restricted cash at beginning of period Cash and cash equivalents and restricted cash at end of period Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Equity securities investment (in shares) Investment Owned, Balance, Shares Cumulative distributions Cumulative Common Stock Dividends The amount as of the balance sheet date representing cumulative distributions to common shareholders. Net income attributable to noncontrolling interest Net income attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Proceeds from issuance of senior unsecured notes, net Proceeds from Issuance of Unsecured Debt Schedule of Equity Method Investments Equity Method Investments [Table Text Block] Common shares of beneficial interest, shares issued (in shares) Common Stock, Shares, Issued Number of unconsolidated joint ventures Number Of Unconsolidated Joint Ventures Number Of Unconsolidated Joint Ventures Total Equity Attributable to Common Shareholders Parent [Member] Income Statement Location [Domain] Income Statement Location [Domain] Acquisition and certain other transaction related costs Business Combination, Acquisition Related Costs Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Debt face amount Debt Instrument, Face Amount Additional equity joint venture percentage Percentage Of Equity Method Investment Sold Percentage Of Equity Method Investment Sold Mortgages 6.28 Percent Due July 2022 Mortgages 6.28 Percent Due July 2022 [Member] Mortgages 6.28 Percent Due July 2022 Percentage target EBITDA of new management agreement not earned Related Party Transaction, Percentage Target EBITDA Of New Management Agreement Not Earned Related Party Transaction, Percentage Target EBITDA Of New Management Agreement Not Earned Schedule of segment reporting information Schedule of Segment Reporting Information, by Segment [Table Text Block] Entity Current Reporting Status Entity Current Reporting Status Real estate improvements accrued, not paid Construction in Progress Expenditures Incurred but Not yet Paid Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Number of consecutive renewal terms of agreement Related Party Transaction, Property Management Agreement, Number of Consecutive Renewal Terms Represents the number of consecutive renewal terms of agreement that the entity has the option to renew. Counterparty Name [Axis] Counterparty Name [Axis] (Loss) gain on sale of properties Gain on sale of properties Gain (Loss) on Sale of Properties Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Office Portfolio Office Portfolio Segment [Member] Office Portfolio Segment Entities [Table] Entities [Table] Schedule of Dividends Declared and Paid Dividends Declared [Table Text Block] Title of Individual [Domain] Title of Individual [Domain] Common shares of beneficial interest, shares authorized (in shares) Common Stock, Shares Authorized Schedule of Related Party Transactions, by Related Party [Table] Schedule of Related Party Transactions, by Related Party [Table] Party transaction property management and construction supervision fees capitalized Property Management And Construction Supervision Fees, Capitalized Property Management And Construction Supervision Fees, Capitalized Corporate Joint Venture Corporate Joint Venture [Member] Maximum Maximum [Member] Senior unsecured notes, 4.375% coupon rate, due 2031 Senior Unsecured Notes 4.375 Percent Due 2031 [Member] Senior Unsecured Notes 4.375 Percent Due 2031 Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Losses on equity securities, net Equity Securities, FV-NI, Gain (Loss) Medical Office Building and Life Science Building Medical Office Building and Life Science Building [Member] Medical Office Building and Life Science Building [Member] Operating Lease, Right-of-Use Asset, Statement of Financial Position Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Entity Smaller Reporting Company Entity Small Business Measurement Basis [Axis] Measurement Basis [Axis] Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Distributions to common shareholders declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Common shares awarded (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Revenues: Revenues: Revenues [Abstract] Senior unsecured notes, net Senior Notes Acquired real estate leases and other intangible assets, net Finite-Lived Intangible Assets, Net Distributions to noncontrolling interest Distributions to noncontrolling interest Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Restricted cash Restricted cash Restricted Cash Straight line rental income, excluding properties held-for-sale Straight Line Rent, Excluding Properties Held-for-Sale Straight Line Rent, Excluding Properties Held-for-Sale Number of properties included in joint venture agreement Number Of Properties Included In Joint Venture Agreement Number Of Properties Included In Joint Venture Agreement Schedule of Carrying Value and Fair Value of the Financial Instruments Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block] Real estate property fair value Real Estate Property Fair Value Real Estate Property Fair Value Unrelated Investor Two Unrelated Investor Two [Member] Unrelated Investor Two Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Number of properties (property) Number of real estate properties Number of Real Estate Properties Title Of Each Class Title of 12(b) Security Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Variable lease, payment Variable Lease, Payment Contract Type [Axis] Contract Type [Axis] Contract Type Noncontrolling interest, ownership percentage by parent Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Finance leased asset, accumulated depreciation Finance Lease, Right-of-Use Asset, Accumulated Amortization Unconsolidated joint venture distributions Proceeds from Equity Method Investment, Distribution Total expenses Costs and Expenses Minimum liquidity requirement Minimum Liquidity Requirement Amount Minimum Liquidity Requirement Amount Share grants (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures Repayments of borrowings on revolving credit facility Repayments of lines of credit Repayments of Lines of Credit Indebtedness Debt Instrument [Line Items] Accrued interest Interest Payable Massachusetts MASSACHUSETTS Operating lease, liability Operating Lease, Liability Segment Reporting Segment Reporting Disclosure [Text Block] Land Land Noncontrolling Interest [Table] Noncontrolling Interest [Table] Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Estimated Fair Value Estimate of Fair Value Measurement [Member] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Other assets, net Increase (Decrease) In Investment In Joint Venture Other Assets, Net Former Employees Of RMR LLC Former Employees Of RMR LLC [Member] Former Employees Of RMR LLC Other assets Increase (Decrease) in Other Operating Assets Contract Type [Domain] Contract Type [Domain] Contract Type Number of employees Entity Number of Employees Senior Unsecured Note Due 2022 Senior Unsecured Note Due 2025 [Member] Senior Unsecured Note Due 2025 Entity Filer Category Entity Filer Category Measurement input Equity Securities, FV-NI, Measurement Input Weighted average common shares outstanding (basic) (in shares) Weighted Average Number of Shares Outstanding, Basic Shareholders' equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Equity method investment ownership percentage Equity method investment ownership percentage Equity Method Investment, Ownership Percentage Commitments and contingencies Commitments and Contingencies Name Of Each Exchange On Which Registered Security Exchange Name Accrued interest Increase (Decrease) in Interest Payable, Net Real Estate Properties Property, Plant and Equipment [Line Items] Revenues Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations [Member] Repayment of other debt Repayments of Other Debt Cover [Abstract] Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Operating Lease, Liability, Statement of Financial Position Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Accumulated depreciation Real Estate Investment Property, Accumulated Depreciation Other assets, net Other Assets Number of properties transitioned Number Of Real Estate Properties Transitioned Number Of Real Estate Properties Transitioned Segment Reporting [Abstract] Segment Reporting [Abstract] Investments in affiliates, fair value Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure Secured debt and finance leases, net Secured Debt And Finance Lease Obligations Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower and amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date. Total Equity Attributable to Noncontrolling Interest Noncontrolling Interest [Member] Forecast Forecast [Member] Senior unsecured notes, 4.750% coupon rate, due 2028 Senior Unsecured Notes 4.75 Percent Due 2028 [Member] Senior Unsecured Notes 4.75 Percent Due 2028 [Member] Property management and construction supervision fees paid Property Management And Construction Supervision Fees Paid Represents the property management and construction supervision fees paid to related parties. Number of states Number Of States Number Of States Total liabilities and shareholders' equity Liabilities and Equity Operating Expense Operating Expense [Member] Investor Third Party Investor Third Party Investor [Member] Third Party Investor Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Related Party [Axis] Related Party [Axis] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Senior Living Communities Senior Living Communities [Member] Senior Living Communities Skilled nursing bed license skilled nursing bed license [Member] skilled nursing bed license Net (loss) income attributable to common shareholders - diluted (in dollars per share) Earnings Per Share, Diluted Consolidation Items [Axis] Consolidation Items [Axis] Deferred leasing costs, net Increase (Decrease) in Deferred Leasing Fees Finance leased asset, gross Finance Lease, Right-of-Use Asset, before Accumulated Amortization Debt instrument, facility fee (as a percent) Line of Credit Facility, Commitment Fee Percentage Life Science Property Life Science Property [Member] Life Science Property Entity Address, Address Line One Entity Address, Address Line One Senior unsecured notes, 9.750% coupon rate, due 2025 Senior Unsecured Notes 9.75 Percent Due 2025 [Member] Senior Unsecured Notes 9.75 Percent Due 2025 Related party transaction business management agreement, annual incentive fee estimate included in management fees Business Management Agreement Annual Incentive Fee Estimate Included in Management Fees Business Management Agreement Annual Incentive Fee Estimate Included in Management Fees Unrelated Investor One Unrelated Investor One [Member] Unrelated Investor One Product and Service [Axis] Product and Service [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Interest expense (including net amortization of debt premiums, discounts and issuance costs of $2,318, $3,017, $4,790 and $5,829, respectively) Interest expense Interest Expense Credit Facility [Axis] Credit Facility [Axis] Share Award Plans Share Award Plans [Member] Share Award Plans Amounts of transaction Related Party Transaction, Amounts of Transaction Entity Tax Identification Number Entity Tax Identification Number Senior unsecured notes, 4.750% coupon rate, due 2024 Senior Unsecured Notes 4.75 Percent Due 2024 [Member] Senior Unsecured Notes 4.75 Percent Due 2024 Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Weighted average interest rate on debt (as a percent) Debt Instrument, Interest Rate During Period (Decrease) increase in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Related party transactions, termination percentage Related Party Transactions, Termination Percentage Related Party Transactions, Termination Percentage Private pay and other third party payer SNF services Private Pay And Other Third Party Payer Services [Member] Private Pay And Other Third Party Payer Services [Member] Straight line rental income Straight line rental income Straight Line Rent Entity Central Index Key Entity Central Index Key Real Estate [Abstract] Real Estate [Abstract] Measurement Frequency [Axis] Measurement Frequency [Axis] Name of Property [Axis] Name of Property [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Measurement Input Type [Axis] Measurement Input Type [Axis] Entity [Domain] Entity [Domain] City Area Code City Area Code General and administrative General and administrative General and Administrative Expense Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Medicare and Medicaid programs Medicare And Medicaid Programs [Member] Medicare And Medicaid Programs [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Extension term Debt Instrument, Extension Option Term Debt Instrument, Extension Option Term Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Share grants Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture Variable Rate [Axis] Variable Rate [Axis] Redemption of senior unsecured notes Repayments of Senior Debt Leases Lessor, Operating Leases [Text Block] Real Estate, Type of Property [Axis] Real Estate, Type of Property [Axis] Equity in earnings of investees Equity in earnings of investees Income (Loss) from Equity Method Investments Disposal Group Classification [Domain] Disposal Group Classification [Domain] Other liabilities Increase (Decrease) in Other Operating Liabilities Impairment of assets Asset Impairment Charges Disaggregation of Revenue Disaggregation of Revenue [Line Items] Proceeds from sale of other assets Proceeds from Sale of Other Assets Revolving credit facility, interest rate payable (as a percent) Line of Credit Facility, Interest Rate at Period End Real Estate [Domain] Real Estate [Domain] Measurement Input, Market Capitalization Rate Measurement Input, Market Capitalization Rate [Member] Measurement Input, Market Capitalization Rate EX-101.PRE 9 dhc-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 10 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover - shares
6 Months Ended
Jun. 30, 2022
Jul. 29, 2022
Entity Information    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2022  
Document Transition Report false  
Entity File Number 1-15319  
Entity Registrant Name DIVERSIFIED HEALTHCARE TRUST  
Entity Incorporation, State or Country Code MD  
Entity Tax Identification Number 04-3445278  
Entity Address, Address Line One Two Newton Place, 255 Washington Street, Suite 300,  
Entity Address, City or Town Newton  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02458-1634  
City Area Code 617  
Local Phone Number 796 - 8350  
Title Of Each Class Common Shares of Beneficial Interest  
Trading Symbol(s) DHC  
Name Of Each Exchange On Which Registered NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Smaller Reporting Company false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   239,123,496
Entity Central Index Key 0001075415  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
5.625% Senior Notes due 2042    
Entity Information    
Title Of Each Class 5.625% Senior Notes due 2042  
Trading Symbol(s) DHCNI  
Name Of Each Exchange On Which Registered NASDAQ  
6.25% Senior Notes due 2046    
Entity Information    
Title Of Each Class 6.25% Senior Notes due 2046  
Trading Symbol(s) DHCNL  
Name Of Each Exchange On Which Registered NASDAQ  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Real estate properties:    
Land $ 652,655 $ 741,501
Buildings and improvements 5,819,802 6,072,055
Total real estate properties, gross 6,472,457 6,813,556
Accumulated depreciation (1,738,379) (1,737,807)
Total real estate properties, net 4,734,078 5,075,749
Investments in unconsolidated joint ventures 158,759 215,127
Cash and cash equivalents 705,160 634,848
Restricted cash 163,242 [1] 382,097
Acquired real estate leases and other intangible assets, net 37,359 48,746
Other assets, net 347,266 266,947
Total assets 6,145,864 6,623,514
Liabilities and Shareholders' Equity    
Revolving credit facility 700,000 800,000
Senior unsecured notes, net 2,315,286 2,806,811
Secured debt and finance leases, net 57,006 69,713
Accrued interest 27,639 29,845
Assumed real estate lease obligations, net 1,293 2,556
Other liabilities 255,015 252,199
Total liabilities 3,356,239 3,961,124
Commitments and contingencies
Shareholders' equity:    
Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 239,123,496 and 238,994,894 shares issued and outstanding, respectively 2,391 2,390
Additional paid in capital 4,616,449 4,615,475
Cumulative net income 2,218,664 2,087,624
Cumulative distributions (4,047,879) (4,043,099)
Total shareholders' equity 2,789,625 2,662,390
Total liabilities and shareholders' equity $ 6,145,864 $ 6,623,514
[1] As of June 30, 2022, restricted cash consists of proceeds from the sale of joint venture interests and proceeds from the sale of properties to joint ventures held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties. Prior to the deconsolidation of the joint venture that owns a life science property located in Boston, Massachusetts, or our Boston life science property joint venture, restricted cash also consisted of cash held for the operations of this joint venture. As of June 30, 2021, restricted cash also included amounts from dispositions held as collateral pursuant to our credit agreement. In June 2022, we sold an additional 10% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022, which will be included in restricted cash in our condensed consolidated balance sheet.
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Common shares of beneficial interest, par value (in dollars per share) $ 0.01 $ 0.01
Common shares of beneficial interest, shares authorized (in shares) 300,000,000 300,000,000
Common shares of beneficial interest, shares issued (in shares) 239,123,496 238,994,894
Beginning balance (in shares) 239,123,496 238,994,894
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues:        
Revenues $ 313,028 $ 346,341 $ 623,761 $ 709,065
Expenses:        
Property operating expenses 266,066 264,632 534,808 552,023
Depreciation and amortization 58,261 67,888 115,520 134,041
General and administrative 7,207 9,126 14,492 16,668
Acquisition and certain other transaction related costs 609 12,071 1,537 12,071
Impairment of assets 0 0 0 (174)
Total expenses 332,143 353,717 666,357 714,629
(Loss) gain on sale of properties (686) 30,760 327,108 30,638
Losses on equity securities, net (10,157) (3,849) (18,710) (12,188)
Interest and other income 2,266 16,038 2,661 18,873
Interest expense (including net amortization of debt premiums, discounts and issuance costs of $2,318, $3,017, $4,790 and $5,829, respectively) (55,975) (67,657) (113,106) (127,748)
Loss on modification or early extinguishment of debt (29,560) (370) (30,043) (2,410)
(Loss) income from continuing operations before income tax benefit (expense) and equity in earnings of investees (113,227) (32,454) 125,314 (98,399)
Income Tax Expense (Benefit) 640 (191) (832) (429)
Equity in earnings of investees 3,204   6,558 0
Net (loss) income (109,383) (32,645) 131,040 (98,828)
Net income attributable to noncontrolling interest 0 (1,577) 0 (2,899)
Net (loss) income attributable to common shareholders $ (109,383) $ (34,222) $ 131,040 $ (101,727)
Weighted average common shares outstanding (basic) (in shares) 238,197 237,871 238,173 237,853
Weighted average common shares outstanding (diluted) (in shares) 238,197 237,871 238,173 237,853
Per common share amounts (basic and diluted):        
Net (loss) income attributable to common shareholders - basic (in dollars per share) $ (0.46) $ (0.14) $ 0.55 $ (0.43)
Net (loss) income attributable to common shareholders - diluted (in dollars per share) $ (0.46) $ (0.14) $ 0.55 $ (0.43)
Affiliated Entity        
Expenses:        
Equity in earnings of investees $ 3,204 $ 0 $ 6,558 $ 0
Rental income        
Revenues:        
Revenues 62,522 102,394 127,807 205,152
Residents fees and services        
Revenues:        
Revenues $ 250,506 $ 243,947 $ 495,954 $ 503,913
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Statement [Abstract]        
Net amortization of debt premiums, discounts and issuance costs $ 2,318 $ 3,017 $ 4,790 $ 5,829
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Total Equity Attributable to Common Shareholders
Common Shares
Additional Paid In Capital
Cumulative Net Income
Cumulative Distributions
Total Equity Attributable to Noncontrolling Interest
Beginning balance at Dec. 31, 2020 $ 2,619,222 $ 2,495,837 $ 2,383 $ 4,613,904 $ 1,913,109 $ (4,033,559) $ 123,385
Beginning balance (in shares) at Dec. 31, 2020     238,268,478        
Increase (Decrease) in Stockholders' Equity              
Net (loss) income (66,183) (67,505)     (67,505)   1,322
Distributions (2,383) (2,383)       (2,383)  
Share grants 228 228   228      
Distributions to noncontrolling interest (5,694)           (5,694)
Ending balance at Mar. 31, 2021 2,545,190 2,426,177 $ 2,383 4,614,132 1,845,604 (4,035,942) 119,013
Ending balance (in shares) at Mar. 31, 2021     238,268,478        
Beginning balance at Dec. 31, 2020 2,619,222 2,495,837 $ 2,383 4,613,904 1,913,109 (4,033,559) 123,385
Beginning balance (in shares) at Dec. 31, 2020     238,268,478        
Increase (Decrease) in Stockholders' Equity              
Net (loss) income (98,828)            
Distributions to noncontrolling interest (11,324)            
Ending balance at Jun. 30, 2021 2,505,149 2,390,189 $ 2,384 4,614,748 1,811,382 (4,038,325) 114,960
Ending balance (in shares) at Jun. 30, 2021     238,374,572        
Beginning balance at Mar. 31, 2021 2,545,190 2,426,177 $ 2,383 4,614,132 1,845,604 (4,035,942) 119,013
Beginning balance (in shares) at Mar. 31, 2021     238,268,478        
Increase (Decrease) in Stockholders' Equity              
Net (loss) income (32,645) (34,222)     (34,222)   1,577
Distributions (2,383) (2,383)       (2,383)  
Share grants (in shares)     120,000        
Share grants 676 676 $ 1 675      
Share repurchases (59) (59)   (59)      
Share repurchases (in shares)     (13,906)        
Distributions to noncontrolling interest (5,630)           (5,630)
Ending balance at Jun. 30, 2021 2,505,149 2,390,189 $ 2,384 4,614,748 1,811,382 (4,038,325) 114,960
Ending balance (in shares) at Jun. 30, 2021     238,374,572        
Beginning balance at Dec. 31, 2021 $ 2,662,390 2,662,390 $ 2,390 4,615,475 2,087,624 (4,043,099) 0
Beginning balance (in shares) at Dec. 31, 2021 238,994,894   238,994,894        
Increase (Decrease) in Stockholders' Equity              
Net (loss) income $ 240,423 240,423     240,423    
Distributions (2,390) (2,390)       (2,390)  
Share grants 318 318   318      
Share repurchases (5) (5)   (5)      
Share repurchases (in shares)     (1,698)        
Share forfeitures (3) (3)   (3)      
Share forfeitures (in shares)     (4,900)        
Ending balance at Mar. 31, 2022 2,900,733 2,900,733 $ 2,390 4,615,785 2,328,047 (4,045,489) 0
Ending balance (in shares) at Mar. 31, 2022     238,988,296        
Beginning balance at Dec. 31, 2021 $ 2,662,390 2,662,390 $ 2,390 4,615,475 2,087,624 (4,043,099) 0
Beginning balance (in shares) at Dec. 31, 2021 238,994,894   238,994,894        
Increase (Decrease) in Stockholders' Equity              
Net (loss) income $ 131,040            
Ending balance at Jun. 30, 2022 $ 2,789,625 2,789,625 $ 2,391 4,616,449 2,218,664 (4,047,879) 0
Ending balance (in shares) at Jun. 30, 2022 239,123,496   239,123,496        
Beginning balance at Mar. 31, 2022 $ 2,900,733 2,900,733 $ 2,390 4,615,785 2,328,047 (4,045,489) 0
Beginning balance (in shares) at Mar. 31, 2022     238,988,296        
Increase (Decrease) in Stockholders' Equity              
Net (loss) income (109,383) (109,383)     (109,383)    
Distributions (2,390) (2,390)       (2,390)  
Share grants (in shares)     140,000        
Share grants 669 669 $ 1 668      
Share forfeitures (4) (4)   (4)      
Share forfeitures (in shares)     (4,800)        
Ending balance at Jun. 30, 2022 $ 2,789,625 $ 2,789,625 $ 2,391 $ 4,616,449 $ 2,218,664 $ (4,047,879) $ 0
Ending balance (in shares) at Jun. 30, 2022 239,123,496   239,123,496        
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net income (loss) $ 131,040 $ (98,828)
Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:    
Depreciation and amortization 115,520 134,041
Net amortization of debt premiums, discounts and issuance costs 4,790 5,829
Straight line rental income (4,455) (2,125)
Amortization of acquired real estate leases 162 (3,715)
Loss on modification or early extinguishment of debt 30,043 2,410
Impairment of assets 0 (174)
Gain on sale of properties (327,108) (30,638)
Losses on equity securities, net 18,710 12,188
Other non-cash adjustments, net (905) (982)
Unconsolidated joint venture distributions 5,660 0
Equity in earnings of investees (6,558) 0
Change in assets and liabilities:    
Deferred leasing costs, net (4,968) (8,258)
Other assets 25,922 (7,937)
Accrued interest (2,206) 8,918
Other liabilities (17,503) 16,317
Net cash (used in) provided by operating activities (31,856) 27,046
Cash flows from investing activities:    
Real estate improvements (116,640) (83,468)
Proceeds from sale of properties, net 792 103,057
Proceeds from sale of properties to joint venture, net 643,892 0
Proceeds from sale of interest in joint venture, net (330) 0
Net cash provided by investing activities 527,714 19,589
Cash flows from financing activities:    
Proceeds from issuance of senior unsecured notes, net 0 492,500
Proceeds from borrowings on revolving credit facility 0 800,000
Repayments of borrowings on revolving credit facility (100,000) 0
Redemption of senior unsecured notes (500,000) (300,000)
Repayment of term loan 0 (200,000)
Repayment of other debt (12,421) (1,558)
Loss on early extinguishment of debt settled in cash (24,375) 0
Payment of debt issuance costs (2,820) (4,188)
Repurchase of common shares (5) (59)
Distributions to noncontrolling interest 0 (11,324)
Distributions to shareholders (4,780) (4,766)
Net cash (used in) provided by financing activities (644,401) 770,605
(Decrease) increase in cash and cash equivalents and restricted cash (148,543) 817,240
Cash and cash equivalents and restricted cash at beginning of period 1,016,945 90,849
Cash and cash equivalents and restricted cash at end of period $ 868,402 $ 908,089
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Supplemental cash flow information:    
Interest paid $ 110,522 $ 113,933
Income taxes paid 895 1,880
Non-cash investing activities:    
Real estate, net (355,669) 0
Investments in unconsolidated joint ventures (108,246) 0
Other assets, net 108,956 0
Real estate improvements accrued, not paid 24,325 20,860
Capitalized interest $ 0 $ 932
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Statement of Cash Flows [Abstract]        
Cash and cash equivalents $ 705,160 $ 634,848 $ 849,079  
Restricted cash 163,242 [1] 382,097 59,010 [1]  
Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows $ 868,402 $ 1,016,945 $ 908,089 $ 90,849
[1] As of June 30, 2022, restricted cash consists of proceeds from the sale of joint venture interests and proceeds from the sale of properties to joint ventures held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties. Prior to the deconsolidation of the joint venture that owns a life science property located in Boston, Massachusetts, or our Boston life science property joint venture, restricted cash also consisted of cash held for the operations of this joint venture. As of June 30, 2021, restricted cash also included amounts from dispositions held as collateral pursuant to our credit agreement. In June 2022, we sold an additional 10% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022, which will be included in restricted cash in our condensed consolidated balance sheet.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Basis of Presentation
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation Basis of Presentation
The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or we, us, or our, are unaudited. Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for complete financial statements have been condensed or omitted. We believe the disclosures made are adequate to make the information presented not misleading. However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2021, or our Annual Report.
In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.

The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.
We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings arising in the ordinary course of our business, some of which may involve material amounts. Also, the defense and resolution of these claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings may require us to incur significant expense. We account for claims and litigation losses in accordance with the Financial Accounting Standards Board Accounting Standards Codification Topic 450, Contingencies, or ASC 450. Under ASC 450, loss contingency provisions are recorded for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the estimated minimum loss amount, which could be zero, is recorded; and then, as information becomes known, the minimum loss amount is updated, as appropriate. A minimum or best estimate amount may be increased or decreased when events result in a changed expectation.
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Real Estate Investments
6 Months Ended
Jun. 30, 2022
Real Estate [Abstract]  
Real Estate Investments Real Estate Investments
As of June 30, 2022, we wholly owned 378 properties located in 36 states and Washington, D.C. and we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet.
Joint Venture Activities:
As of June 30, 2022, we had equity investments in joint ventures as follows:
Joint VentureDHC Ownership
DHC Carrying Value of Investment at June 30, 2022
Number of PropertiesLocationSquare Feet
Seaport Innovation LLC10%$108,286 1MA1,134,479 
The LSMD Fund REIT LLC20%50,473 10CA, MA, NY, TX, WA1,068,763 
$158,759 112,203,242 
The following table provides a summary of the mortgage debts of these joint ventures:
Joint VentureCoupon RateMaturity Date
Principal Balance at June 30, 2022 (1)
Mortgage Notes Payable (secured by one property in Massachusetts) (2)
3.53%8/6/2026$620,000 
Mortgage Notes Payable (secured by nine properties in five states)3.46%2/11/2032189,800 
Mortgage Notes Payable (secured by one property in California) (3)
3.18%2/9/2024266,825 
3.43%$1,076,625 
(1)Amounts are not adjusted for our minority equity interest.
(2)Following the deconsolidation in December 2021 of the net assets of our Boston life science property joint venture, we no longer include this $620,000 of secured debt financing in our condensed consolidated balance sheet; however, we continue to provide certain guaranties on this debt.
(3)The maturity date of February 9, 2024 is subject to three, one year extension options and requires interest to be paid at an annual rate based on the secured overnight financing rate, or SOFR, plus a premium of 1.90%. The interest rate is as of June 30, 2022. This joint venture has also purchased an interest rate cap through February 2024 with a SOFR strike rate equal to 4.00%.

In December 2021, we sold an additional 35% equity interest from our then remaining 55% equity interest in our Boston life science property joint venture to another third party institutional investor for $378,000, before closing costs and other adjustments. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. Prior to the deconsolidation of the net assets of this joint venture, the joint venture investor's interest in this consolidated entity was reflected as noncontrolling interest in our consolidated financial statements. In June 2022, we sold an additional 10% equity interest from our then remaining 20% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022. We recognized a net loss on sale of $1,226 related to this transaction, which is included in (loss) gain on sale of properties in our condensed consolidated statements of comprehensive income (loss). After giving effect to these sales, we continue to own a 10% equity interest in this joint venture. Our investment amount was based on a property valuation of $1,700,000, less $620,000 of existing mortgage debts on the property that this joint venture assumed. See Note 5 for more information regarding the valuation of our investment in this joint venture.
In January 2022, we entered into a joint venture with two unrelated third party institutional investors for 10 medical office and life science properties we owned, or our 10 medical office and life science properties joint venture. We sold equity interests in this joint venture to those investors for aggregate proceeds, before closing costs and other adjustments, of approximately $653,300. We deconsolidated the net assets of these properties effective as of the date of the sale and recognized a net gain on sale of $327,542 related to this transaction, which is included in (loss) gain on sale of properties in our condensed consolidated statements of comprehensive income (loss). The equity interests that the investors acquired from us equaled 41% and 39%, respectively, of the total equity interests in the joint venture and we retained a 20% equity interest in the joint venture. Following the sale, we account for this joint venture using the equity method of accounting under the fair value option. The investment amounts are based upon a property valuation of approximately $702,500, less approximately $456,600 of secured debt on the properties incurred by this joint venture. See Note 5 for more information regarding the valuation of our investment in this joint venture.
Acquisitions and Dispositions:
In July 2022, we acquired one life science property located in California with approximately 89,000 square feet for a purchase price of approximately $82,000, excluding closing costs. We did not acquire or dispose of any properties during the six months ended June 30, 2022.
Impairment:
We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value. No
material impairment charges were recorded on held and used properties during the three or six months ended June 30, 2022 or 2021.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Leases
6 Months Ended
Jun. 30, 2022
Leases [Abstract]  
Leases Leases
We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.
Certain of our leases provide for base rent payments and in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term.
We increased rental income to record revenue on a straight line basis by $2,710 and $1,321 for the three months ended June 30, 2022 and 2021, respectively, and $4,455 and $2,125 for the six months ended June 30, 2022 and 2021, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $71,902 and $82,131 of straight line rent receivables at June 30, 2022 and December 31, 2021, respectively, and are included in other assets, net in our condensed consolidated balance sheets.
We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $10,430 and $18,476 for the three months ended June 30, 2022 and 2021, respectively, of which tenant reimbursements totaled $10,350 and $18,440, respectively, and $21,138 and $36,704 for the six months ended June 30, 2022 and 2021, respectively, of which tenant reimbursements totaled $21,013 and $36,620, respectively.
Right of Use Asset and Lease Liability. For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use assets and related liabilities representing our future obligation under the respective lease arrangements for which we are the lessee were $28,003 and $28,382, respectively, as of June 30, 2022, and $4,153 and $4,352, respectively, as of December 31, 2021. The right of use assets and related lease liabilities are included within other assets, net and other liabilities, respectively, within our condensed consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our condensed consolidated balance sheets.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.22.2
Indebtedness
6 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Indebtedness Indebtedness
Our principal debt obligations, excluding any debt obligations of our joint ventures, at June 30, 2022 were: (1) outstanding borrowings under our $700,000 revolving credit facility; (2) $2,350,000 outstanding principal amount of senior unsecured notes; and (3) $50,715 aggregate principal amount of mortgage notes secured by five properties. These five mortgaged properties had a gross book value of $87,870 at June 30, 2022. We also had two properties subject to finance leases with lease obligations totaling $5,999 at June 30, 2022; these two properties had gross book value and accumulated depreciation of $37,630 and $18,632, respectively, at June 30, 2022, and $36,730 and $18,203, respectively, at December 31, 2021, and the finance leases expire in 2026.
We have a $700,000 revolving credit facility that is used for general business purposes. The maturity date of our revolving credit facility is January 2024. Our revolving credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. As of June 30, 2022, our revolving credit facility required interest to be paid on borrowings at the annual rate of 4.2%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility.
The weighted average annual interest rates for borrowings under our revolving credit facility were 3.3% and 2.9% for the three months ended June 30, 2022 and 2021, respectively, and 3.1% and 2.9% for the six months ended June 30, 2022 and 2021, respectively. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. As of June 30, 2022 and July 29, 2022, we were fully drawn under our revolving credit facility.
In February 2022, we and our lenders amended our credit agreement. Pursuant to the amendment:
the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022, or the Amendment Period;
the revolving credit facility commitments have been reduced from $800,000 to $700,000 following our repayment of $100,000, and as a result of the reduction in commitments, we recorded a loss on modification or early extinguishment of debt of $483 for the six months ended June 30, 2022;
we have the ability to fund $400,000 of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;
the interest rate premium under our revolving credit facility increased by 15 basis points; and
certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period.
Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586,373 in January 2023 and as such, further repayment of our revolving credit facility will be required by that time.
Pursuant to our credit agreement, we pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement and agreed to provide, and as of September 2021 had provided, first mortgage liens on 61 medical office and life science properties with an aggregate gross book value of real estate assets of $996,709 as of June 30, 2022 to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things.
In April 2022, we prepaid a mortgage note secured by one of our medical office properties with an outstanding principal balance of approximately $10,934, a maturity date in July 2022 and an annual interest rate of 6.28%, using cash on hand.
In June 2022, we redeemed $500,000 of our outstanding 9.75% senior notes due 2025 for a redemption price equal to 104.875% of the $500,000 principal amount of the notes being redeemed plus accrued and unpaid interest of $1,083, using restricted cash on hand. As a result of this redemption, we recorded a loss on early extinguishment of debt of $29,576 for the six months ended June 30, 2022.
In July 2022, we prepaid a mortgage note secured by two of our senior living communities with an outstanding principal balance of approximately $15,273, a maturity date in October 2022 and an annual interest rate of 5.75%, using cash on hand.
Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a change of control of us, as defined, which includes The RMR Group LLC, or RMR, ceasing to act as our business and property manager. Our credit agreement and our senior unsecured notes indentures and their supplements also contain covenants, including covenants that restrict our ability to incur debts, and generally require us to maintain certain financial ratios, and our credit agreement restricts our ability to make distributions under certain circumstances. As of June 30, 2022, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are unable to incur additional debt until this ratio is at or above 1.5x on a pro forma basis. We believe we were in compliance with the remaining terms and conditions of the respective covenants under our credit agreement and our senior unsecured notes indentures and their supplements at June 30, 2022, subject to the waivers noted above. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the
economy or the industries in which our properties and businesses operate may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value of Assets and Liabilities
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value of Assets and Liabilities Fair Value of Assets and Liabilities
The following table presents certain of our assets that are measured at fair value at June 30, 2022 and December 31, 2021, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.
As of June 30, 2022As of December 31, 2021
DescriptionCarrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
Recurring Fair Value Measurements Assets:    
Investment in AlerisLife (Level 1) (1)
$12,830 $12,830 $31,540 $31,540 
Investment in unconsolidated joint venture (Level 3) (2)
$108,286 $108,286 $215,127 $215,127 
Investment in unconsolidated joint venture (Level 3) (3)
$50,473 $50,473 $— $— 
(1)Our 10,691,658 shares of common stock of AlerisLife Inc., or AlerisLife, are included in other assets, net in our condensed consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs). During the three months ended June 30, 2022 and 2021, we recorded unrealized losses of $10,157 and $3,849, respectively, and during the six months ended June 30, 2022 and 2021, we recorded unrealized losses of $18,710 and $12,188, respectively, which are included in losses on equity securities, net in our condensed consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Note 11 for further information about our investment in AlerisLife.
(2)The 10% equity interest we own in our Boston life science property joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 5.58%, an exit capitalization rate of 5.25%, a holding period of approximately 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.
(3)The 20% equity interest we own in our 10 medical office and life science properties joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 5.67% and 8.93%, exit capitalization rates of between 4.75% and 6.00%, holding periods of approximately 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.
In addition to the assets described in the table above, our financial instruments at June 30, 2022 and December 31, 2021 included cash and cash equivalents, restricted cash, other assets, our revolving credit facility, senior unsecured notes, secured debt and finance leases and other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:
 As of June 30, 2022As of December 31, 2021
Description
Carrying Amount (1)
Estimated Fair Value
Carrying Amount (1)
Estimated Fair Value
Senior unsecured notes, 4.750% coupon rate, due 2024
$249,488 $224,353 $249,348 $257,695 
Senior unsecured notes, 9.750% coupon rate, due 2025
494,838 493,125 987,903 1,081,990 
Senior unsecured notes, 4.750% coupon rate, due 2028
492,836 368,125 492,199 491,480 
Senior unsecured notes, 4.375% coupon rate, due 2031
492,557 340,000 492,127 480,763 
Senior unsecured notes, 5.625% coupon rate, due 2042
342,374 227,850 342,183 309,260 
Senior unsecured notes, 6.250% coupon rate, due 2046
243,193 170,700 243,051 226,500 
Secured debts (2)
57,006 56,161 69,713 71,963 
 $2,372,292 $1,880,314 $2,876,524 $2,919,651 
(1)Includes unamortized net debt issuance costs, premiums and discounts.
(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.
We estimated the fair value of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on Nasdaq (Level 1 input) as of June 30, 2022 and December 31, 2021, respectively. We estimated the fair values of our four issuances of senior unsecured notes due 2024, 2025, 2028 and 2031 using an average of the bid and ask price on Nasdaq on or about June 30, 2022 and December 31, 2021 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Noncontrolling Interest
6 Months Ended
Jun. 30, 2022
Noncontrolling Interest [Abstract]  
Noncontrolling Interest Noncontrolling InterestIn March 2017, we entered into our Boston life science property joint venture. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a variable interest entity, or VIE, and that we controlled the activities that most significantly impacted the economic performance of this entity; we therefore consolidated the results of this joint venture in our financial statements. In December 2021, we sold an additional 35% equity interest in our Boston life science property joint venture to another third party institutional investor. After giving effect to the sale, we owned a 20% equity interest in this joint venture, but determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated these properties and accounted for this joint venture using the equity method of accounting under the fair value option. In June 2022, we sold an additional 10% equity interest from our then remaining 20% equity interest in this joint venture to an existing joint venture investor and continue to account for this joint venture using the equity method of accounting under the fair value option. The portion of the joint venture's net income and comprehensive income not attributable to us, or $1,577 and $2,899 for the three and six months ended June 30, 2021, respectively, is reported as a noncontrolling interest in our condensed consolidated statements of comprehensive income (loss). This joint venture made aggregate cash distributions to the other joint venture investor of $5,630 and $11,324 for the three and six months ended June 30, 2021, respectively, which are reflected as a decrease in total equity attributable to noncontrolling interest in our condensed consolidated statement of shareholders' equity.
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity
6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Equity
Common Share Awards:
On June 2, 2022, in accordance with our Trustee compensation arrangements, we awarded to each of our seven Trustees 20,000 of our common shares, valued at $2.14 per share, the closing price of our common shares on Nasdaq on that day.
Common Share Repurchases:
During the six months ended June 30, 2022, we purchased 1,698 of our common shares, valued at $3.20 per common share, from a former employee of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of prior awards of our common shares.
Distributions:
During the six months ended June 30, 2022, we declared and paid quarterly distributions to common shareholders as follows:
Declaration DateRecord DatePayment DateDistribution Per ShareTotal Distributions
January 13, 2022January 24, 2022February 17, 2022$0.01 $2,390 
April 14, 2022April 25, 2022May 19, 20220.01 2,390 
$0.02 $4,780 
On July 14, 2022, we declared a quarterly distribution to common shareholders of record on July 25, 2022 of $0.01 per share, or approximately $2,391. We expect to pay this distribution on or about August 18, 2022.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting
6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
We operate in, and report financial information for, the following two segments: Office Portfolio and senior housing operating portfolio, or SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities.
We also report “non-segment” operations, consisting of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.
 For the Three Months Ended June 30, 2022
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$52,610 $— $9,912 $62,522 
Residents fees and services— 250,506 — 250,506 
Total revenues52,610 250,506 9,912 313,028 
Expenses:    
Property operating expenses22,026 244,040 — 266,066 
Depreciation and amortization17,997 37,369 2,895 58,261 
General and administrative— — 7,207 7,207 
Acquisition and certain other transaction related costs
— — 609 609 
Total expenses40,023 281,409 10,711 332,143 
(Loss) gain on sale of properties(1,226)540 — (686)
Losses on equity securities, net— — (10,157)(10,157)
Interest and other income— 760 1,506 2,266 
Interest expense(216)(491)(55,268)(55,975)
Gain (loss) on modification or early extinguishment of debt16 — (29,576)(29,560)
Income (loss) from continuing operations before income tax benefit and equity in earnings of investees11,161 (30,094)(94,294)(113,227)
Income tax benefit— — 640 640 
Equity in earnings of investees3,204 — — 3,204 
Net income (loss)$14,365 $(30,094)$(93,654)$(109,383)
 For the Six Months Ended June 30, 2022
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$107,607 $— $20,200 $127,807 
Residents fees and services— 495,954 — 495,954 
Total revenues107,607 495,954 20,200 623,761 
Expenses:    
Property operating expenses45,473 489,335 — 534,808 
Depreciation and amortization36,387 73,352 5,781 115,520 
General and administrative— — 14,492 14,492 
Acquisition and certain other transaction related costs
— — 1,537 1,537 
Total expenses81,860 562,687 21,810 666,357 
Gain on sale of properties326,316 792 — 327,108 
Losses on equity securities, net— — (18,710)(18,710)
Interest and other income— 959 1,702 2,661 
Interest expense(581)(985)(111,540)(113,106)
Gain (loss) on modification or early extinguishment of debt16 — (30,059)(30,043)
Income (loss) from continuing operations before income tax expense and equity in earnings of investees351,498 (65,967)(160,217)125,314 
Income tax expense— — (832)(832)
Equity in earnings of investees6,558 — — 6,558 
Net income (loss)$358,056 $(65,967)$(161,049)$131,040 
Under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the U.S. Department of Health and Human Services, or HHS, established a Provider Relief Fund. Retention and use of the funds received under the CARES Act are subject to certain terms and conditions. The terms and conditions require that the funds be utilized to compensate for lost revenues that are attributable to the COVID-19 pandemic and for eligible costs to prevent, prepare for and respond to the COVID-19 pandemic that are not covered by other sources. Further, fund recipients are required to be participating in Medicare at the time of distribution and are subject to certain other terms and conditions, including quarterly reporting requirements. In addition, fund recipients are required to have billed Medicare during 2019 and to continue to provide care after January 31, 2020 for diagnosis, testing or care for individuals with possible or actual COVID-19 cases. Any funds not used in accordance with the terms and conditions must be returned to HHS. We recognize income from government grants on a systematic and rational basis over the period in which we recognize the related expenses or loss of revenues for which the grants are intended to compensate when there is reasonable assurance that we will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. We have recognized $959 and $18,181 as other income in our condensed consolidated statements of comprehensive income (loss) with respect to our SHOP segment for the six months ended June 30, 2022 and 2021, respectively.
 As of June 30, 2022
 Office PortfolioSHOP Non-SegmentConsolidated
Total assets$1,892,417 $3,001,413 $1,252,034 $6,145,864 
 For the Three Months Ended June 30, 2021
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$92,804 $— $9,590 $102,394 
Residents fees and services— 243,947 — 243,947 
Total revenues92,804 243,947 9,590 346,341 
Expenses:    
Property operating expenses31,321 233,311 — 264,632 
Depreciation and amortization32,497 32,538 2,853 67,888 
General and administrative— — 9,126 9,126 
Acquisition and certain other transaction related costs
— — 12,071 12,071 
Total expenses63,818 265,849 24,050 353,717 
Gain on sale of properties30,760 — — 30,760 
Losses on equity securities, net— — (3,849)(3,849)
Interest and other income— 15,748 290 16,038 
Interest expense(5,992)(525)(61,140)(67,657)
Loss on modification or early extinguishment of debt— — (370)(370)
Income (loss) from continuing operations before income tax expense53,754 (6,679)(79,529)(32,454)
Income tax expense— — (191)(191)
Net income (loss)53,754 (6,679)(79,720)(32,645)
Net income attributable to noncontrolling interest
(1,577)— — (1,577)
Net income (loss) attributable to common shareholders
$52,177 $(6,679)$(79,720)$(34,222)
 For the Six Months Ended June 30, 2021
 Office PortfolioSHOP Non-SegmentConsolidated
Revenues:    
Rental income$186,127 $— $19,025 $205,152 
Residents fees and services— 503,913 — 503,913 
Total revenues186,127 503,913 19,025 709,065 
Expenses:    
Property operating expenses62,614 489,409 — 552,023 
Depreciation and amortization64,435 63,899 5,707 134,041 
General and administrative— — 16,668 16,668 
Acquisition and certain other transaction related costs
— — 12,071 12,071 
Impairment of assets— (174)— (174)
Total expenses127,049 553,134 34,446 714,629 
Gain on sale of properties30,638 — — 30,638 
Losses on equity securities, net— — (12,188)(12,188)
Interest and other income— 18,181 692 18,873 
Interest expense(11,931)(1,053)(114,764)(127,748)
Loss on modification or early extinguishment of debt— — (2,410)(2,410)
Income (loss) from continuing operations before income tax expense77,785 (32,093)(144,091)(98,399)
Income tax expense— — (429)(429)
Net income (loss)77,785 (32,093)(144,520)(98,828)
Net income attributable to noncontrolling interest
(2,899)— — (2,899)
Net income (loss) attributable to common shareholders
$74,886 $(32,093)$(144,520)$(101,727)
 As of December 31, 2021
Office PortfolioSHOP Non-SegmentConsolidated
Total assets$2,282,652 $2,995,819 $1,345,043 $6,623,514 
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Senior Living Community Management Agreements
6 Months Ended
Jun. 30, 2022
Risks and Uncertainties [Abstract]  
Senior Living Community Management Agreements Senior Living Community Management Agreements
Our managed senior living communities are operated by third parties pursuant to management agreements. Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, manages certain of our SHOP communities.
2021 Amendments to our Management Arrangements with Five Star. On June 9, 2021, we amended our management arrangements with Five Star. The principal changes to the management arrangements included:
that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;
that we no longer have the right to sell up to an additional $682,000 of senior living communities currently managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star upon sale;
that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, were closed and are being evaluated and repositioned;
that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target earnings before interest, taxes, depreciation and amortization for the applicable period;
that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;
that RMR will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and
that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.
Pursuant to these changes, we and Five Star entered into an amended and restated master management agreement, or the Master Management Agreement, for the senior living communities that Five Star is continuing to manage and interim management agreements for the senior living communities that we and Five Star agreed to transition to new third party managers. These agreements replaced our prior master leases and management and pooling agreements with Five Star. In addition, AlerisLife delivered to us a related amended and restated guaranty agreement pursuant to which AlerisLife is continuing to guarantee the payment and performance of its subsidiaries' obligations under the applicable management agreements.
As of December 31, 2021, we had transitioned 107 of the 108 senior living communities, containing 7,340 living units, from Five Star to new third party managers. The remaining senior living community was closed in February 2022 and we are assessing opportunities to redevelop that property. We continue to lease our senior living communities that have been transitioned to new managers to our taxable REIT subsidiaries, or TRSs. We incurred costs related to retention and other transition costs for these communities. We recorded $517 and $11,914 for the three months ended June 30, 2022 and 2021, respectively, and $1,445 and $11,914 for the six months ended June 30, 2022 and 2021, respectively, of these costs to acquisition and certain other transaction related costs in our condensed consolidated statements of comprehensive income (loss).
Our Senior Living Communities Managed by Five Star. Five Star managed 120 and 235 of our senior living communities as of June 30, 2022 and 2021, respectively. We lease our senior living communities that are managed by Five Star to our TRSs.
We incurred management fees payable to Five Star of $8,971 and $12,927 for the three months ended June 30, 2022 and 2021, respectively, and $17,903 and $26,777 for the six months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, $8,274 and $12,212, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $697 and $715, respectively, were capitalized in our condensed consolidated balance sheets. For the six months ended June 30, 2022 and 2021, $16,416 and $25,228, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,487 and $1,549, respectively, were capitalized in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We incurred fees of $1,736 and $2,630 for the three months ended June 30, 2022 and 2021, respectively, and $3,652 and $8,071 for the six months ended June 30, 2022 and 2021, respectively, with respect to rehabilitation services Five Star provided at our senior living communities that are payable by us. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).
We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services. We recorded $379 and $398 for the three months ended June 30, 2022 and 2021, respectively, and $767 and $795 for the six months ended June 30, 2022 and 2021, respectively, with respect to these leases.
Our Senior Living Communities Managed by Other Third Party Managers. We incurred management fees payable to our other third party managers of $5,218 and $10,326 for the three and six months ended June 30, 2022, respectively. These amounts are included in property operating expenses in our condensed consolidated financial statements.
The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:
Three Months Ended June 30,Six Months Ended June 30,
Revenue from contracts with customers:2022202120222021
Basic housing and support services$196,999 $188,169 $389,873 $376,198 
Medicare and Medicaid programs18,966 24,907 38,783 60,855 
Private pay and other third party payer SNF services 34,541 30,871 67,298 66,860 
Total residents fees and services$250,506 $243,947 $495,954 $503,913 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Business and Property Management Agreements with RMR
6 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
Business and Property Management Agreements with RMR LLC Business and Property Management Agreements with RMR
We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally; and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. See Note 11 for further information regarding our relationship, agreements and transactions with RMR.
We recognized net business management fees of $4,506 and $6,324 for the three months ended June 30, 2022 and 2021, respectively, and $9,319 and $11,641 for the six months ended June 30, 2022 and 2021, respectively. Based on our common share total return, as defined in our business management agreement, as of each of June 30, 2022 and 2021, no estimated incentive fees are included in the net business management fees we recognized for the three or six months ended June 30, 2022 or 2021. The actual amount of annual incentive fees for 2022, if any, will be based on our common share total return as defined in our business management agreement, for the three-year period ending December 31, 2022, and will be payable in January 2023. We did not incur any incentive fee payable for the year ended December 31, 2021. We recognize business management and incentive fees in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss). RMR provides management services to our joint ventures. See Note 11 for further information regarding our joint ventures' management arrangements with RMR and the related impact on our management fees payable to RMR.
We and RMR amended our business management agreement effective August 1, 2021 to provide that (i) for periods beginning on and after August 1, 2021, the MSCI U.S. REIT/Health Care REIT Index will be used to calculate benchmark returns per share for purposes of determining any incentive management fee payable by us to RMR, and (ii) for periods prior to August 1, 2021, the SNL U.S. REIT Healthcare Index will continue to be used. This change of index was due to S&P Global ceasing to publish the SNL U.S. REIT Healthcare Index.
We recognized aggregate net property management and construction supervision fees of $2,518 and $3,191 for the three months ended June 30, 2022 and 2021, respectively, and $4,909 and $6,345 for the six months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, $1,272 and $2,465, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,246 and $726, respectively, were capitalized as building improvements in our condensed consolidated balance sheets. For the six months ended June 30, 2022 and 2021, $2,621 and $4,950, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $2,288 and $1,395, respectively, were capitalized as building improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.
We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR's centralized accounting personnel, our share of RMR's costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $3,111 and $3,202 for these expenses and costs for the three months ended June 30,
2022 and 2021, respectively, and $6,075 and $6,499 for the six months ended June 30, 2022 and 2021, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss) for these periods.
On June 9, 2021, we and RMR amended our property management agreement to, among other things, provide for RMR's oversight of any major capital projects and repositionings at our senior living communities, including our senior living communities which Five Star is continuing to manage, and that RMR receives the same fee previously paid to Five Star for such services, which is equal to 3% of the cost of any such major capital project or repositioning.
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Related Person Transactions
6 Months Ended
Jun. 30, 2022
Related Party Transactions [Abstract]  
Related Person Transactions Related Person Transactions
We have relationships and historical and continuing transactions with RMR, The RMR Group Inc., or RMR Inc., AlerisLife (including Five Star) and others related to them, including other companies to which RMR or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the managing member of RMR. The Chair of our Board and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., the chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and the chair of the board of directors and a managing director of AlerisLife. Jennifer F. Francis, our other Managing Trustee and our President and Chief Executive Officer, and our Chief Financial Officer and Treasurer are also employees and officers of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust and a managing director and the secretary of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR. Some of our Independent Trustees also serve as independent trustees or independent directors of other public companies to which RMR or its subsidiaries provide management services. Adam Portnoy serves as the chair of the board and as a managing director or managing trustee of these companies. Other officers of RMR, including Ms. Clark and certain of our officers, serve as managing trustees, managing directors or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR or its subsidiaries provide management services.
AlerisLife. We are currently AlerisLife's largest stockholder. As of June 30, 2022, we owned approximately 32.8% of AlerisLife's outstanding common shares. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own pursuant to the Master Management Agreement. RMR provides management services to both us and AlerisLife. See Note 9 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star) and Note 5 for further information regarding our investment in AlerisLife.
As of June 30, 2022, ABP Acquisition LLC, a subsidiary of ABP Trust, the controlling shareholder of RMR Inc., together with ABP Trust, owned approximately 6.2% of AlerisLife's outstanding common shares.
Our Joint Ventures. We have two separate joint venture arrangements with two third party institutional investors, our Boston life science property joint venture and our 10 medical office and life science properties joint venture. We own a 10% equity interest in our Boston life science property joint venture and a 20% equity interest in our 10 medical office and life science properties joint venture; from January 2022 until June 28, 2022, we owned a 20% equity interest in our Boston life science property joint venture. We initially entered into our Boston life science property joint venture prior to January 1, 2021, and we entered into our 10 medical office and life science properties joint venture in January 2022. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures. Prior to December 23, 2021, our Boston life science property joint venture was our consolidated subsidiary and, as such, we were previously obligated to pay management fees to RMR under our management agreements with RMR for the services it provided regarding that joint venture; however, that joint venture paid management fees directly to RMR, and any such fees paid by that joint venture were credited against the fees payable by us to RMR. In addition, we wholly owned the 10 medical office and life science properties until the contribution of these properties to the applicable joint venture in January 2022 and we paid management fees to RMR for the management services it provided to us for those properties up until that time. As of June 30, 2022, in connection with the closing of our 10 medical office and life science properties joint venture in January 2022, we paid mortgage escrow amounts and closing costs of $11,113 that were payable by that joint venture. Those costs are presented as other assets, net, in our condensed consolidated balance sheet.
Our Manager, RMR. We have two agreements with RMR to provide management services to us. See Note 10 for further information regarding our management agreements with RMR.
For further information about these and other such relationships and certain other related person transactions, see our Annual Report.
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Income Taxes
6 Months Ended
Jun. 30, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income TaxesWe have elected to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, and, as such, are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT. Our current income tax expense (or benefit) fluctuates from period to period based primarily on the timing of our income, including gains on the disposition of properties or losses in a particular quarter. For the three months ended June 30, 2022 and 2021, we recognized income tax benefit of $640 and expense of $191, respectively, and for the six months ended June 30, 2022 and 2021, we recognized income tax expense of $832 and $429, respectively.
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Weighted Average Common Shares (shares amounts in thousands)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Weighted Average Common Shares (shares amounts in thousands) Weighted Average Common Shares (share amounts in thousands)We calculate basic earnings per common share using the two class method. We calculate diluted earnings per share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares, together with the related impact on earnings, are considered when calculating diluted earnings per share. For purposes of calculating diluted earnings per share, we did not include 833 and 837 of unvested share awards for the three and six months ended June 30, 2022, respectively, because to do so would have been antidilutive.
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Real Estate Investments (Tables)
6 Months Ended
Jun. 30, 2022
Real Estate [Abstract]  
Schedule of Equity Method Investments
As of June 30, 2022, we had equity investments in joint ventures as follows:
Joint VentureDHC Ownership
DHC Carrying Value of Investment at June 30, 2022
Number of PropertiesLocationSquare Feet
Seaport Innovation LLC10%$108,286 1MA1,134,479 
The LSMD Fund REIT LLC20%50,473 10CA, MA, NY, TX, WA1,068,763 
$158,759 112,203,242 
The following table provides a summary of the mortgage debts of these joint ventures:
Joint VentureCoupon RateMaturity Date
Principal Balance at June 30, 2022 (1)
Mortgage Notes Payable (secured by one property in Massachusetts) (2)
3.53%8/6/2026$620,000 
Mortgage Notes Payable (secured by nine properties in five states)3.46%2/11/2032189,800 
Mortgage Notes Payable (secured by one property in California) (3)
3.18%2/9/2024266,825 
3.43%$1,076,625 
(1)Amounts are not adjusted for our minority equity interest.
(2)Following the deconsolidation in December 2021 of the net assets of our Boston life science property joint venture, we no longer include this $620,000 of secured debt financing in our condensed consolidated balance sheet; however, we continue to provide certain guaranties on this debt.
(3)The maturity date of February 9, 2024 is subject to three, one year extension options and requires interest to be paid at an annual rate based on the secured overnight financing rate, or SOFR, plus a premium of 1.90%. The interest rate is as of June 30, 2022. This joint venture has also purchased an interest rate cap through February 2024 with a SOFR strike rate equal to 4.00%.
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value of Assets and Liabilities (Tables)
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value
The following table presents certain of our assets that are measured at fair value at June 30, 2022 and December 31, 2021, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.
As of June 30, 2022As of December 31, 2021
DescriptionCarrying AmountEstimated Fair ValueCarrying AmountEstimated Fair Value
Recurring Fair Value Measurements Assets:    
Investment in AlerisLife (Level 1) (1)
$12,830 $12,830 $31,540 $31,540 
Investment in unconsolidated joint venture (Level 3) (2)
$108,286 $108,286 $215,127 $215,127 
Investment in unconsolidated joint venture (Level 3) (3)
$50,473 $50,473 $— $— 
(1)Our 10,691,658 shares of common stock of AlerisLife Inc., or AlerisLife, are included in other assets, net in our condensed consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs). During the three months ended June 30, 2022 and 2021, we recorded unrealized losses of $10,157 and $3,849, respectively, and during the six months ended June 30, 2022 and 2021, we recorded unrealized losses of $18,710 and $12,188, respectively, which are included in losses on equity securities, net in our condensed consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Note 11 for further information about our investment in AlerisLife.
(2)The 10% equity interest we own in our Boston life science property joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 5.58%, an exit capitalization rate of 5.25%, a holding period of approximately 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.
(3)The 20% equity interest we own in our 10 medical office and life science properties joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 5.67% and 8.93%, exit capitalization rates of between 4.75% and 6.00%, holding periods of approximately 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.
Schedule of Carrying Value and Fair Value of the Financial Instruments The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:
 As of June 30, 2022As of December 31, 2021
Description
Carrying Amount (1)
Estimated Fair Value
Carrying Amount (1)
Estimated Fair Value
Senior unsecured notes, 4.750% coupon rate, due 2024
$249,488 $224,353 $249,348 $257,695 
Senior unsecured notes, 9.750% coupon rate, due 2025
494,838 493,125 987,903 1,081,990 
Senior unsecured notes, 4.750% coupon rate, due 2028
492,836 368,125 492,199 491,480 
Senior unsecured notes, 4.375% coupon rate, due 2031
492,557 340,000 492,127 480,763 
Senior unsecured notes, 5.625% coupon rate, due 2042
342,374 227,850 342,183 309,260 
Senior unsecured notes, 6.250% coupon rate, due 2046
243,193 170,700 243,051 226,500 
Secured debts (2)
57,006 56,161 69,713 71,963 
 $2,372,292 $1,880,314 $2,876,524 $2,919,651 
(1)Includes unamortized net debt issuance costs, premiums and discounts.
(2)We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity (Tables)
6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of Dividends Declared and Paid
During the six months ended June 30, 2022, we declared and paid quarterly distributions to common shareholders as follows:
Declaration DateRecord DatePayment DateDistribution Per ShareTotal Distributions
January 13, 2022January 24, 2022February 17, 2022$0.01 $2,390 
April 14, 2022April 25, 2022May 19, 20220.01 2,390 
$0.02 $4,780 
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Schedule of segment reporting information
 For the Three Months Ended June 30, 2022
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$52,610 $— $9,912 $62,522 
Residents fees and services— 250,506 — 250,506 
Total revenues52,610 250,506 9,912 313,028 
Expenses:    
Property operating expenses22,026 244,040 — 266,066 
Depreciation and amortization17,997 37,369 2,895 58,261 
General and administrative— — 7,207 7,207 
Acquisition and certain other transaction related costs
— — 609 609 
Total expenses40,023 281,409 10,711 332,143 
(Loss) gain on sale of properties(1,226)540 — (686)
Losses on equity securities, net— — (10,157)(10,157)
Interest and other income— 760 1,506 2,266 
Interest expense(216)(491)(55,268)(55,975)
Gain (loss) on modification or early extinguishment of debt16 — (29,576)(29,560)
Income (loss) from continuing operations before income tax benefit and equity in earnings of investees11,161 (30,094)(94,294)(113,227)
Income tax benefit— — 640 640 
Equity in earnings of investees3,204 — — 3,204 
Net income (loss)$14,365 $(30,094)$(93,654)$(109,383)
 For the Six Months Ended June 30, 2022
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$107,607 $— $20,200 $127,807 
Residents fees and services— 495,954 — 495,954 
Total revenues107,607 495,954 20,200 623,761 
Expenses:    
Property operating expenses45,473 489,335 — 534,808 
Depreciation and amortization36,387 73,352 5,781 115,520 
General and administrative— — 14,492 14,492 
Acquisition and certain other transaction related costs
— — 1,537 1,537 
Total expenses81,860 562,687 21,810 666,357 
Gain on sale of properties326,316 792 — 327,108 
Losses on equity securities, net— — (18,710)(18,710)
Interest and other income— 959 1,702 2,661 
Interest expense(581)(985)(111,540)(113,106)
Gain (loss) on modification or early extinguishment of debt16 — (30,059)(30,043)
Income (loss) from continuing operations before income tax expense and equity in earnings of investees351,498 (65,967)(160,217)125,314 
Income tax expense— — (832)(832)
Equity in earnings of investees6,558 — — 6,558 
Net income (loss)$358,056 $(65,967)$(161,049)$131,040 
 As of June 30, 2022
 Office PortfolioSHOP Non-SegmentConsolidated
Total assets$1,892,417 $3,001,413 $1,252,034 $6,145,864 
 For the Three Months Ended June 30, 2021
 Office PortfolioSHOPNon-SegmentConsolidated
Revenues:    
Rental income$92,804 $— $9,590 $102,394 
Residents fees and services— 243,947 — 243,947 
Total revenues92,804 243,947 9,590 346,341 
Expenses:    
Property operating expenses31,321 233,311 — 264,632 
Depreciation and amortization32,497 32,538 2,853 67,888 
General and administrative— — 9,126 9,126 
Acquisition and certain other transaction related costs
— — 12,071 12,071 
Total expenses63,818 265,849 24,050 353,717 
Gain on sale of properties30,760 — — 30,760 
Losses on equity securities, net— — (3,849)(3,849)
Interest and other income— 15,748 290 16,038 
Interest expense(5,992)(525)(61,140)(67,657)
Loss on modification or early extinguishment of debt— — (370)(370)
Income (loss) from continuing operations before income tax expense53,754 (6,679)(79,529)(32,454)
Income tax expense— — (191)(191)
Net income (loss)53,754 (6,679)(79,720)(32,645)
Net income attributable to noncontrolling interest
(1,577)— — (1,577)
Net income (loss) attributable to common shareholders
$52,177 $(6,679)$(79,720)$(34,222)
 For the Six Months Ended June 30, 2021
 Office PortfolioSHOP Non-SegmentConsolidated
Revenues:    
Rental income$186,127 $— $19,025 $205,152 
Residents fees and services— 503,913 — 503,913 
Total revenues186,127 503,913 19,025 709,065 
Expenses:    
Property operating expenses62,614 489,409 — 552,023 
Depreciation and amortization64,435 63,899 5,707 134,041 
General and administrative— — 16,668 16,668 
Acquisition and certain other transaction related costs
— — 12,071 12,071 
Impairment of assets— (174)— (174)
Total expenses127,049 553,134 34,446 714,629 
Gain on sale of properties30,638 — — 30,638 
Losses on equity securities, net— — (12,188)(12,188)
Interest and other income— 18,181 692 18,873 
Interest expense(11,931)(1,053)(114,764)(127,748)
Loss on modification or early extinguishment of debt— — (2,410)(2,410)
Income (loss) from continuing operations before income tax expense77,785 (32,093)(144,091)(98,399)
Income tax expense— — (429)(429)
Net income (loss)77,785 (32,093)(144,520)(98,828)
Net income attributable to noncontrolling interest
(2,899)— — (2,899)
Net income (loss) attributable to common shareholders
$74,886 $(32,093)$(144,520)$(101,727)
 As of December 31, 2021
Office PortfolioSHOP Non-SegmentConsolidated
Total assets$2,282,652 $2,995,819 $1,345,043 $6,623,514 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.22.2
Senior Living Community Management Agreements (Tables)
6 Months Ended
Jun. 30, 2022
Risks and Uncertainties [Abstract]  
Schedule of Disaggregation of Revenue
The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:
Three Months Ended June 30,Six Months Ended June 30,
Revenue from contracts with customers:2022202120222021
Basic housing and support services$196,999 $188,169 $389,873 $376,198 
Medicare and Medicaid programs18,966 24,907 38,783 60,855 
Private pay and other third party payer SNF services 34,541 30,871 67,298 66,860 
Total residents fees and services$250,506 $243,947 $495,954 $503,913 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Real Estate Investments - Narrative (Details)
$ in Thousands
1 Months Ended 6 Months Ended
Jul. 31, 2022
USD ($)
ft²
trustee
Jun. 30, 2022
USD ($)
ft²
jointVenture
property
state
Jan. 31, 2022
USD ($)
investor
property
Dec. 31, 2021
USD ($)
Jun. 30, 2022
USD ($)
ft²
jointVenture
property
state
Jun. 28, 2022
Dec. 30, 2021
Real Estate Properties              
Number of properties (property) | property   378     378    
Number of states in which properties are located | state   36     36    
Number of states | state         5    
Subsequent Event | Life Science Building Located In California              
Real Estate Properties              
Number of properties (property) | trustee 1            
Area of real estate property | ft² 89,000            
Purchase price $ 82,000            
Senior Living Communities | Skilled nursing bed license              
Real Estate Properties              
Gain (loss) on sales of beds   $ (1,226) $ 327,542        
Seaport Innovation LLC              
Real Estate Properties              
Aggregate principal amount of mortgage debt       $ 620,000      
Real estate property fair value   $ 1,700,000     $ 1,700,000    
Corporate Joint Venture              
Real Estate Properties              
Number of properties (property) | property   11     11    
Area of real estate property | ft²   2,203,242     2,203,242    
Aggregate principal amount of mortgage debt     456,600        
Real estate property fair value     702,500        
Corporate Joint Venture | Medical Office Building and Life Science Building              
Real Estate Properties              
Proceeds from sale of interest in joint venture, net     $ 653,300        
Number of third party institutional investors | investor     2        
Number of properties included in joint venture agreement | property     10        
Corporate Joint Venture | Diversified Healthcare Trusts | Medical Office Building and Life Science Building              
Real Estate Properties              
Equity method investment ownership percentage     20.00%        
Corporate Joint Venture | Diversified Healthcare Trusts | Unrelated Investor One | Medical Office Building and Life Science Building              
Real Estate Properties              
Equity method investment ownership percentage     41.00%        
Corporate Joint Venture | Diversified Healthcare Trusts | Unrelated Investor Two | Medical Office Building and Life Science Building              
Real Estate Properties              
Equity method investment ownership percentage     39.00%        
Corporate Joint Venture | Seaport Innovation LLC              
Real Estate Properties              
Number of properties (property) | property   1     1    
Area of real estate property | ft²   1,134,479     1,134,479    
Additional equity joint venture percentage   10.00%   35.00%      
Equity method investment ownership percentage   10.00%     10.00% 20.00% 55.00%
Proceeds from sale of interest in joint venture, net   $ 108,000   $ 378,000      
Proceeds from sale of other assets   $ 108,956          
Corporate Joint Venture | Seaport Innovation LLC | Medical Office Building and Life Science Building              
Real Estate Properties              
Equity method investment ownership percentage   10.00%     10.00%    
Joint Venture              
Real Estate Properties              
Number of unconsolidated joint ventures | jointVenture   2     2    
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Real Estate Investments - Equity Investment In Joint Venture (Details)
$ in Thousands
Jun. 30, 2022
USD ($)
ft²
property
Jun. 28, 2022
Dec. 31, 2021
USD ($)
Dec. 30, 2021
Real Estate        
Investments in unconsolidated joint ventures | $ $ 158,759   $ 215,127  
Number of properties (property) | property 378      
Corporate Joint Venture        
Real Estate        
Investments in unconsolidated joint ventures | $ $ 158,759      
Number of properties (property) | property 11      
Area of real estate property | ft² 2,203,242      
Seaport Innovation LLC | Corporate Joint Venture        
Real Estate        
Equity method investment ownership percentage 10.00% 20.00%   55.00%
Investments in unconsolidated joint ventures | $ $ 108,286      
Number of properties (property) | property 1      
Area of real estate property | ft² 1,134,479      
The LSMD Fund REIT LLC | Corporate Joint Venture        
Real Estate        
Equity method investment ownership percentage 20.00%      
Investments in unconsolidated joint ventures | $ $ 50,473      
Number of properties (property) | property 10      
Area of real estate property | ft² 1,068,763      
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Real Estate Investments - Mortgage Debt Joint Venture (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
option
Jan. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Seaport Innovation LLC      
Real Estate      
Aggregate principal amount of mortgage debt     $ 620,000,000
Corporate Joint Venture      
Real Estate      
Coupon rate (percent) 3.43%    
Debt face amount $ 1,076,625,000    
Aggregate principal amount of mortgage debt   $ 456,600,000  
Seaport Innovation LLC | Corporate Joint Venture | Massachusetts      
Real Estate      
Coupon rate (percent) 3.53%    
Debt face amount $ 620,000,000    
The LSMD Fund REIT LLC | Corporate Joint Venture      
Real Estate      
Coupon rate (percent) 3.46%    
Debt face amount $ 189,800,000    
The LSMD Fund REIT LLC | Corporate Joint Venture | California      
Real Estate      
Coupon rate (percent) 3.18%    
Debt face amount $ 266,825,000    
Number of extension options | option 3    
Extension term 1 year    
The LSMD Fund REIT LLC | Corporate Joint Venture | California | SOFR      
Real Estate      
Basis points per annum (as a percent) 1.90%    
The LSMD Fund REIT LLC | Corporate Joint Venture | California | SOFR | Interest Rate Cap      
Real Estate      
Basis points per annum (as a percent) 4.00%    
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Leases (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Leases [Abstract]          
Straight line rental income $ 2,710 $ 1,321 $ 4,455 $ 2,125  
Straight line rental income, excluding properties held-for-sale 71,902   71,902   $ 82,131
Variable lease, payment 10,430 18,476 21,138 36,704  
Reimbursement revenue lease 10,350 $ 18,440 21,013 $ 36,620  
Operating lease, right-of-use asset 28,003   28,003   4,153
Operating lease, liability $ 28,382   $ 28,382   $ 4,352
Operating Lease, Right-of-Use Asset, Statement of Financial Position Other assets, net   Other assets, net   Other assets, net
Operating Lease, Liability, Statement of Financial Position Other liabilities   Other liabilities   Other liabilities
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Indebtedness (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 31, 2022
USD ($)
property
Jun. 30, 2022
USD ($)
property
Apr. 30, 2022
USD ($)
property
Feb. 28, 2022
USD ($)
Jun. 30, 2022
USD ($)
property
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
property
Jun. 30, 2021
USD ($)
Jan. 31, 2023
USD ($)
Jan. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Indebtedness                      
Number of properties (property) | property   378     378   378        
Total real estate properties, gross   $ 6,472,457,000     $ 6,472,457,000   $ 6,472,457,000       $ 6,813,556,000
Repayments of lines of credit             100,000,000 $ 0      
Gain (loss) on extinguishment of debt         (29,560,000) $ (370,000) (30,043,000) $ (2,410,000)      
Accrued interest   $ 27,639,000     $ 27,639,000   $ 27,639,000       29,845,000
Debt ratio   150.00%     150.00%   150.00%        
Finance Leased Properties                      
Indebtedness                      
Number of properties (property) | property   2     2   2        
Finance lease obligations   $ 5,999,000     $ 5,999,000   $ 5,999,000        
Finance leased asset, gross   37,630,000     37,630,000   37,630,000       36,730,000
Finance leased asset, accumulated depreciation   18,632,000     18,632,000   18,632,000       $ 18,203,000
Unsecured Debt                      
Indebtedness                      
Debt face amount   2,350,000,000     2,350,000,000   2,350,000,000        
Unsecured Revolving Credit Facility                      
Indebtedness                      
Unsecured revolving credit facility, maximum borrowing capacity   $ 700,000,000   $ 700,000,000 $ 700,000,000   $ 700,000,000     $ 800,000,000  
Revolving credit facility, interest rate payable (as a percent)   4.20%     4.20%   4.20%        
Debt instrument, facility fee (as a percent)             0.30%        
Weighted average interest rate on debt (as a percent)         3.30% 2.90% 3.10% 2.90%      
Repayments of lines of credit       100,000,000              
Gain (loss) on extinguishment of debt             $ (483,000)        
Capital expenditure       400,000,000              
Minimum liquidity requirement       $ 200,000,000              
Unsecured Revolving Credit Facility | Forecast                      
Indebtedness                      
Unsecured revolving credit facility, maximum borrowing capacity                 $ 586,373,000    
Unsecured Revolving Credit Facility | Revolving Credit Facility | LIBOR                      
Indebtedness                      
Basis points per annum (as a percent)       0.15%              
Unsecured Revolving Credit Facility | Medical Office And Life Science                      
Indebtedness                      
Number of properties (property) | property   61     61   61        
Total real estate properties, gross   $ 996,709,000     $ 996,709,000   $ 996,709,000        
Mortgages                      
Indebtedness                      
Aggregate principal amount of mortgage debt   $ 50,715,000     $ 50,715,000   $ 50,715,000        
Number of properties (property) | property   5     5   5        
Total real estate properties, gross   $ 87,870,000     $ 87,870,000   $ 87,870,000        
Mortgages 6.28 Percent Due July 2022 | Medical Office Building                      
Indebtedness                      
Number of properties (property) | property     1                
Repayments of debt     $ 10,934,000                
Coupon rate (percent)     6.28%                
Mortgages 6.28 Percent Due July 2022 | Senior Living Communities | Subsequent Event                      
Indebtedness                      
Number of properties (property) | property 2                    
Repayments of debt $ 15,273,000                    
Coupon rate (percent) 5.75%                    
Senior Unsecured Note Due 2022                      
Indebtedness                      
Gain (loss) on extinguishment of debt             $ (29,576,000)        
Coupon rate (percent)   9.75%     9.75%   9.75%        
Debt instrument, amount redeemed   $ 500,000,000     $ 500,000,000   $ 500,000,000        
Redemption price (as a percent)   104.875%                  
Accrued interest   $ 1,083,000     $ 1,083,000   $ 1,083,000        
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value of Assets and Liabilities - Assets and Liabilities (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
property
shares
Jun. 30, 2021
USD ($)
Jun. 28, 2022
Dec. 31, 2021
USD ($)
Mar. 31, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Losses on equity securities, net $ (10,157) $ (3,849) $ (18,710) $ (12,188)      
Corporate Joint Venture | Life Science Property              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Equity method investment ownership percentage 10.00%   10.00%   20.00% 20.00% 55.00%
Holding period     10 years        
Corporate Joint Venture | Life Science Property | Measurement Input, Discount Rate              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Measurement input 0.0558   0.0558        
Corporate Joint Venture | Life Science Property | Measurement Input, Market Capitalization Rate              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Measurement input 0.0525   0.0525        
Corporate Joint Venture | Medical Office and Life Science Properties              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Equity method investment ownership percentage 20.00%   20.00%        
Holding period     10 years        
Number of owned properties | property     10        
Corporate Joint Venture | Medical Office and Life Science Properties | Measurement Input, Discount Rate | Minimum              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Measurement input 0.0567   0.0567        
Corporate Joint Venture | Medical Office and Life Science Properties | Measurement Input, Discount Rate | Maximum              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Measurement input 0.0893   0.0893        
Corporate Joint Venture | Medical Office and Life Science Properties | Measurement Input, Market Capitalization Rate | Minimum              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Measurement input 0.0475   0.0475        
Corporate Joint Venture | Medical Office and Life Science Properties | Measurement Input, Market Capitalization Rate | Maximum              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Measurement input 0.0600   0.0600        
Recurring | Level 1 | Carrying Amount | AlerisLife Inc              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Investments in affiliates, fair value $ 12,830   $ 12,830     $ 31,540  
Equity securities investment (in shares) | shares 10,691,658   10,691,658        
Recurring | Level 1 | Estimated Fair Value | AlerisLife Inc              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Investments in affiliates, fair value $ 12,830   $ 12,830     31,540  
Recurring | Level 3 | Joint Venture | Carrying Amount | Life Science Property              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Investments in affiliates, fair value 108,286   108,286     215,127  
Recurring | Level 3 | Joint Venture | Carrying Amount | Medical Office and Life Science Properties              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Investments in affiliates, fair value 50,473   50,473     0  
Recurring | Level 3 | Joint Venture | Estimated Fair Value | Life Science Property              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Investments in affiliates, fair value 108,286   108,286     215,127  
Recurring | Level 3 | Joint Venture | Estimated Fair Value | Medical Office and Life Science Properties              
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis              
Investments in affiliates, fair value $ 50,473   $ 50,473     $ 0  
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value of Assets and Liabilities - Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Carrying Amount    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure $ 2,372,292 $ 2,876,524
Carrying Amount | Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2024    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate (percent) 4.75%  
Fair value disclosure $ 249,488 249,348
Carrying Amount | Senior Unsecured Notes | Senior unsecured notes, 9.750% coupon rate, due 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate (percent) 9.75%  
Fair value disclosure $ 494,838 987,903
Carrying Amount | Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2028    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate (percent) 4.75%  
Fair value disclosure $ 492,836 492,199
Carrying Amount | Senior Unsecured Notes | Senior unsecured notes, 4.375% coupon rate, due 2031    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate (percent) 4.375%  
Fair value disclosure $ 492,557 492,127
Carrying Amount | Senior Unsecured Notes | Senior unsecured notes, 5.625% coupon rate, due 2042    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate (percent) 5.625%  
Fair value disclosure $ 342,374 342,183
Carrying Amount | Senior Unsecured Notes | Senior unsecured notes, 6.250% coupon rate, due 2046    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Coupon rate (percent) 6.25%  
Fair value disclosure $ 243,193 243,051
Carrying Amount | Secured Debts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 57,006 69,713
Estimated Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 1,880,314 2,919,651
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2024    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 224,353 257,695
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 9.750% coupon rate, due 2025    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 493,125 1,081,990
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 4.750% coupon rate, due 2028    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 368,125 491,480
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 4.375% coupon rate, due 2031    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 340,000 480,763
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 5.625% coupon rate, due 2042    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 227,850 309,260
Estimated Fair Value | Senior Unsecured Notes | Senior unsecured notes, 6.250% coupon rate, due 2046    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure 170,700 226,500
Estimated Fair Value | Secured Debts    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value disclosure $ 56,161 $ 71,963
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value of Assets and Liabilities - Narrative (Details) - security
Jun. 30, 2022
Dec. 31, 2021
Fair Value, Inputs, Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value measurement, number of debt securities 2 2
Fair Value, Inputs, Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Fair value measurement, number of debt securities 4 4
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.22.2
Noncontrolling Interest (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 28, 2022
Mar. 31, 2017
Noncontrolling Interest                  
Net income attributable to noncontrolling interest     $ 0 $ 1,577   $ 0 $ 2,899    
Distributions to noncontrolling interest       $ 5,630 $ 5,694   $ 11,324    
Life Science Property | Corporate Joint Venture                  
Noncontrolling Interest                  
Equity method investment ownership percentage 10.00% 20.00% 10.00%     10.00%   20.00% 55.00%
Additional equity joint venture percentage 10.00% 35.00%              
Life Science Property | Corporate Joint Venture | Investor                  
Noncontrolling Interest                  
Equity method investment ownership percentage                 45.00%
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jul. 14, 2022
Jun. 02, 2022
May 19, 2022
Feb. 17, 2022
Mar. 31, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award                
Weighted average share price (in dollars per share)             $ 3.20  
Distributions to shareholders     $ 2,390 $ 2,390     $ 4,780 $ 4,766
Subsequent Event                
Share-based Compensation Arrangement by Share-based Payment Award                
Distributions to common shareholders declared (in dollars per share) $ 0.01              
Distributions to shareholders $ 2,391              
Common Shares                
Share-based Compensation Arrangement by Share-based Payment Award                
Number of shares (in shares)         1,698 13,906    
Former Employees Of RMR LLC | Common Shares                
Share-based Compensation Arrangement by Share-based Payment Award                
Number of shares (in shares)             1,698  
Trustee | Share Award Plans | RMR                
Share-based Compensation Arrangement by Share-based Payment Award                
Common shares awarded (in shares)   20,000            
Share price (in dollars per share)   $ 2.14            
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.22.2
Shareholders' Equity - Schedule of Dividends Declared and Paid (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
May 19, 2022
Feb. 17, 2022
Jun. 30, 2022
Jun. 30, 2021
Stockholders' Equity Note [Abstract]        
Distribution per share (in dollars per share) $ 0.01 $ 0.01 $ 0.02  
Total Distributions $ 2,390 $ 2,390 $ 4,780 $ 4,766
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
segment
Jun. 30, 2021
USD ($)
Segment reporting        
Number of operating segments | segment     2  
Interest and other income $ 2,266 $ 16,038 $ 2,661 $ 18,873
Operating Segments | SHOP        
Segment reporting        
Interest and other income $ 760 $ 15,748 $ 959 $ 18,181
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting - Income Statements (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues:            
Total revenues $ 313,028   $ 346,341   $ 623,761 $ 709,065
Expenses:            
Property operating expenses 266,066   264,632   534,808 552,023
Depreciation and amortization 58,261   67,888   115,520 134,041
General and administrative 7,207   9,126   14,492 16,668
Acquisition and certain other transaction related costs 609   12,071   1,537 12,071
Impairment of assets 0   0   0 (174)
Total expenses 332,143   353,717   666,357 714,629
(Loss) gain on sale of properties (686)   30,760   327,108 30,638
Losses on equity securities, net (10,157)   (3,849)   (18,710) (12,188)
Interest and other income 2,266   16,038   2,661 18,873
Interest expense (55,975)   (67,657)   (113,106) (127,748)
Gain (loss) on modification or early extinguishment of debt (29,560)   (370)   (30,043) (2,410)
Income (loss) from continuing operations before income tax benefit (expense) and equity in earnings of investees (113,227)   (32,454)   125,314 (98,399)
Income tax benefit (expense) (640)   191   832 429
Equity in earnings of investees 3,204       6,558 0
Net (loss) income (109,383) $ 240,423 (32,645) $ (66,183) 131,040 (98,828)
Net income attributable to noncontrolling interest 0   (1,577)   0 (2,899)
Net (loss) income attributable to common shareholders (109,383)   (34,222)   131,040 (101,727)
Rental income            
Revenues:            
Total revenues 62,522   102,394   127,807 205,152
Residents fees and services            
Revenues:            
Total revenues 250,506   243,947   495,954 503,913
Operating Segments | Office Portfolio            
Revenues:            
Total revenues 52,610   92,804   107,607 186,127
Expenses:            
Property operating expenses 22,026   31,321   45,473 62,614
Depreciation and amortization 17,997   32,497   36,387 64,435
General and administrative 0   0   0 0
Acquisition and certain other transaction related costs 0   0   0 0
Impairment of assets           0
Total expenses 40,023   63,818   81,860 127,049
(Loss) gain on sale of properties (1,226)   30,760   326,316 30,638
Losses on equity securities, net 0   0   0 0
Interest and other income 0   0   0 0
Interest expense (216)   (5,992)   (581) (11,931)
Gain (loss) on modification or early extinguishment of debt 16   0   16 0
Income (loss) from continuing operations before income tax benefit (expense) and equity in earnings of investees 11,161   53,754   351,498 77,785
Income tax benefit (expense) 0   0   0 0
Equity in earnings of investees 3,204       6,558  
Net (loss) income 14,365   53,754   358,056 77,785
Net income attributable to noncontrolling interest     (1,577)     (2,899)
Net (loss) income attributable to common shareholders     52,177     74,886
Operating Segments | SHOP            
Revenues:            
Total revenues 250,506   243,947   495,954 503,913
Expenses:            
Property operating expenses 244,040   233,311   489,335 489,409
Depreciation and amortization 37,369   32,538   73,352 63,899
General and administrative 0   0   0 0
Acquisition and certain other transaction related costs 0   0   0 0
Impairment of assets           (174)
Total expenses 281,409   265,849   562,687 553,134
(Loss) gain on sale of properties 540   0   792 0
Losses on equity securities, net 0   0   0 0
Interest and other income 760   15,748   959 18,181
Interest expense (491)   (525)   (985) (1,053)
Gain (loss) on modification or early extinguishment of debt 0   0   0 0
Income (loss) from continuing operations before income tax benefit (expense) and equity in earnings of investees (30,094)   (6,679)   (65,967) (32,093)
Income tax benefit (expense) 0   0   0 0
Equity in earnings of investees 0       0  
Net (loss) income (30,094)   (6,679)   (65,967) (32,093)
Net income attributable to noncontrolling interest     0     0
Net (loss) income attributable to common shareholders     (6,679)     (32,093)
Operating Segments | Rental income | Office Portfolio            
Revenues:            
Total revenues 52,610   92,804   107,607 186,127
Operating Segments | Rental income | SHOP            
Revenues:            
Total revenues 0   0   0 0
Operating Segments | Residents fees and services | Office Portfolio            
Revenues:            
Total revenues 0   0   0 0
Operating Segments | Residents fees and services | SHOP            
Revenues:            
Total revenues 250,506   243,947   495,954 503,913
Non-Segment            
Revenues:            
Total revenues 9,912   9,590   20,200 19,025
Expenses:            
Property operating expenses 0   0   0 0
Depreciation and amortization 2,895   2,853   5,781 5,707
General and administrative 7,207   9,126   14,492 16,668
Acquisition and certain other transaction related costs 609   12,071   1,537 12,071
Impairment of assets           0
Total expenses 10,711   24,050   21,810 34,446
(Loss) gain on sale of properties 0   0   0 0
Losses on equity securities, net (10,157)   (3,849)   (18,710) (12,188)
Interest and other income 1,506   290   1,702 692
Interest expense (55,268)   (61,140)   (111,540) (114,764)
Gain (loss) on modification or early extinguishment of debt (29,576)   (370)   (30,059) (2,410)
Income (loss) from continuing operations before income tax benefit (expense) and equity in earnings of investees (94,294)   (79,529)   (160,217) (144,091)
Income tax benefit (expense) (640)   191   832 429
Equity in earnings of investees 0       0  
Net (loss) income (93,654)   (79,720)   (161,049) (144,520)
Net income attributable to noncontrolling interest     0     0
Net (loss) income attributable to common shareholders     (79,720)     (144,520)
Non-Segment | Rental income            
Revenues:            
Total revenues 9,912   9,590   20,200 19,025
Non-Segment | Residents fees and services            
Revenues:            
Total revenues $ 0   $ 0   $ 0 $ 0
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.22.2
Segment Reporting - Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Segment reporting    
Total assets $ 6,145,864 $ 6,623,514
Operating Segments | Office Portfolio    
Segment reporting    
Total assets 1,892,417 2,282,652
Operating Segments | SHOP    
Segment reporting    
Total assets 3,001,413 2,995,819
Non-Segment    
Segment reporting    
Total assets $ 1,252,034 $ 1,345,043
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.22.2
Senior Living Community Management Agreements - Narrative (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 09, 2021
USD ($)
unit
community
Jun. 30, 2022
USD ($)
property
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
property
community
Jun. 30, 2021
USD ($)
community
Dec. 31, 2021
community
unit
Number of properties (property) | property   378   378    
Affiliated Entity            
Lease income   $ 379 $ 398 $ 767 $ 795  
Five Star            
Property management agreement expense   8,971 12,927 17,903 26,777  
Related party transaction capitalized amount   697 715 1,487 1,549  
Five Star | Rehabilitation Services            
Expenses from transactions with related party   1,736 2,630 3,652 8,071  
Five Star | Operating Expense            
Property management agreement expense   8,274 12,212      
Related party transaction capitalized amount       16,416 25,228  
Senior Living Communities | Five Star            
Number of properties (property) | community 120          
Related party transactions, termination percentage 10.00%          
Percentage target EBITDA of new management agreement not earned 80.00%          
Senior Living Communities | Five Star | Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations            
Number of properties (property) | community 108          
Number of property units (units) | unit 7,500         7,340
Amounts of transaction $ 682,000 517 $ 11,914 $ 1,445 $ 11,914  
Number of properties transitioned | community           107
Senior Living Communities | Five Star | Closed            
Number of properties (property) | community           108
Number of property units (units) | unit 1,500          
Senior Living Communities | Affiliated Entity | Five Star            
Number of communities managed | community       120 235  
Five Star | Third Party Investor            
Property management agreement expense   $ 5,218   $ 10,326    
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.22.2
Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disaggregation of Revenue        
Revenues $ 313,028 $ 346,341 $ 623,761 $ 709,065
Residents fees and services        
Disaggregation of Revenue        
Revenues 250,506 243,947 495,954 503,913
Residents fees and services | Basic housing and support services        
Disaggregation of Revenue        
Revenues 196,999 188,169 389,873 376,198
Residents fees and services | Medicare and Medicaid programs        
Disaggregation of Revenue        
Revenues 18,966 24,907 38,783 60,855
Residents fees and services | Private pay and other third party payer SNF services        
Disaggregation of Revenue        
Revenues $ 34,541 $ 30,871 $ 67,298 $ 66,860
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.22.2
Business and Property Management Agreements with RMR (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
employee
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
employee
agreement
Jun. 30, 2021
USD ($)
Related person transactions        
Number of employees | employee 0   0  
Property management and construction supervision fees $ 2,518,000 $ 3,191,000 $ 4,909,000 $ 6,345,000
Property management and construction supervision fees paid 3,111,000 3,202,000 6,075,000 6,499,000
RMR        
Related person transactions        
Business management fees incurred 4,506,000 6,324,000 $ 9,319,000 11,641,000
Related party transaction business management agreement, annual incentive fee estimate included in management fees 0 0    
Period of actual amount of incentive fees     3 years  
Property management and construction supervision fees 1,272,000 2,465,000 $ 2,621,000 4,950,000
Party transaction property management and construction supervision fees capitalized $ 1,246,000 $ 726,000 $ 2,288,000 $ 1,395,000
Property management fee 3.00%   3.00%  
Senior Living Communities | RMR        
Related person transactions        
Number of consecutive renewal terms of agreement | agreement     2  
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.22.2
Related Person Transactions (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
investor
property
agreement
jointVenture_arrangement
Jan. 31, 2022
property
Related person transactions    
Number of real estate properties 378  
AlerisLife Inc    
Related person transactions    
Investment owned, percentage of total shares outstanding 32.80%  
RMR    
Related person transactions    
Number joint venture arrangements | jointVenture_arrangement 2  
Number of third party institutional investors | investor 2  
Number of medical office and life science properties 10  
Related party transaction, closing cost | $ $ 11,113  
Number of real estate properties   10
Number of management agreements | agreement 2  
RMR | Medical Office and Life Science Properties    
Related person transactions    
Number of real estate properties 10  
AlerisLife Inc | AlerisLife Inc    
Related person transactions    
Noncontrolling interest, ownership percentage by parent 6.20%  
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.22.2
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Income Tax Disclosure [Abstract]        
Income Tax Expense (Benefit) $ 640 $ (191) $ (832) $ (429)
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.22.2
Weighted Average Common Shares (shares amounts in thousands) (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Earnings Per Share [Abstract]    
Antidilutive securities excluded from computation of earnings per share (in shares) 833 837
XML 57 dhc-20220630_htm.xml IDEA: XBRL DOCUMENT 0001075415 2022-01-01 2022-06-30 0001075415 dhc:SeniorNotesDue2042Member 2022-01-01 2022-06-30 0001075415 dhc:SeniorNotesDue2046Member 2022-01-01 2022-06-30 0001075415 2022-07-29 0001075415 2022-06-30 0001075415 2021-12-31 0001075415 dhc:RentalIncomeMember 2022-04-01 2022-06-30 0001075415 dhc:RentalIncomeMember 2021-04-01 2021-06-30 0001075415 dhc:RentalIncomeMember 2022-01-01 2022-06-30 0001075415 dhc:RentalIncomeMember 2021-01-01 2021-06-30 0001075415 dhc:ResidentFeesAndServicesMember 2022-04-01 2022-06-30 0001075415 dhc:ResidentFeesAndServicesMember 2021-04-01 2021-06-30 0001075415 dhc:ResidentFeesAndServicesMember 2022-01-01 2022-06-30 0001075415 dhc:ResidentFeesAndServicesMember 2021-01-01 2021-06-30 0001075415 2022-04-01 2022-06-30 0001075415 2021-04-01 2021-06-30 0001075415 2021-01-01 2021-06-30 0001075415 srt:AffiliatedEntityMember 2022-04-01 2022-06-30 0001075415 srt:AffiliatedEntityMember 2021-04-01 2021-06-30 0001075415 srt:AffiliatedEntityMember 2022-01-01 2022-06-30 0001075415 srt:AffiliatedEntityMember 2021-01-01 2021-06-30 0001075415 us-gaap:CommonStockMember 2021-12-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001075415 us-gaap:RetainedEarningsMember 2021-12-31 0001075415 dhc:CumulativeCommonDistributionsMember 2021-12-31 0001075415 us-gaap:ParentMember 2021-12-31 0001075415 us-gaap:NoncontrollingInterestMember 2021-12-31 0001075415 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001075415 us-gaap:ParentMember 2022-01-01 2022-03-31 0001075415 2022-01-01 2022-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2022-01-01 2022-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001075415 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001075415 us-gaap:CommonStockMember 2022-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001075415 us-gaap:RetainedEarningsMember 2022-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2022-03-31 0001075415 us-gaap:ParentMember 2022-03-31 0001075415 us-gaap:NoncontrollingInterestMember 2022-03-31 0001075415 2022-03-31 0001075415 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001075415 us-gaap:ParentMember 2022-04-01 2022-06-30 0001075415 dhc:CumulativeCommonDistributionsMember 2022-04-01 2022-06-30 0001075415 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001075415 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001075415 us-gaap:CommonStockMember 2022-06-30 0001075415 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001075415 us-gaap:RetainedEarningsMember 2022-06-30 0001075415 dhc:CumulativeCommonDistributionsMember 2022-06-30 0001075415 us-gaap:ParentMember 2022-06-30 0001075415 us-gaap:NoncontrollingInterestMember 2022-06-30 0001075415 us-gaap:CommonStockMember 2020-12-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001075415 us-gaap:RetainedEarningsMember 2020-12-31 0001075415 dhc:CumulativeCommonDistributionsMember 2020-12-31 0001075415 us-gaap:ParentMember 2020-12-31 0001075415 us-gaap:NoncontrollingInterestMember 2020-12-31 0001075415 2020-12-31 0001075415 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001075415 us-gaap:ParentMember 2021-01-01 2021-03-31 0001075415 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001075415 2021-01-01 2021-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2021-01-01 2021-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001075415 us-gaap:CommonStockMember 2021-03-31 0001075415 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001075415 us-gaap:RetainedEarningsMember 2021-03-31 0001075415 dhc:CumulativeCommonDistributionsMember 2021-03-31 0001075415 us-gaap:ParentMember 2021-03-31 0001075415 us-gaap:NoncontrollingInterestMember 2021-03-31 0001075415 2021-03-31 0001075415 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001075415 us-gaap:ParentMember 2021-04-01 2021-06-30 0001075415 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001075415 dhc:CumulativeCommonDistributionsMember 2021-04-01 2021-06-30 0001075415 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001075415 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001075415 us-gaap:CommonStockMember 2021-06-30 0001075415 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001075415 us-gaap:RetainedEarningsMember 2021-06-30 0001075415 dhc:CumulativeCommonDistributionsMember 2021-06-30 0001075415 us-gaap:ParentMember 2021-06-30 0001075415 us-gaap:NoncontrollingInterestMember 2021-06-30 0001075415 2021-06-30 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2022-06-01 2022-06-30 0001075415 dhc:JointVentureMember 2022-06-30 0001075415 us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:TheLSMDFundREITLLCMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:SeaportInnovationLLCMember stpr:MA us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:SeaportInnovationLLCMember 2021-12-31 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember 2022-01-01 2022-06-30 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:CorporateJointVentureMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-01-01 2022-06-30 0001075415 dhc:TheLSMDFundREITLLCMember stpr:CA us-gaap:InterestRateCapMember us-gaap:CorporateJointVentureMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-01-01 2022-06-30 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2021-12-01 2021-12-31 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2021-12-30 0001075415 dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2022-06-28 0001075415 dhc:SeniorLivingCommunitiesMember dhc:SkilledNursingBedLicenseMember 2022-06-01 2022-06-30 0001075415 dhc:MedicalOfficeBuildingandLifeScienceBuildingMember dhc:SeaportInnovationLLCMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:SeaportInnovationLLCMember 2022-06-30 0001075415 dhc:MedicalOfficeBuildingandLifeScienceBuildingMember us-gaap:CorporateJointVentureMember 2022-01-01 2022-01-31 0001075415 dhc:SeniorLivingCommunitiesMember dhc:SkilledNursingBedLicenseMember 2022-01-01 2022-01-31 0001075415 dhc:MedicalOfficeBuildingandLifeScienceBuildingMember dhc:DiversifiedHealthcareTrustsMember us-gaap:CorporateJointVentureMember dhc:UnrelatedInvestorOneMember 2022-01-31 0001075415 dhc:MedicalOfficeBuildingandLifeScienceBuildingMember dhc:DiversifiedHealthcareTrustsMember us-gaap:CorporateJointVentureMember dhc:UnrelatedInvestorTwoMember 2022-01-31 0001075415 dhc:MedicalOfficeBuildingandLifeScienceBuildingMember dhc:DiversifiedHealthcareTrustsMember us-gaap:CorporateJointVentureMember 2022-01-31 0001075415 us-gaap:CorporateJointVentureMember 2022-01-31 0001075415 dhc:LifeScienceBuildingLocatedInCaliforniaMember us-gaap:SubsequentEventMember 2022-07-31 0001075415 dhc:LifeScienceBuildingLocatedInCaliforniaMember us-gaap:SubsequentEventMember 2022-07-01 2022-07-31 0001075415 us-gaap:LineOfCreditMember 2022-06-30 0001075415 us-gaap:UnsecuredDebtMember 2022-06-30 0001075415 us-gaap:MortgagesMember 2022-06-30 0001075415 dhc:FinanceLeasedPropertiesMember 2022-06-30 0001075415 dhc:FinanceLeasedPropertiesMember 2021-12-31 0001075415 us-gaap:LineOfCreditMember 2022-01-01 2022-06-30 0001075415 us-gaap:LineOfCreditMember 2022-04-01 2022-06-30 0001075415 us-gaap:LineOfCreditMember 2021-04-01 2021-06-30 0001075415 us-gaap:LineOfCreditMember 2021-01-01 2021-06-30 0001075415 us-gaap:LineOfCreditMember 2022-01-31 0001075415 us-gaap:LineOfCreditMember 2022-02-28 0001075415 us-gaap:LineOfCreditMember 2022-02-01 2022-02-28 0001075415 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2022-02-01 2022-02-28 0001075415 srt:ScenarioForecastMember us-gaap:LineOfCreditMember 2023-01-31 0001075415 dhc:MedicalOfficeAndLifeScienceMember us-gaap:LineOfCreditMember 2022-06-30 0001075415 dhc:MedicalOfficeBuildingMember dhc:Mortgages628PercentDueJuly2022Member 2022-04-30 0001075415 dhc:MedicalOfficeBuildingMember dhc:Mortgages628PercentDueJuly2022Member 2022-04-01 2022-04-30 0001075415 dhc:SeniorUnsecuredNoteDue2025Member 2022-06-30 0001075415 dhc:SeniorUnsecuredNoteDue2025Member 2022-06-01 2022-06-30 0001075415 dhc:SeniorUnsecuredNoteDue2025Member 2022-01-01 2022-06-30 0001075415 dhc:SeniorLivingCommunitiesMember dhc:Mortgages628PercentDueJuly2022Member us-gaap:SubsequentEventMember 2022-07-31 0001075415 dhc:SeniorLivingCommunitiesMember dhc:Mortgages628PercentDueJuly2022Member us-gaap:SubsequentEventMember 2022-07-01 2022-07-31 0001075415 dhc:AlerisLifeIncMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001075415 dhc:AlerisLifeIncMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001075415 dhc:AlerisLifeIncMember us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001075415 dhc:AlerisLifeIncMember us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2022-06-30 0001075415 dhc:LifeSciencePropertyMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2022-06-30 0001075415 dhc:LifeSciencePropertyMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2021-12-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2021-12-31 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2022-06-30 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2022-06-30 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:FairValueInputsLevel3Member us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2021-12-31 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueMeasurementsRecurringMember dhc:JointVentureMember 2021-12-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:LifeSciencePropertyMember us-gaap:MeasurementInputDiscountRateMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:LifeSciencePropertyMember dhc:MeasurementInputMarketCapitalizationRateMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2022-01-01 2022-06-30 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:CorporateJointVentureMember 2022-01-01 2022-06-30 0001075415 srt:MinimumMember dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:MeasurementInputDiscountRateMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 srt:MaximumMember dhc:MedicalOfficeAndLifeSciencePropertiesMember us-gaap:MeasurementInputDiscountRateMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 srt:MinimumMember dhc:MedicalOfficeAndLifeSciencePropertiesMember dhc:MeasurementInputMarketCapitalizationRateMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 srt:MaximumMember dhc:MedicalOfficeAndLifeSciencePropertiesMember dhc:MeasurementInputMarketCapitalizationRateMember us-gaap:CorporateJointVentureMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2024Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2024Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes975PercentDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes975PercentDue2025Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes975PercentDue2025Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes975PercentDue2025Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes4.75PercentDue2028Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes4375PercentDue2031Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes5625PercentDue2042Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2022-06-30 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:CarryingReportedAmountFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 dhc:SeniorUnsecuredNotes625PercentDue2046Member us-gaap:EstimateOfFairValueFairValueDisclosureMember dhc:SeniorUnsecuredNotesMember 2021-12-31 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2022-06-30 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2022-06-30 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:SecuredDebtMember 2021-12-31 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:SecuredDebtMember 2021-12-31 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-06-30 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-06-30 0001075415 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-12-31 0001075415 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-12-31 0001075415 us-gaap:FairValueInputsLevel1Member 2022-06-30 0001075415 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001075415 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001075415 us-gaap:FairValueInputsLevel2Member 2022-06-30 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember dhc:ThirdPartyInvestorMember 2017-03-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2017-03-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2021-12-01 2021-12-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2021-12-31 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2022-06-01 2022-06-30 0001075415 dhc:LifeSciencePropertyMember us-gaap:CorporateJointVentureMember 2022-06-28 0001075415 dhc:TrusteeMember dhc:ShareAwardPlansMember dhc:ReitManagementAndResearchMember 2022-06-02 2022-06-02 0001075415 dhc:TrusteeMember dhc:ShareAwardPlansMember dhc:ReitManagementAndResearchMember 2022-06-02 0001075415 dhc:FormerEmployeesOfRMRLLCMember us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001075415 2022-02-17 2022-02-17 0001075415 2022-05-19 2022-05-19 0001075415 us-gaap:SubsequentEventMember 2022-07-14 2022-07-14 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:OfficePortfolioSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:RentalIncomeMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:OfficePortfolioSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:ResidentFeesAndServicesMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:OfficePortfolioSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:OfficePortfolioSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:RentalIncomeMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:OfficePortfolioSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:ResidentFeesAndServicesMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:OfficePortfolioSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:OfficePortfolioSegmentMember 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2022-06-30 0001075415 us-gaap:CorporateNonSegmentMember 2022-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:OfficePortfolioSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:RentalIncomeMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:OfficePortfolioSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:ResidentFeesAndServicesMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:OfficePortfolioSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:CorporateNonSegmentMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:OfficePortfolioSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:RentalIncomeMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:RentalIncomeMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:OfficePortfolioSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:ResidentFeesAndServicesMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:CorporateNonSegmentMember dhc:ResidentFeesAndServicesMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:OfficePortfolioSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:CorporateNonSegmentMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingSegmentsMember dhc:OfficePortfolioSegmentMember 2021-12-31 0001075415 us-gaap:OperatingSegmentsMember dhc:SeniorHousingOperatingPortfolioSegmentMember 2021-12-31 0001075415 us-gaap:CorporateNonSegmentMember 2021-12-31 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-06-09 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-06-09 2021-06-09 0001075415 dhc:SeniorLivingCommunityMember dhc:FiveStarQualityCareIncMember 2021-06-09 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-06-09 0001075415 dhc:SeniorLivingCommunityMember dhc:FiveStarQualityCareIncMember 2021-06-09 2021-06-09 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-12-31 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-12-31 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2022-04-01 2022-06-30 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-04-01 2021-06-30 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2022-01-01 2022-06-30 0001075415 dhc:SeniorLivingCommunityMember us-gaap:DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember dhc:FiveStarQualityCareIncMember 2021-01-01 2021-06-30 0001075415 dhc:FiveStarQualityCareIncMember dhc:SeniorLivingCommunityMember srt:AffiliatedEntityMember 2022-01-01 2022-06-30 0001075415 dhc:FiveStarQualityCareIncMember dhc:SeniorLivingCommunityMember srt:AffiliatedEntityMember 2021-01-01 2021-06-30 0001075415 dhc:FiveStarQualityCareIncMember 2022-04-01 2022-06-30 0001075415 dhc:FiveStarQualityCareIncMember 2021-04-01 2021-06-30 0001075415 dhc:FiveStarQualityCareIncMember 2022-01-01 2022-06-30 0001075415 dhc:FiveStarQualityCareIncMember 2021-01-01 2021-06-30 0001075415 us-gaap:OperatingExpenseMember dhc:FiveStarQualityCareIncMember 2022-04-01 2022-06-30 0001075415 us-gaap:OperatingExpenseMember dhc:FiveStarQualityCareIncMember 2021-04-01 2021-06-30 0001075415 us-gaap:OperatingExpenseMember dhc:FiveStarQualityCareIncMember 2022-01-01 2022-06-30 0001075415 us-gaap:OperatingExpenseMember dhc:FiveStarQualityCareIncMember 2021-01-01 2021-06-30 0001075415 dhc:RehabilitationServicesMember dhc:FiveStarQualityCareIncMember 2022-04-01 2022-06-30 0001075415 dhc:RehabilitationServicesMember dhc:FiveStarQualityCareIncMember 2021-04-01 2021-06-30 0001075415 dhc:RehabilitationServicesMember dhc:FiveStarQualityCareIncMember 2022-01-01 2022-06-30 0001075415 dhc:RehabilitationServicesMember dhc:FiveStarQualityCareIncMember 2021-01-01 2021-06-30 0001075415 srt:AffiliatedEntityMember 2022-04-01 2022-06-30 0001075415 srt:AffiliatedEntityMember 2021-04-01 2021-06-30 0001075415 srt:AffiliatedEntityMember 2022-01-01 2022-06-30 0001075415 srt:AffiliatedEntityMember 2021-01-01 2021-06-30 0001075415 dhc:FiveStarQualityCareIncMember dhc:ThirdPartyInvestorMember 2022-04-01 2022-06-30 0001075415 dhc:FiveStarQualityCareIncMember dhc:ThirdPartyInvestorMember 2022-01-01 2022-06-30 0001075415 dhc:BasicHousingAndSupportServicesMember dhc:ResidentFeesAndServicesMember 2022-04-01 2022-06-30 0001075415 dhc:BasicHousingAndSupportServicesMember dhc:ResidentFeesAndServicesMember 2021-04-01 2021-06-30 0001075415 dhc:BasicHousingAndSupportServicesMember dhc:ResidentFeesAndServicesMember 2022-01-01 2022-06-30 0001075415 dhc:BasicHousingAndSupportServicesMember dhc:ResidentFeesAndServicesMember 2021-01-01 2021-06-30 0001075415 dhc:MedicareAndMedicaidProgramsMember dhc:ResidentFeesAndServicesMember 2022-04-01 2022-06-30 0001075415 dhc:MedicareAndMedicaidProgramsMember dhc:ResidentFeesAndServicesMember 2021-04-01 2021-06-30 0001075415 dhc:MedicareAndMedicaidProgramsMember dhc:ResidentFeesAndServicesMember 2022-01-01 2022-06-30 0001075415 dhc:MedicareAndMedicaidProgramsMember dhc:ResidentFeesAndServicesMember 2021-01-01 2021-06-30 0001075415 dhc:PrivatePayAndOtherThirdPartyPayerServicesMember dhc:ResidentFeesAndServicesMember 2022-04-01 2022-06-30 0001075415 dhc:PrivatePayAndOtherThirdPartyPayerServicesMember dhc:ResidentFeesAndServicesMember 2021-04-01 2021-06-30 0001075415 dhc:PrivatePayAndOtherThirdPartyPayerServicesMember dhc:ResidentFeesAndServicesMember 2022-01-01 2022-06-30 0001075415 dhc:PrivatePayAndOtherThirdPartyPayerServicesMember dhc:ResidentFeesAndServicesMember 2021-01-01 2021-06-30 0001075415 dhc:SeniorLivingCommunityMember dhc:ReitManagementAndResearchMember 2022-01-01 2022-06-30 0001075415 dhc:ReitManagementAndResearchMember 2022-04-01 2022-06-30 0001075415 dhc:ReitManagementAndResearchMember 2021-04-01 2021-06-30 0001075415 dhc:ReitManagementAndResearchMember 2022-01-01 2022-06-30 0001075415 dhc:ReitManagementAndResearchMember 2021-01-01 2021-06-30 0001075415 dhc:ReitManagementAndResearchMember 2022-06-30 0001075415 dhc:AlerisLifeIncMember 2022-06-30 0001075415 dhc:AlerisLifeIncMember dhc:AlerisLifeIncMember 2022-06-30 0001075415 dhc:MedicalOfficeAndLifeSciencePropertiesMember dhc:ReitManagementAndResearchMember 2022-06-30 0001075415 dhc:ReitManagementAndResearchMember 2022-01-31 shares iso4217:USD iso4217:USD shares pure dhc:property dhc:state dhc:jointVenture utr:sqft dhc:option dhc:investor dhc:trustee dhc:security dhc:segment dhc:community dhc:unit dhc:employee dhc:agreement dhc:jointVenture_arrangement 0001075415 false --12-31 2022 Q2 http://fasb.org/us-gaap/2022#OtherAssets http://fasb.org/us-gaap/2022#OtherAssets http://fasb.org/us-gaap/2022#OtherLiabilities http://fasb.org/us-gaap/2022#OtherLiabilities 238197000 238197000 237871000 237871000 238173000 238173000 237853000 237853000 238197000 238197000 237871000 238173000 237853000 10-Q true 2022-06-30 false 1-15319 DIVERSIFIED HEALTHCARE TRUST MD 04-3445278 Two Newton Place, 255 Washington Street, Suite 300, Newton MA 02458-1634 617 796 - 8350 Common Shares of Beneficial Interest DHC NASDAQ 5.625% Senior Notes due 2042 DHCNI NASDAQ 6.25% Senior Notes due 2046 DHCNL NASDAQ Yes Yes Large Accelerated Filer false false false 239123496 652655000 741501000 5819802000 6072055000 6472457000 6813556000 1738379000 1737807000 4734078000 5075749000 158759000 215127000 705160000 634848000 163242000 382097000 37359000 48746000 347266000 266947000 6145864000 6623514000 700000000 800000000 2315286000 2806811000 57006000 69713000 27639000 29845000 1293000 2556000 255015000 252199000 3356239000 3961124000 0.01 0.01 300000000 300000000 239123496 239123496 238994894 238994894 2391000 2390000 4616449000 4615475000 2218664000 2087624000 4047879000 4043099000 2789625000 2662390000 6145864000 6623514000 62522000 102394000 127807000 205152000 250506000 243947000 495954000 503913000 313028000 346341000 623761000 709065000 266066000 264632000 534808000 552023000 58261000 67888000 115520000 134041000 7207000 9126000 14492000 16668000 609000 12071000 1537000 12071000 0 0 0 -174000 332143000 353717000 666357000 714629000 -686000 30760000 327108000 30638000 -10157000 -3849000 -18710000 -12188000 2266000 16038000 2661000 18873000 2318000 3017000 4790000 5829000 55975000 67657000 113106000 127748000 -29560000 -370000 -30043000 -2410000 -113227000 -32454000 125314000 -98399000 -640000 191000 832000 429000 3204000 0 6558000 0 -109383000 -32645000 131040000 -98828000 0 1577000 0 2899000 -109383000 -34222000 131040000 -101727000 238197000 238197000 237871000 237871000 238173000 238173000 237853000 237853000 -0.46 -0.46 -0.14 -0.14 0.55 0.55 -0.43 -0.43 238994894 2390000 4615475000 2087624000 -4043099000 2662390000 0 2662390000 240423000 240423000 240423000 2390000 2390000 2390000 318000 318000 318000 1698 5000 5000 5000 4900 3000 3000 3000 238988296 2390000 4615785000 2328047000 -4045489000 2900733000 0 2900733000 -109383000 -109383000 -109383000 2390000 2390000 2390000 140000 1000 668000 669000 669000 4800 4000 4000 4000 239123496 2391000 4616449000 2218664000 -4047879000 2789625000 0 2789625000 238268478 2383000 4613904000 1913109000 -4033559000 2495837000 123385000 2619222000 -67505000 -67505000 1322000 -66183000 2383000 2383000 2383000 228000 228000 228000 5694000 5694000 238268478 2383000 4614132000 1845604000 -4035942000 2426177000 119013000 2545190000 -34222000 -34222000 1577000 -32645000 2383000 2383000 2383000 120000 1000 675000 676000 676000 13906 59000 59000 59000 5630000 5630000 238374572 2384000 4614748000 1811382000 -4038325000 2390189000 114960000 2505149000 131040000 -98828000 115520000 134041000 4790000 5829000 4455000 2125000 162000 -3715000 -30043000 -2410000 0 -174000 327108000 30638000 -18710000 -12188000 905000 982000 5660000 0 6558000 0 4968000 8258000 -25922000 7937000 -2206000 8918000 -17503000 16317000 -31856000 27046000 116640000 83468000 792000 103057000 643892000 0 -330000 0 527714000 19589000 0 492500000 0 800000000 100000000 0 500000000 300000000 0 200000000 12421000 1558000 24375000 0 2820000 4188000 5000 59000 0 11324000 4780000 4766000 -644401000 770605000 -148543000 817240000 1016945000 90849000 868402000 908089000 110522000 113933000 895000 1880000 355669000 0 108246000 0 108956000 0 24325000 20860000 0 932000 705160000 849079000 163242000 59010000 868402000 908089000 0.10 108000000 108956000 Basis of Presentation<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements of Diversified Healthcare Trust and its subsidiaries, or we, us, or our, are unaudited. Certain information and disclosures required by U.S. generally accepted accounting principles, or GAAP, for complete financial statements have been condensed or omitted. We believe the disclosures made are adequate to make the information presented not misleading. However, the accompanying condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes contained in our Annual Report on Form 10-K for the year ended December 31, 2021, or our Annual Report.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair statement of results for the interim period have been included. All intercompany transactions and balances with or among our consolidated subsidiaries have been eliminated. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in our condensed consolidated financial statements include purchase price allocations, useful lives of fixed assets and impairments of real estate and intangible assets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been, are currently, and expect in the future to be involved in claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings arising in the ordinary course of our business, some of which may involve material amounts. Also, the defense and resolution of these claims, lawsuits, and regulatory and other governmental audits, investigations and proceedings may require us to incur significant expense. We account for claims and litigation losses in accordance with the Financial Accounting Standards Board Accounting Standards Codification Topic 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 450. Under ASC 450, loss contingency provisions are recorded for probable and estimable losses at our best estimate of a loss or, when a best estimate cannot be made, at our estimate of the minimum loss. These estimates are often developed prior to knowing the amount of the ultimate loss, require the application of considerable judgment, and are refined as additional information becomes known. Accordingly, we are often initially unable to develop a best estimate of loss and therefore the estimated minimum loss amount, which could be zero, is recorded; and then, as information becomes known, the minimum loss amount is updated, as appropriate. A minimum or best estimate amount may be increased or decreased when events result in a changed expectation.</span></div> Real Estate Investments<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, we wholly owned 378 properties located in 36 states and Washington, D.C. and we owned an equity interest in each of two unconsolidated joint ventures that own medical office and life science properties located in five states with an aggregate of approximately 2.2 million rentable square feet.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joint Venture Activities:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, we had equity investments in joint ventures as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Ownership</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Carrying Value of Investment at June 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Square Feet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seaport Innovation LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134,479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The LSMD Fund REIT LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CA, MA, NY, TX, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,068,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,203,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the mortgage debts of these joint ventures:</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:51.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Balance at June 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in Massachusetts) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/6/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by nine properties in five states)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/11/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in California) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.18%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/9/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.43%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,076,625 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts are not adjusted for our minority equity interest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Following the deconsolidation in December 2021 of the net assets of our Boston life science property joint venture, we no longer include this $620,000 of secured debt financing in our condensed consolidated balance sheet; however, we continue to provide certain guaranties on this debt.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The maturity date of February 9, 2024 is subject to three, one year extension options and requires interest to be paid at an annual rate based on the secured overnight financing rate, or SOFR, plus a premium of 1.90%. The interest rate is as of June 30, 2022. This joint venture has also purchased an interest rate cap through February 2024 with a SOFR strike rate equal to 4.00%.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we sold an additional 35% equity interest from our then remaining 55% equity interest in our Boston life science property joint venture to another third party institutional investor for $378,000, before closing costs and other adjustments. Effective as of the date of the sale, we deconsolidated this joint venture and we now account for this joint venture using the equity method of accounting under the fair value option. Prior to the deconsolidation of the net assets of this joint venture, the joint venture investor's interest in this consolidated entity was reflected as noncontrolling interest in our consolidated financial statements. In June 2022, we sold an additional 10% equity interest from our then remaining 20% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022. We recognized a net loss on sale of $1,226 related to this transaction, which is included in (loss) gain on sale of properties in our condensed consolidated statements of comprehensive income (loss). After giving effect to these sales, we continue to own a 10% equity interest in this joint venture. Our investment amount was based on a property valuation of $1,700,000, less $620,000 of existing mortgage debts on the property that this joint venture assumed. See Note 5 for more information regarding the valuation of our investment in this joint venture.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, we entered into a joint venture with two unrelated third party institutional investors for 10 medical office and life science properties we owned, or our 10 medical office and life science properties joint venture. We sold equity interests in this joint venture to those investors for aggregate proceeds, before closing costs and other adjustments, of approximately $653,300. We deconsolidated the net assets of these properties effective as of the date of the sale and recognized a net gain on sale of $327,542 related to this transaction, which is included in (loss) gain on sale of properties in our condensed consolidated statements of comprehensive income (loss). The equity interests that the investors acquired from us equaled 41% and 39%, respectively, of the total equity interests in the joint venture and we retained a 20% equity interest in the joint venture. Following the sale, we account for this joint venture using the equity method of accounting under the fair value option. The investment amounts are based upon a property valuation of approximately $702,500, less approximately $456,600 of secured debt on the properties incurred by this joint venture. See Note 5 for more information regarding the valuation of our investment in this joint venture.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions and Dispositions:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, we acquired one life science property located in California with approximately 89,000 square feet for a purchase price of approximately $82,000, excluding closing costs. We did not acquire or dispose of any properties during the six months ended June 30, 2022.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our assets for indicators of impairment. Impairment indicators may include declining tenant or resident occupancy, weak or declining profitability from the property, decreasing tenant cash flows or liquidity, our decision to dispose of an asset before the end of its estimated useful life, and legislative, market or industry changes that could permanently reduce the value of an asset. If indicators of impairment are present, we evaluate the carrying value of the affected assets by comparing it to the expected future cash flows to be generated from those assets. The future cash flows are subjective and are based in part on assumptions regarding hold periods, market rents and terminal capitalization rates. If the sum of these expected future cash flows is less than the carrying value, we reduce the net carrying value of the asset to its estimated fair value. No </span></div>material impairment charges were recorded on held and used properties during the three or six months ended June 30, 2022 or 2021. 378 36 2 5 2200000 <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, we had equity investments in joint ventures as follows:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.995%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Ownership</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DHC Carrying Value of Investment at June 30, 2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Properties</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Square Feet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Seaport Innovation LLC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,286 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">MA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,134,479 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The LSMD Fund REIT LLC</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CA, MA, NY, TX, WA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,068,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158,759 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,203,242 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of the mortgage debts of these joint ventures:</span></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:51.132%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.419%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Joint Venture</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Coupon Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Principal Balance at June 30, 2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in Massachusetts) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.53%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/6/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">620,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by nine properties in five states)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.46%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/11/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mortgage Notes Payable (secured by one property in California) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.18%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/9/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,825 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.43%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,076,625 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Amounts are not adjusted for our minority equity interest.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Following the deconsolidation in December 2021 of the net assets of our Boston life science property joint venture, we no longer include this $620,000 of secured debt financing in our condensed consolidated balance sheet; however, we continue to provide certain guaranties on this debt.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">The maturity date of February 9, 2024 is subject to three, one year extension options and requires interest to be paid at an annual rate based on the secured overnight financing rate, or SOFR, plus a premium of 1.90%. The interest rate is as of June 30, 2022. This joint venture has also purchased an interest rate cap through February 2024 with a SOFR strike rate equal to 4.00%.</span></div> 0.10 108286000 1 1134479 0.20 50473000 10 1068763 158759000 11 2203242 0.0353 620000000 0.0346 189800000 0.0318 266825000 0.0343 1076625000 620000000 3 P1Y 0.0190 0.0400 0.35 0.55 378000000 0.10 0.20 108000000 108956000 -1226000 0.10 1700000000 620000000 2 10 10 653300000 327542000 0.41 0.39 0.20 702500000 456600000 1 89000 82000000 Leases<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a lessor of medical office and life science properties, senior living communities and other healthcare related properties. Our leases provide our tenants with the contractual right to use and economically benefit from all of the premises demised under the leases; therefore, we have determined to evaluate our leases as lease arrangements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our leases provide for base rent payments and in addition, may include variable payments. Rental income from operating leases, including any payments derived by index or market based indices, is recognized on a straight line basis over the lease term when we have determined that the collectability of substantially all of the lease payments is probable. Some of our leases have options to extend or terminate the lease exercisable at the option of our tenants, which are considered when determining the lease term.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We increased rental income to record revenue on a straight line basis by $2,710 and $1,321 for the three months ended June 30, 2022 and 2021, respectively, and $4,455 and $2,125 for the six months ended June 30, 2022 and 2021, respectively. Rents receivable, excluding receivables related to our properties classified as held for sale, if any, include $71,902 and $82,131 of straight line rent receivables at June 30, 2022 and December 31, 2021, respectively, and are included in other assets, net in our condensed consolidated balance sheets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not include in our measurement of our lease receivables certain variable payments, including changes in the index or market based indices after the inception of the lease, certain tenant reimbursements and other income until the specific events that trigger the variable payments have occurred. Such payments totaled $10,430 and $18,476 for the three months ended June 30, 2022 and 2021, respectively, of which tenant reimbursements totaled $10,350 and $18,440, respectively, and $21,138 and $36,704 for the six months ended June 30, 2022 and 2021, respectively, of which tenant reimbursements totaled $21,013 and $36,620, respectively.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Right of Use Asset and Lease Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For leases where we are the lessee, we recognized a right of use asset and a lease liability equal to the present value of the minimum lease payments with rental payments being applied to the lease liability and the right of use asset being amortized over the term of the lease. The values of the right of use assets and related liabilities representing our future obligation under the respective lease arrangements for which we are the lessee were $28,003 and $28,382, respectively, as of June 30, 2022, and $4,153 and $4,352, respectively, as of December 31, 2021. The right of use assets and related lease liabilities are included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIzYmYxNDM2OWE0YzRjYmE4Y2I2OTdiNGM0YThkYTQ0L3NlYzpiM2JmMTQzNjlhNGM0Y2JhOGNiNjk3YjRjNGE4ZGE0NF80MC9mcmFnOmY0OTJmY2RkMmU0NjRmZDJiZTBkMDJiMDdjYTcwZmQwL3RleHRyZWdpb246ZjQ5MmZjZGQyZTQ2NGZkMmJlMGQwMmIwN2NhNzBmZDBfMjM5Ng_086770fd-ebde-4e44-a2ec-24b6fdb6039a"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIzYmYxNDM2OWE0YzRjYmE4Y2I2OTdiNGM0YThkYTQ0L3NlYzpiM2JmMTQzNjlhNGM0Y2JhOGNiNjk3YjRjNGE4ZGE0NF80MC9mcmFnOmY0OTJmY2RkMmU0NjRmZDJiZTBkMDJiMDdjYTcwZmQwL3RleHRyZWdpb246ZjQ5MmZjZGQyZTQ2NGZkMmJlMGQwMmIwN2NhNzBmZDBfMjM5Ng_245969d5-b32e-4356-877b-fd396c8dd355">other assets, net</span></span> and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIzYmYxNDM2OWE0YzRjYmE4Y2I2OTdiNGM0YThkYTQ0L3NlYzpiM2JmMTQzNjlhNGM0Y2JhOGNiNjk3YjRjNGE4ZGE0NF80MC9mcmFnOmY0OTJmY2RkMmU0NjRmZDJiZTBkMDJiMDdjYTcwZmQwL3RleHRyZWdpb246ZjQ5MmZjZGQyZTQ2NGZkMmJlMGQwMmIwN2NhNzBmZDBfMjQwMw_aea4d7f8-ce7c-4da1-a1b0-6602df90a56c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmIzYmYxNDM2OWE0YzRjYmE4Y2I2OTdiNGM0YThkYTQ0L3NlYzpiM2JmMTQzNjlhNGM0Y2JhOGNiNjk3YjRjNGE4ZGE0NF80MC9mcmFnOmY0OTJmY2RkMmU0NjRmZDJiZTBkMDJiMDdjYTcwZmQwL3RleHRyZWdpb246ZjQ5MmZjZGQyZTQ2NGZkMmJlMGQwMmIwN2NhNzBmZDBfMjQwMw_c2b9a269-dfa0-407c-a32d-3e6f169f76d8">other liabilities</span></span>, respectively, within our condensed consolidated balance sheets. In addition, we lease equipment at certain of our managed senior living communities. These leases are short term in nature, are cancelable with no fee or do not result in an annual expense in excess of our capitalization policy and, as a result, are not recorded on our condensed consolidated balance sheets.</span></div> 2710000 1321000 4455000 2125000 71902000 82131000 10430000 18476000 10350000 18440000 21138000 36704000 21013000 36620000 28003000 28382000 4153000 4352000 Indebtedness<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal debt obligations, excluding any debt obligations of our joint ventures, at June 30, 2022 were: (1) outstanding borrowings under our $700,000 revolving credit facility; (2) $2,350,000 outstanding principal amount of senior unsecured notes; and (3) $50,715 aggregate principal amount of mortgage notes secured by five properties. These five mortgaged properties had a gross book value of $87,870 at June 30, 2022. We also had two properties subject to finance leases with lease obligations totaling $5,999 at June 30, 2022; these two properties had gross book value and accumulated depreciation of $37,630 and $18,632, respectively, at June 30, 2022, and $36,730 and $18,203, respectively, at December 31, 2021, and the finance leases expire in 2026. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a $700,000 revolving credit facility that is used for general business purposes. The maturity date of our revolving credit facility is January 2024. Our revolving credit facility generally provides that we can borrow, repay and re-borrow funds available under our revolving credit facility until maturity, and no principal repayment is due until maturity. As of June 30, 2022, our revolving credit facility required interest to be paid on borrowings at the annual rate of 4.2%, plus a facility fee of 30 basis points per annum on the total amount of lending commitments under the facility.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average annual interest rates for borrowings under our revolving credit facility were 3.3% and 2.9% for the three months ended June 30, 2022 and 2021, respectively, and 3.1% and 2.9% for the six months ended June 30, 2022 and 2021, respectively. The interest rate premium and facility fee are each subject to adjustment based upon changes to our credit ratings. As of June 30, 2022 and July 29, 2022, we were fully drawn under our revolving credit facility.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, we and our lenders amended our credit agreement. Pursuant to the amendment:</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the waiver of the fixed charge coverage ratio covenant included in our credit agreement has been extended through December 31, 2022, or the Amendment Period;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the revolving credit facility commitments have been reduced from $800,000 to $700,000 following our repayment of $100,000, and as a result of the reduction in commitments, we recorded a loss on modification or early extinguishment of debt of $483 for the six months ended June 30, 2022;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have the ability to fund $400,000 of capital expenditures per year and we are restricted in our ability to acquire real property as defined in our credit agreement;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the interest rate premium under our revolving credit facility increased by 15 basis points; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain covenants and restrictions on distributions to common shareholders, share repurchases, capital expenditures, acquiring additional properties and incurring additional indebtedness (in each case subject to various exceptions), and the minimum liquidity requirement of $200,000 will remain in place during the Amendment Period.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in February 2022, we exercised our option to extend the maturity date of our revolving credit facility by one year to January 2024. Pursuant to our credit agreement, the borrowing capacity under our revolving credit facility will be reduced to $586,373 in January 2023 and as such, further repayment of our revolving credit facility will be required by that time.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our credit agreement, we pledged certain equity interests of subsidiaries owning properties to secure our obligations under our credit agreement and agreed to provide, and as of September 2021 had provided, first mortgage liens on 61 medical office and life science properties with an aggregate gross book value of real estate assets of $996,709 as of June 30, 2022 to secure our obligations, which pledges and/or mortgage liens may be removed or new ones may be added during the Amendment Period based on outstanding debt amounts, among other things.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, we prepaid a mortgage note secured by one of our medical office properties with an outstanding principal balance of approximately $10,934, a maturity date in July 2022 and an annual interest rate of 6.28%, using cash on hand. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we redeemed $500,000 of our outstanding 9.75% senior notes due 2025 for a redemption price equal to 104.875% of the $500,000 principal amount of the notes being redeemed plus accrued and unpaid interest of $1,083, using restricted cash on hand. As a result of this redemption, we recorded a loss on early extinguishment of debt of $29,576 for the six months ended June 30, 2022.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, we prepaid a mortgage note secured by two of our senior living communities with an outstanding principal balance of approximately $15,273, a maturity date in October 2022 and an annual interest rate of 5.75%, using cash on hand. </span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit agreement and our senior unsecured notes indentures and their supplements provide for acceleration of payment of all amounts due thereunder upon the occurrence and continuation of certain events of default, such as, in the case of our credit agreement, a change of control of us, as defined, which includes The RMR Group LLC, or RMR, ceasing to act as our business and property manager. Our credit agreement and our senior unsecured notes indentures and their supplements also contain covenants, including covenants that restrict our ability to incur debts, and generally require us to maintain certain financial ratios, and our credit agreement restricts our ability to make distributions under certain circumstances. As of June 30, 2022, our ratio of consolidated income available for debt service to debt service was below the 1.5x incurrence requirement under our revolving credit facility and our public debt covenants as the effects of the COVID-19 pandemic continued to adversely impact our operations. We are unable to incur additional debt until this ratio is at or above 1.5x on a pro forma basis. We believe we were in compliance with the remaining terms and conditions of the respective covenants under our credit agreement and our senior unsecured notes indentures and their supplements at June 30, 2022, subject to the waivers noted above. Although we have taken steps to enhance our ability to maintain sufficient liquidity, a protracted negative impact on the </span></div>economy or the industries in which our properties and businesses operate may cause increased pressure on our ability to satisfy financial and other covenants. Continued availability of borrowings under our revolving credit facility is subject to our satisfying certain financial covenants and other credit facility conditions. If our operating results and financial condition are significantly negatively impacted by economic conditions or otherwise, we may fail to satisfy covenants and conditions under our credit agreement or fail to satisfy our public debt covenants 700000000 2350000000 50715000 5 5 87870000 2 5999000 2 37630000 18632000 36730000 18203000 700000000 0.042 0.0030 0.033 0.029 0.031 0.029 800000000 700000000 100000000 -483000 400000000 0.0015 200000000 586373000 61 996709000 1 10934000 0.0628 500000000 0.0975 1.04875 500000000 1083000 -29576000 2 15273000 0.0575 1.5 1.5 Fair Value of Assets and Liabilities<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain of our assets that are measured at fair value at June 30, 2022 and December 31, 2021, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"/><td style="width:43.620%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Recurring Fair Value Measurements Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in AlerisLife (Level 1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Our 10,691,658 shares of common stock of AlerisLife Inc., or AlerisLife, are included in other assets, net in our condensed consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs). During the three months ended June 30, 2022 and 2021, we recorded unrealized losses of $10,157 and $3,849, respectively, and during the six months ended June 30, 2022 and 2021, we recorded unrealized losses of $18,710 and $12,188, respectively, which are included in losses on equity securities, net in our condensed consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Note 11 for further information about our investment in AlerisLife.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 10% equity interest we own in our Boston life science property joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 5.58%, an exit capitalization rate of 5.25%, a holding period of approximately 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 20% equity interest we own in our 10 medical office and life science properties joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 5.67% and 8.93%, exit capitalization rates of between 4.75% and 6.00%, holding periods of approximately 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the assets described in the table above, our financial instruments at June 30, 2022 and December 31, 2021 included cash and cash equivalents, restricted cash, other assets, our revolving credit facility, senior unsecured notes, secured debt and finance leases and other unsecured obligations and liabilities. The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:</span></div><div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:42.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.750% coupon rate, due 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,353 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,348 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 9.750% coupon rate, due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493,125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,081,990 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.750% coupon rate, due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.375% coupon rate, due 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,557 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 5.625% coupon rate, due 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,374 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 6.250% coupon rate, due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured debts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,963 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,372,292 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,880,314 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,876,524 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,919,651 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes unamortized net debt issuance costs, premiums and discounts.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimated the fair value of our two issuances of senior unsecured notes due 2042 and 2046 based on the closing price on Nasdaq (Level 1 input) as of June 30, 2022 and December 31, 2021, respectively. We estimated the fair values of our four issuances of senior unsecured notes due 2024, 2025, 2028 and 2031 using an average of the bid and ask price on Nasdaq on or about June 30, 2022 and December 31, 2021 (Level 2 inputs as defined in the fair value hierarchy under GAAP). We estimated the fair values of our secured debts by using discounted cash flows analyses and currently prevailing market terms as of the measurement date (Level 3 inputs as defined in the fair value hierarchy under GAAP). Because Level 3 inputs are unobservable, our estimated fair values may differ materially from the actual fair values.</span></div> <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain of our assets that are measured at fair value at June 30, 2022 and December 31, 2021, categorized by the level of inputs as defined in the fair value hierarchy under GAAP, used in the valuation of each asset.</span></div><div style="margin-bottom:9pt;margin-top:5pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"/><td style="width:43.620%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.943%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Recurring Fair Value Measurements Assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in AlerisLife (Level 1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,830 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,540 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">108,286 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">215,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment in unconsolidated joint venture (Level 3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,473 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Our 10,691,658 shares of common stock of AlerisLife Inc., or AlerisLife, are included in other assets, net in our condensed consolidated balance sheets, and are reported at fair value, which is based upon quoted market prices on The Nasdaq Stock Market LLC, or Nasdaq, (Level 1 inputs). During the three months ended June 30, 2022 and 2021, we recorded unrealized losses of $10,157 and $3,849, respectively, and during the six months ended June 30, 2022 and 2021, we recorded unrealized losses of $18,710 and $12,188, respectively, which are included in losses on equity securities, net in our condensed consolidated statements of comprehensive income (loss), to adjust the carrying value of our investment in AlerisLife common shares to their fair value. See Note 11 for further information about our investment in AlerisLife.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 10% equity interest we own in our Boston life science property joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are a discount rate of 5.58%, an exit capitalization rate of 5.25%, a holding period of approximately 10 years and market rents. The assumptions made in the fair value analysis are based on the location, type and nature of the property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The 20% equity interest we own in our 10 medical office and life science properties joint venture is included in investments in unconsolidated joint ventures in our condensed consolidated balance sheet, and is reported at fair value, which is based on significant unobservable inputs (Level 3 inputs). The significant unobservable inputs used in the fair value analysis are discount rates of between 5.67% and 8.93%, exit capitalization rates of between 4.75% and 6.00%, holding periods of approximately 10 years and market rents. The assumptions we made in the fair value analysis are based on the location, type and nature of each property, and current and anticipated market conditions, which are derived from appraisers, industry publications and our experience. See Note 2 for further information regarding this joint venture.</span></div> 12830000 12830000 31540000 31540000 108286000 108286000 215127000 215127000 50473000 50473000 0 0 10691658 -10157000 -3849000 -18710000 -12188000 0.10 0.0558 0.0525 P10Y 0.20 10 0.0567 0.0893 0.0475 0.0600 P10Y The fair values of these financial instruments approximated their carrying values in our condensed consolidated financial statements as of such dates, except as follows:<div style="text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:42.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Carrying Amount </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.750% coupon rate, due 2024</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,488 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,353 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,348 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">257,695 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 9.750% coupon rate, due 2025</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">494,838 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">493,125 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">987,903 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,081,990 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.750% coupon rate, due 2028</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,836 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368,125 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,199 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">491,480 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 4.375% coupon rate, due 2031</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,557 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">492,127 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480,763 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 5.625% coupon rate, due 2042</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,374 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">227,850 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">342,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">309,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior unsecured notes, 6.250% coupon rate, due 2046</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,193 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">170,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226,500 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Secured debts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,161 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69,713 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,963 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,372,292 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,880,314 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,876,524 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,919,651 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes unamortized net debt issuance costs, premiums and discounts.</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">We assumed certain of these secured debts in connection with our acquisition of certain properties. We recorded the assumed mortgage notes at estimated fair value on the date of acquisition and we are amortizing the fair value adjustments, if any, to interest expense over the respective terms of the mortgage notes to adjust interest expense to the estimated market interest rates as of the date of acquisition.</span></div> 0.04750 249488000 224353000 249348000 257695000 0.09750 494838000 493125000 987903000 1081990000 0.04750 492836000 368125000 492199000 491480000 0.04375 492557000 340000000 492127000 480763000 0.05625 342374000 227850000 342183000 309260000 0.06250 243193000 170700000 243051000 226500000 57006000 56161000 69713000 71963000 2372292000 1880314000 2876524000 2919651000 2 2 4 4 Noncontrolling InterestIn March 2017, we entered into our Boston life science property joint venture. The investor owned a 45% equity interest in the joint venture, and we owned the remaining 55% equity interest in the joint venture. We determined that, while we owned a 55% equity interest in this joint venture, this joint venture was a variable interest entity, or VIE, and that we controlled the activities that most significantly impacted the economic performance of this entity; we therefore consolidated the results of this joint venture in our financial statements. In December 2021, we sold an additional 35% equity interest in our Boston life science property joint venture to another third party institutional investor. After giving effect to the sale, we owned a 20% equity interest in this joint venture, but determined that we are no longer the primary beneficiary. Effective as of the date of the sale, we deconsolidated these properties and accounted for this joint venture using the equity method of accounting under the fair value option. In June 2022, we sold an additional 10% equity interest from our then remaining 20% equity interest in this joint venture to an existing joint venture investor and continue to account for this joint venture using the equity method of accounting under the fair value option. The portion of the joint venture's net income and comprehensive income not attributable to us, or $1,577 and $2,899 for the three and six months ended June 30, 2021, respectively, is reported as a noncontrolling interest in our condensed consolidated statements of comprehensive income (loss). This joint venture made aggregate cash distributions to the other joint venture investor of $5,630 and $11,324 for the three and six months ended June 30, 2021, respectively, which are reflected as a decrease in total equity attributable to noncontrolling interest in our condensed consolidated statement of shareholders' equity. 0.45 0.55 0.55 0.35 0.20 0.10 0.20 1577000 2899000 5630000 11324000 Shareholders' Equity<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Share Awards:</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2022, in accordance with our Trustee compensation arrangements, we awarded to each of our seven Trustees 20,000 of our common shares, valued at $2.14 per share, the closing price of our common shares on Nasdaq on that day</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Common Share Repurchases:</span></div><div style="margin-bottom:10pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, we purchased 1,698 of our common shares, valued at $3.20 per common share, from a former employee of RMR in satisfaction of tax withholding and payment obligations in connection with the vesting of prior awards of our common shares.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributions:</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, we declared and paid quarterly distributions to common shareholders as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.368%"><tr><td style="width:1.0%"/><td style="width:20.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.255%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Distributions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 13, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 17, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,390 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,390 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.02 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,780 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 14, 2022, we declared a quarterly distribution to common shareholders of record on July 25, 2022 of $0.01 per share, or approximately $2,391. We expect to pay this distribution on or about August 18, 2022.</span></div> 20000 2.14 1698 3.20 <div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, we declared and paid quarterly distributions to common shareholders as follows:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:72.368%"><tr><td style="width:1.0%"/><td style="width:20.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.255%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Declaration Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Record Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Distribution Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total Distributions</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 13, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 24, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 17, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,390 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 19, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.01 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,390 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.02 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,780 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.01 2390000 0.01 2390000 0.02 4780000 0.01 2391000 Segment Reporting<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in, and report financial information for, the following two segments: Office Portfolio and senior housing operating portfolio, or SHOP. We aggregate each of these two reporting segments based on their similar operating and economic characteristics. Our Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Our SHOP segment consists of managed senior living communities that provide short term and long term residential living and, in some instances, care and other services for residents where we pay fees to managers to operate the communities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also report “non-segment” operations, consisting of triple net leased senior living communities and wellness centers that are leased to third party operators from which we receive rents, which we do not consider to be sufficiently material to constitute a separate reporting segment, and any other income or expenses that are not attributable to a specific reporting segment.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,610 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,610 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,028 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,040 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,369 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,023 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,409 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,711 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,143 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) gain on sale of properties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax benefit and equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,161 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,094)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,294)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,365 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,094)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,654)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,383)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"/><td style="width:43.628%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,607 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,200 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,761 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,808 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,860 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562,687 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,810 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666,357 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,316 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,702 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(985)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,540)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,043)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax expense and equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,498 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,967)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,056 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,967)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(161,049)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,040 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the U.S. Department of Health and Human Services, or HHS, established a Provider Relief Fund. Retention and use of the funds received under the CARES Act are subject to certain terms and conditions. The terms and conditions require that the funds be utilized to compensate for lost revenues that are attributable to the COVID-19 pandemic and for eligible costs to prevent, prepare for and respond to the COVID-19 pandemic that are not covered by other sources. Further, fund recipients are required to be participating in Medicare at the time of distribution and are subject to certain other terms and conditions, including quarterly reporting requirements. In addition, fund recipients are required to have billed Medicare during 2019 and to continue to provide care after January 31, 2020 for diagnosis, testing or care for individuals with possible or actual COVID-19 cases. Any funds not used in accordance with the terms and conditions must be returned to HHS. We recognize income from government grants on a systematic and rational basis over the period in which we recognize the related expenses or loss of revenues for which the grants are intended to compensate when there is reasonable assurance that we will comply with the applicable terms and conditions of the grant and there is reasonable assurance that the grant will be received. We have recognized $959 and $18,181 as other income in our condensed consolidated statements of comprehensive income (loss) with respect to our SHOP segment for the six months ended June 30, 2022 and 2021, respectively.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.970%"><tr><td style="width:1.0%"/><td style="width:36.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.709%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,892,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,001,413 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,252,034 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,145,864 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,394 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346,341 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,632 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,818 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,849 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,050 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353,717 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,849)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,849)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,679)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,529)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,454)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,679)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,177 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,720)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,222)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,127 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,025 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,065 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,614 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489,409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552,023 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,446 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">714,629 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,093)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,091)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,399)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,093)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,520)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,828)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,886 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,093)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,520)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,727)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:36.147%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,282,652 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,995,819 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345,043 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,514 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 2 2 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,610 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,912 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,522 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,610 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,912 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,028 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,026 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">244,040 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,066 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,997 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37,369 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58,261 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,207 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">609 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,023 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,409 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,711 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332,143 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Loss) gain on sale of properties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(686)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,506 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,266 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(29,560)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax benefit and equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,161 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,094)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(94,294)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,227)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">640 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,204 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,365 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,094)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(93,654)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(109,383)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"/><td style="width:43.628%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.918%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.598%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,607 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,807 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107,607 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,200 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">623,761 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,473 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534,808 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,387 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,352 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,781 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,492 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81,860 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">562,687 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,810 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">666,357 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">326,316 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">792 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">327,108 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,710)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">959 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,702 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,661 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(985)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(111,540)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(113,106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,059)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,043)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax expense and equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">351,498 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,967)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(160,217)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125,314 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(832)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in earnings of investees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,558 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">358,056 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65,967)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(161,049)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131,040 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.970%"><tr><td style="width:1.0%"/><td style="width:36.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.709%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,892,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,001,413 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,252,034 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,145,864 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Three Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,590 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102,394 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,804 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,590 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">346,341 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,321 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233,311 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,632 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,497 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,538 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,853 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,888 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,126 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,818 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">265,849 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,050 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">353,717 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,760 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,849)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,849)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,748 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,038 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,992)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(525)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(61,140)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(67,657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,679)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,529)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,454)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53,754 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,679)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,720)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,645)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,577)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,177 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,679)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,720)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,222)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:43.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rental income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,127 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">205,152 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">186,127 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,025 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">709,065 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,614 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">489,409 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">552,023 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64,435 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,899 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134,041 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,668 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition and certain other transaction related costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,071 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127,049 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">553,134 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,446 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">714,629 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of properties</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,638 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Losses on equity securities, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest and other income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,181 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">692 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,873 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,053)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(114,764)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(127,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on modification or early extinguishment of debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,410)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from continuing operations before income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,093)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,091)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,399)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(429)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,785 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,093)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,520)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(98,828)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) attributable to common shareholders</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,886 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,093)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(144,520)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101,727)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.678%"><tr><td style="width:1.0%"/><td style="width:36.147%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.762%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.717%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Office Portfolio</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SHOP </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Segment</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,282,652 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,995,819 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,345,043 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,514 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 52610000 0 9912000 62522000 0 250506000 0 250506000 52610000 250506000 9912000 313028000 22026000 244040000 0 266066000 17997000 37369000 2895000 58261000 0 0 7207000 7207000 0 0 609000 609000 40023000 281409000 10711000 332143000 -1226000 540000 0 -686000 0 0 -10157000 -10157000 0 760000 1506000 2266000 216000 491000 55268000 55975000 16000 0 -29576000 -29560000 11161000 -30094000 -94294000 -113227000 0 0 -640000 -640000 3204000 0 0 3204000 14365000 -30094000 -93654000 -109383000 107607000 0 20200000 127807000 0 495954000 0 495954000 107607000 495954000 20200000 623761000 45473000 489335000 0 534808000 36387000 73352000 5781000 115520000 0 0 14492000 14492000 0 0 1537000 1537000 81860000 562687000 21810000 666357000 326316000 792000 0 327108000 0 0 -18710000 -18710000 0 959000 1702000 2661000 581000 985000 111540000 113106000 16000 0 -30059000 -30043000 351498000 -65967000 -160217000 125314000 0 0 832000 832000 6558000 0 0 6558000 358056000 -65967000 -161049000 131040000 959000 18181000 1892417000 3001413000 1252034000 6145864000 92804000 0 9590000 102394000 0 243947000 0 243947000 92804000 243947000 9590000 346341000 31321000 233311000 0 264632000 32497000 32538000 2853000 67888000 0 0 9126000 9126000 0 0 12071000 12071000 63818000 265849000 24050000 353717000 30760000 0 0 30760000 0 0 -3849000 -3849000 0 15748000 290000 16038000 5992000 525000 61140000 67657000 0 0 -370000 -370000 53754000 -6679000 -79529000 -32454000 0 0 191000 191000 53754000 -6679000 -79720000 -32645000 1577000 0 0 1577000 52177000 -6679000 -79720000 -34222000 186127000 0 19025000 205152000 0 503913000 0 503913000 186127000 503913000 19025000 709065000 62614000 489409000 0 552023000 64435000 63899000 5707000 134041000 0 0 16668000 16668000 0 0 12071000 12071000 0 -174000 0 -174000 127049000 553134000 34446000 714629000 30638000 0 0 30638000 0 0 -12188000 -12188000 0 18181000 692000 18873000 11931000 1053000 114764000 127748000 0 0 -2410000 -2410000 77785000 -32093000 -144091000 -98399000 0 0 429000 429000 77785000 -32093000 -144520000 -98828000 2899000 0 0 2899000 74886000 -32093000 -144520000 -101727000 2282652000 2995819000 1345043000 6623514000 Senior Living Community Management Agreements<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our managed senior living communities are operated by third parties pursuant to management agreements. Five Star Senior Living, or Five Star, which is an operating division of AlerisLife, manages certain of our SHOP communities.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Amendments to our Management Arrangements with Five Star.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On June 9, 2021, we amended our management arrangements with Five Star. The principal changes to the management arrangements included:</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that Five Star agreed to cooperate with us in transitioning 108 of our senior living communities with approximately 7,500 living units to other third party managers without our payment of any termination fee to Five Star;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that we no longer have the right to sell up to an additional $682,000 of senior living communities currently managed by Five Star and terminate Five Star's management of those communities without our payment of a fee to Five Star upon sale;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that Five Star is continuing to manage 120 of our senior living communities, and that the skilled nursing units in all of our continuing care retirement communities that Five Star is continuing to manage, which then included approximately 1,500 living units, were closed and are being evaluated and repositioned;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that beginning in 2025, we will have the right to terminate up to 10% of the senior living communities that Five Star is continuing to manage, based on total revenues per year for failure to meet 80% of a target earnings before interest, taxes, depreciation and amortization for the applicable period;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that the incentive fee that Five Star may earn in any calendar year for the senior living communities that Five Star is continuing to manage is no longer subject to a cap and that any senior living communities that are undergoing a major renovation or repositioning are excluded from the calculation of the incentive fee;</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that RMR will oversee any major renovation or repositioning activities at the senior living communities that Five Star is continuing to manage; and</span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">that the term of our management agreements with Five Star for our senior living communities that Five Star is continuing to manage was extended by two years to December 31, 2036.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to these changes, we and Five Star entered into an amended and restated master management agreement, or the Master Management Agreement, for the senior living communities that Five Star is continuing to manage and interim management agreements for the senior living communities that we and Five Star agreed to transition to new third party managers. These agreements replaced our prior master leases and management and pooling agreements with Five Star. In addition, AlerisLife delivered to us a related amended and restated guaranty agreement pursuant to which AlerisLife is continuing to guarantee the payment and performance of its subsidiaries' obligations under the applicable management agreements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had transitioned 107 of the 108 senior living communities, containing 7,340 living units, from Five Star to new third party managers. The remaining senior living community was closed in February 2022 and we are assessing opportunities to redevelop that property. We continue to lease our senior living communities that have been transitioned to new managers to our taxable REIT subsidiaries, or TRSs. We incurred costs related to retention and other transition costs for these communities. We recorded $517 and $11,914 for the three months ended June 30, 2022 and 2021, respectively, and $1,445 and $11,914 for the six months ended June 30, 2022 and 2021, respectively, of these costs to acquisition and certain other transaction related costs in our condensed consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Senior Living Communities Managed by Five Star.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Five Star managed 120 and 235 of our senior living communities as of June 30, 2022 and 2021, respectively. We lease our senior living communities that are managed by Five Star to our TRSs.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred management fees payable to Five Star of $8,971 and $12,927 for the three months ended June 30, 2022 and 2021, respectively, and $17,903 and $26,777 for the six months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, $8,274 and $12,212, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $697 and $715, respectively, were capitalized in our condensed consolidated balance sheets. For the six months ended June 30, 2022 and 2021, $16,416 and $25,228, respectively, of the total management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,487 and $1,549, respectively, were capitalized in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred fees of $1,736 and $2,630 for the three months ended June 30, 2022 and 2021, respectively, and $3,652 and $8,071 for the six months ended June 30, 2022 and 2021, respectively, with respect to rehabilitation services Five Star provided at our senior living communities that are payable by us. These amounts are included in property operating expenses in our condensed consolidated statements of comprehensive income (loss).</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease to Five Star space at certain of our senior living communities, which it uses to provide certain outpatient rehabilitation and wellness services. We recorded $379 and $398 for the three months ended June 30, 2022 and 2021, respectively, and $767 and $795 for the six months ended June 30, 2022 and 2021, respectively, with respect to these leases.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Senior Living Communities Managed by Other Third Party Managers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We incurred management fees payable to our other third party managers of $5,218 and $10,326 for the three and six months ended June 30, 2022, respectively. These amounts are included in property operating expenses in our condensed consolidated financial statements.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue from contracts with customers:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic housing and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,999 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,169 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">389,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,198 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicaid programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,855 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private pay and other third party payer SNF services </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,871 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 108 7500 682000000 120 1500 0.10 0.80 107 108 7340 517000 11914000 1445000 11914000 120 235 8971000 12927000 17903000 26777000 8274000 12212000 697000 715000 16416000 25228000 1487000 1549000 1736000 2630000 3652000 8071000 379000 398000 767000 795000 5218000 10326000 <div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents residents fees and services revenue from all of our managed senior living communities disaggregated by the type of contract and payer:</span></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:38.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.300%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue from contracts with customers:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic housing and support services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">196,999 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">188,169 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">389,873 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,198 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Medicare and Medicaid programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,966 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,907 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,783 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,855 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Private pay and other third party payer SNF services </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34,541 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,871 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67,298 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,860 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total residents fees and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,506 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">243,947 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">495,954 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">503,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 196999000 188169000 389873000 376198000 18966000 24907000 38783000 60855000 34541000 30871000 67298000 66860000 250506000 243947000 495954000 503913000 Business and Property Management Agreements with RMR<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no employees. The personnel and various services we require to operate our business are provided to us by RMR. We have two agreements with RMR to provide management services to us: (1) a business management agreement, which relates to our business generally; and (2) a property management agreement, which relates to the property level operations of our medical office and life science properties and major renovation or repositioning activities at our senior living communities that we may request RMR to manage from time to time. See Note 11 for further information regarding our relationship, agreements and transactions with RMR.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized net business management fees of $4,506 and $6,324 for the three months ended June 30, 2022 and 2021, respectively, and $9,319 and $11,641 for the six months ended June 30, 2022 and 2021, respectively. Based on our common share total return, as defined in our business management agreement, as of each of June 30, 2022 and 2021, no estimated incentive fees are included in the net business management fees we recognized for the three or six months ended June 30, 2022 or 2021. The actual amount of annual incentive fees for 2022, if any, will be based on our common share total return as defined in our business management agreement, for the three-year period ending December 31, 2022, and will be payable in January 2023. We did not incur any incentive fee payable for the year ended December 31, 2021. We recognize business management and incentive fees in general and administrative expenses in our condensed consolidated statements of comprehensive income (loss). RMR provides management services to our joint ventures. See Note 11 for further information regarding our joint ventures' management arrangements with RMR and the related impact on our management fees payable to RMR.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and RMR amended our business management agreement effective August 1, 2021 to provide that (i) for periods beginning on and after August 1, 2021, the MSCI U.S. REIT/Health Care REIT Index will be used to calculate benchmark returns per share for purposes of determining any incentive management fee payable by us to RMR, and (ii) for periods prior to August 1, 2021, the SNL U.S. REIT Healthcare Index will continue to be used. This change of index was due to S&amp;P Global ceasing to publish the SNL U.S. REIT Healthcare Index.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized aggregate net property management and construction supervision fees of $2,518 and $3,191 for the three months ended June 30, 2022 and 2021, respectively, and $4,909 and $6,345 for the six months ended June 30, 2022 and 2021, respectively. For the three months ended June 30, 2022 and 2021, $1,272 and $2,465, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $1,246 and $726, respectively, were capitalized as building improvements in our condensed consolidated balance sheets. For the six months ended June 30, 2022 and 2021, $2,621 and $4,950, respectively, of the total property management fees were expensed to property operating expenses in our condensed consolidated statements of comprehensive income (loss) and $2,288 and $1,395, respectively, were capitalized as building improvements in our condensed consolidated balance sheets. The amounts capitalized are being depreciated over the estimated useful lives of the related capital assets.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are generally responsible for all our operating expenses, including certain expenses incurred or arranged by RMR on our behalf. We are generally not responsible for payment of RMR's employment, office or administrative expenses incurred to provide management services to us, except for the employment and related expenses of RMR's employees assigned to work exclusively or partly at our properties, our share of the wages, benefits and other related costs of RMR's centralized accounting personnel, our share of RMR's costs for providing our internal audit function, or as otherwise agreed. Our property level operating expenses are generally incorporated into the rents charged to our tenants, including certain payroll and related costs incurred by RMR. We reimbursed RMR $3,111 and $3,202 for these expenses and costs for the three months ended June 30, </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 and 2021, respectively, and $6,075 and $6,499 for the six months ended June 30, 2022 and 2021, respectively. These amounts are included in property operating expenses or general and administrative expenses, as applicable, in our condensed consolidated statements of comprehensive income (loss) for these periods.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, we and RMR amended our property management agreement to, among other things, provide for RMR's oversight of any major capital projects and repositionings at our senior living communities, including our senior living communities which Five Star is continuing to manage, and that RMR receives the same fee previously paid to Five Star for such services, which is equal to 3% of the cost of any such major capital project or repositioning.</span></div> 0 2 4506000 6324000 9319000 11641000 0 0 P3Y 2518000 3191000 4909000 6345000 1272000 2465000 1246000 726000 2621000 4950000 2288000 1395000 3111000 3202000 6075000 6499000 0.03 Related Person Transactions<div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relationships and historical and continuing transactions with RMR, The RMR Group Inc., or RMR Inc., AlerisLife (including Five Star) and others related to them, including other companies to which RMR or its subsidiaries provide management services and some of which have trustees, directors or officers who are also our Trustees or officers. RMR Inc. is the managing member of RMR. The Chair of our Board and one of our Managing Trustees, Adam D. Portnoy, is the sole trustee, an officer and the controlling shareholder of ABP Trust, which is the controlling shareholder of RMR Inc., the chair of the board of directors, a managing director and the president and chief executive officer of RMR Inc., an officer and employee of RMR and the chair of the board of directors and a managing director of AlerisLife. Jennifer F. Francis, our other Managing Trustee and our President and Chief Executive Officer, and our Chief Financial Officer and Treasurer are also employees and officers of RMR. Jennifer B. Clark, our Secretary and former Managing Trustee, also serves as a managing director and the executive vice president, general counsel and secretary of RMR Inc., an officer and employee of RMR, an officer of ABP Trust and a managing director and the secretary of AlerisLife. Certain of AlerisLife's officers are officers and employees of RMR. Some of our Independent Trustees also serve as independent trustees or independent directors of other public companies to which RMR or its subsidiaries provide management services. Adam Portnoy serves as the chair of the board and as a managing director or managing trustee of these companies. Other officers of RMR, including Ms. Clark and certain of our officers, serve as managing trustees, managing directors or officers of certain of these companies. In addition, officers of RMR and RMR Inc. serve as our officers and officers of other companies to which RMR or its subsidiaries provide management services.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">AlerisLife.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are currently AlerisLife's largest stockholder. As of June 30, 2022, we owned approximately 32.8% of AlerisLife's outstanding common shares. Five Star is an operating division of AlerisLife. Five Star manages certain of the senior living communities we own pursuant to the Master Management Agreement. RMR provides management services to both us and AlerisLife. See Note 9 for further information regarding our relationships, agreements and transactions with AlerisLife (including Five Star) and Note 5 for further information regarding our investment in AlerisLife.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, ABP Acquisition LLC, a subsidiary of ABP Trust, the controlling shareholder of RMR Inc., together with ABP Trust, owned approximately 6.2% of AlerisLife's outstanding common shares.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Joint Ventures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have two separate joint venture arrangements with two third party institutional investors, our Boston life science property joint venture and our 10 medical office and life science properties joint venture. We own a 10% equity interest in our Boston life science property joint venture and a 20% equity interest in our 10 medical office and life science properties joint venture; from January 2022 until June 28, 2022, we owned a 20% equity interest in our Boston life science property joint venture. We initially entered into our Boston life science property joint venture prior to January 1, 2021, and we entered into our 10 medical office and life science properties joint venture in January 2022. RMR provides management services to both of these joint ventures. Our joint ventures are not our consolidated subsidiaries and, as a result, we are not obligated to pay management fees to RMR under our management agreements with RMR for the services it provides regarding the joint ventures. Prior to December 23, 2021, our Boston life science property joint venture was our consolidated subsidiary and, as such, we were previously obligated to pay management fees to RMR under our management agreements with RMR for the services it provided regarding that joint venture; however, that joint venture paid management fees directly to RMR, and any such fees paid by that joint venture were credited against the fees payable by us to RMR. In addition, we wholly owned the 10 medical office and life science properties until the contribution of these properties to the applicable joint venture in January 2022 and we paid management fees to RMR for the management services it provided to us for those properties up until that time. As of June 30, 2022, in connection with the closing of our 10 medical office and life science properties joint venture in January 2022, we paid mortgage escrow amounts and closing costs of $11,113 that were payable by that joint venture. Those costs are presented as other assets, net, in our condensed consolidated balance sheet.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Manager, RMR.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have two agreements with RMR to provide management services to us. See Note 10 for further information regarding our management agreements with RMR.</span></div><div style="margin-bottom:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information about these and other such relationships and certain other related person transactions, see our Annual Report.</span></div> 0.328 0.062 2 2 10 0.10 0.20 10 0.20 10 10 10 11113000 2 Income TaxesWe have elected to be taxed as a real estate investment trust, or REIT, under the Internal Revenue Code of 1986, as amended, and, as such, are generally not subject to federal and most state income taxation on our operating income provided we distribute our taxable income to our shareholders and meet certain organization and operating requirements. We do, however, lease our managed senior living communities to our wholly owned TRSs that, unlike most of our subsidiaries, file a separate consolidated federal corporate income tax return and are subject to federal and state income taxes. Our consolidated income tax provision includes the income tax provision related to the operations of our TRSs and certain state income taxes we incur despite our taxation as a REIT. Our current income tax expense (or benefit) fluctuates from period to period based primarily on the timing of our income, including gains on the disposition of properties or losses in a particular quarter. For the three months ended June 30, 2022 and 2021, we recognized income tax benefit of $640 and expense of $191, respectively, and for the six months ended June 30, 2022 and 2021, we recognized income tax expense of $832 and $429, respectively. -640000 191000 832000 429000 Weighted Average Common Shares (share amounts in thousands)We calculate basic earnings per common share using the two class method. We calculate diluted earnings per share using the more dilutive of the two class method or the treasury stock method. Unvested share awards and other potentially dilutive common shares, together with the related impact on earnings, are considered when calculating diluted earnings per share. For purposes of calculating diluted earnings per share, we did not include 833 and 837 of unvested share awards for the three and six months ended June 30, 2022, respectively, because to do so would have been antidilutive. 833000 837000 As of June 30, 2022, restricted cash consists of proceeds from the sale of joint venture interests and proceeds from the sale of properties to joint ventures held as collateral pursuant to the agreement governing our revolving credit facility, or our credit agreement. We may use these funds to pay for approved expenditures in accordance with our credit agreement. Restricted cash also consists of amounts escrowed for real estate taxes, insurance and capital expenditures at certain of our mortgaged properties. Prior to the deconsolidation of the joint venture that owns a life science property located in Boston, Massachusetts, or our Boston life science property joint venture, restricted cash also consisted of cash held for the operations of this joint venture. As of June 30, 2021, restricted cash also included amounts from dispositions held as collateral pursuant to our credit agreement. In June 2022, we sold an additional 10% equity interest in our Boston life science property joint venture to an existing joint venture investor for $108,000, before closing costs and other adjustments. The net proceeds of $108,956, which include working capital prorations and formation costs, are included as a receivable in other assets, net in our condensed consolidated balance sheet as of June 30, 2022. We received the proceeds from this sale in July 2022, which will be included in restricted cash in our condensed consolidated balance sheet. EXCEL 58 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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end XML 59 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 60 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 61 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 296 225 1 true 85 0 false 18 false false R1.htm 0001001 - Document - Cover Sheet http://dhcreit.com/role/Cover Cover Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical) Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 7 false false R8.htm 1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Unaudited) (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Unaudited) (Parenthetical) Statements 8 false false R9.htm 1008009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Unaudited) (Parenthetical) Sheet http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Unaudited) (Parenthetical) Statements 9 false false R10.htm 2101101 - Disclosure - Basis of Presentation Sheet http://dhcreit.com/role/BasisofPresentation Basis of Presentation Notes 10 false false R11.htm 2102102 - Disclosure - Real Estate Investments Sheet http://dhcreit.com/role/RealEstateInvestments Real Estate Investments Notes 11 false false R12.htm 2107103 - Disclosure - Leases Sheet http://dhcreit.com/role/Leases Leases Notes 12 false false R13.htm 2109104 - Disclosure - Indebtedness Sheet http://dhcreit.com/role/Indebtedness Indebtedness Notes 13 false false R14.htm 2111105 - Disclosure - Fair Value of Assets and Liabilities Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilities Fair Value of Assets and Liabilities Notes 14 false false R15.htm 2116106 - Disclosure - Noncontrolling Interest Sheet http://dhcreit.com/role/NoncontrollingInterest Noncontrolling Interest Notes 15 false false R16.htm 2118107 - Disclosure - Shareholders' Equity Sheet http://dhcreit.com/role/ShareholdersEquity Shareholders' Equity Notes 16 false false R17.htm 2122108 - Disclosure - Segment Reporting Sheet http://dhcreit.com/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 2127109 - Disclosure - Senior Living Community Management Agreements Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements Senior Living Community Management Agreements Notes 18 false false R19.htm 2131110 - Disclosure - Business and Property Management Agreements with RMR Sheet http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR Business and Property Management Agreements with RMR Notes 19 false false R20.htm 2133111 - Disclosure - Related Person Transactions Sheet http://dhcreit.com/role/RelatedPersonTransactions Related Person Transactions Notes 20 false false R21.htm 2135112 - Disclosure - Income Taxes Sheet http://dhcreit.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 2137113 - Disclosure - Weighted Average Common Shares (shares amounts in thousands) Sheet http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousands Weighted Average Common Shares (shares amounts in thousands) Notes 22 false false R23.htm 2303301 - Disclosure - Real Estate Investments (Tables) Sheet http://dhcreit.com/role/RealEstateInvestmentsTables Real Estate Investments (Tables) Tables http://dhcreit.com/role/RealEstateInvestments 23 false false R24.htm 2312302 - Disclosure - Fair Value of Assets and Liabilities (Tables) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables Fair Value of Assets and Liabilities (Tables) Tables http://dhcreit.com/role/FairValueofAssetsandLiabilities 24 false false R25.htm 2319303 - Disclosure - Shareholders' Equity (Tables) Sheet http://dhcreit.com/role/ShareholdersEquityTables Shareholders' Equity (Tables) Tables http://dhcreit.com/role/ShareholdersEquity 25 false false R26.htm 2323304 - Disclosure - Segment Reporting (Tables) Sheet http://dhcreit.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://dhcreit.com/role/SegmentReporting 26 false false R27.htm 2328305 - Disclosure - Senior Living Community Management Agreements (Tables) Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsTables Senior Living Community Management Agreements (Tables) Tables http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements 27 false false R28.htm 2404401 - Disclosure - Real Estate Investments - Narrative (Details) Sheet http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails Real Estate Investments - Narrative (Details) Details 28 false false R29.htm 2405402 - Disclosure - Real Estate Investments - Equity Investment In Joint Venture (Details) Sheet http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails Real Estate Investments - Equity Investment In Joint Venture (Details) Details 29 false false R30.htm 2406403 - Disclosure - Real Estate Investments - Mortgage Debt Joint Venture (Details) Sheet http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails Real Estate Investments - Mortgage Debt Joint Venture (Details) Details 30 false false R31.htm 2408404 - Disclosure - Leases (Details) Sheet http://dhcreit.com/role/LeasesDetails Leases (Details) Details http://dhcreit.com/role/Leases 31 false false R32.htm 2410405 - Disclosure - Indebtedness (Details) Sheet http://dhcreit.com/role/IndebtednessDetails Indebtedness (Details) Details http://dhcreit.com/role/Indebtedness 32 false false R33.htm 2413406 - Disclosure - Fair Value of Assets and Liabilities - Assets and Liabilities (Details) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails Fair Value of Assets and Liabilities - Assets and Liabilities (Details) Details 33 false false R34.htm 2414407 - Disclosure - Fair Value of Assets and Liabilities - Liabilities (Details) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails Fair Value of Assets and Liabilities - Liabilities (Details) Details 34 false false R35.htm 2415408 - Disclosure - Fair Value of Assets and Liabilities - Narrative (Details) Sheet http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails Fair Value of Assets and Liabilities - Narrative (Details) Details 35 false false R36.htm 2417409 - Disclosure - Noncontrolling Interest (Details) Sheet http://dhcreit.com/role/NoncontrollingInterestDetails Noncontrolling Interest (Details) Details http://dhcreit.com/role/NoncontrollingInterest 36 false false R37.htm 2420410 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://dhcreit.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 37 false false R38.htm 2421411 - Disclosure - Shareholders' Equity - Schedule of Dividends Declared and Paid (Details) Sheet http://dhcreit.com/role/ShareholdersEquityScheduleofDividendsDeclaredandPaidDetails Shareholders' Equity - Schedule of Dividends Declared and Paid (Details) Details 38 false false R39.htm 2424412 - Disclosure - Segment Reporting - Narrative (Details) Sheet http://dhcreit.com/role/SegmentReportingNarrativeDetails Segment Reporting - Narrative (Details) Details 39 false false R40.htm 2425413 - Disclosure - Segment Reporting - Income Statements (Details) Sheet http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails Segment Reporting - Income Statements (Details) Details 40 false false R41.htm 2426414 - Disclosure - Segment Reporting - Assets (Details) Sheet http://dhcreit.com/role/SegmentReportingAssetsDetails Segment Reporting - Assets (Details) Details 41 false false R42.htm 2429415 - Disclosure - Senior Living Community Management Agreements - Narrative (Details) Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails Senior Living Community Management Agreements - Narrative (Details) Details 42 false false R43.htm 2430416 - Disclosure - Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) Sheet http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details) Details 43 false false R44.htm 2432417 - Disclosure - Business and Property Management Agreements with RMR (Details) Sheet http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails Business and Property Management Agreements with RMR (Details) Details http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR 44 false false R45.htm 2434418 - Disclosure - Related Person Transactions (Details) Sheet http://dhcreit.com/role/RelatedPersonTransactionsDetails Related Person Transactions (Details) Details http://dhcreit.com/role/RelatedPersonTransactions 45 false false R46.htm 2436419 - Disclosure - Income Taxes (Details) Sheet http://dhcreit.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://dhcreit.com/role/IncomeTaxes 46 false false R47.htm 2438420 - Disclosure - Weighted Average Common Shares (shares amounts in thousands) (Details) Sheet http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousandsDetails Weighted Average Common Shares (shares amounts in thousands) (Details) Details http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousands 47 false false All Reports Book All Reports dhc-20220630.htm dhc-20220630.xsd dhc-20220630_cal.xml dhc-20220630_def.xml dhc-20220630_lab.xml dhc-20220630_pre.xml dhc_063022xexhibitx311.htm dhc_063022xexhibitx312.htm dhc_063022xexhibitx321.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 64 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "dhc-20220630.htm": { "axisCustom": 1, "axisStandard": 30, "contextCount": 296, "dts": { "calculationLink": { "local": [ "dhc-20220630_cal.xml" ] }, "definitionLink": { "local": [ "dhc-20220630_def.xml" ] }, "inline": { "local": [ "dhc-20220630.htm" ] }, "labelLink": { "local": [ "dhc-20220630_lab.xml" ] }, "presentationLink": { "local": [ "dhc-20220630_pre.xml" ] }, "schema": { "local": [ "dhc-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 420, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 17, "http://xbrl.sec.gov/dei/2022": 5, "total": 22 }, "keyCustom": 47, "keyStandard": 178, "memberCustom": 44, "memberStandard": 33, "nsprefix": "dhc", "nsuri": "http://dhcreit.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://dhcreit.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Basis of Presentation", "role": "http://dhcreit.com/role/BasisofPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102102 - Disclosure - Real Estate Investments", "role": "http://dhcreit.com/role/RealEstateInvestments", "shortName": "Real Estate Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RealEstateDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107103 - Disclosure - Leases", "role": "http://dhcreit.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109104 - Disclosure - Indebtedness", "role": "http://dhcreit.com/role/Indebtedness", "shortName": "Indebtedness", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111105 - Disclosure - Fair Value of Assets and Liabilities", "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilities", "shortName": "Fair Value of Assets and Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2116106 - Disclosure - Noncontrolling Interest", "role": "http://dhcreit.com/role/NoncontrollingInterest", "shortName": "Noncontrolling Interest", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MinorityInterestDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118107 - Disclosure - Shareholders' Equity", "role": "http://dhcreit.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122108 - Disclosure - Segment Reporting", "role": "http://dhcreit.com/role/SegmentReporting", "shortName": "Segment Reporting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2127109 - Disclosure - Senior Living Community Management Agreements", "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements", "shortName": "Senior Living Community Management Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dhc:BusinessAndPropertyManagementAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2131110 - Disclosure - Business and Property Management Agreements with RMR", "role": "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR", "shortName": "Business and Property Management Agreements with RMR", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dhc:BusinessAndPropertyManagementAgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Land", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2133111 - Disclosure - Related Person Transactions", "role": "http://dhcreit.com/role/RelatedPersonTransactions", "shortName": "Related Person Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2135112 - Disclosure - Income Taxes", "role": "http://dhcreit.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2137113 - Disclosure - Weighted Average Common Shares (shares amounts in thousands)", "role": "http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousands", "shortName": "Weighted Average Common Shares (shares amounts in thousands)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Real Estate Investments (Tables)", "role": "http://dhcreit.com/role/RealEstateInvestmentsTables", "shortName": "Real Estate Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312302 - Disclosure - Fair Value of Assets and Liabilities (Tables)", "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables", "shortName": "Fair Value of Assets and Liabilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DividendsDeclaredTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319303 - Disclosure - Shareholders' Equity (Tables)", "role": "http://dhcreit.com/role/ShareholdersEquityTables", "shortName": "Shareholders' Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DividendsDeclaredTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2323304 - Disclosure - Segment Reporting (Tables)", "role": "http://dhcreit.com/role/SegmentReportingTables", "shortName": "Segment Reporting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2328305 - Disclosure - Senior Living Community Management Agreements (Tables)", "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsTables", "shortName": "Senior Living Community Management Agreements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404401 - Disclosure - Real Estate Investments - Narrative (Details)", "role": "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "shortName": "Real Estate Investments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "INF", "lang": "en-US", "name": "dhc:NumberOfStates", "reportCount": 1, "unique": true, "unitRef": "state", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Real Estate Investments - Equity Investment In Joint Venture (Details)", "role": "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "shortName": "Real Estate Investments - Equity Investment In Joint Venture (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EquityMethodInvestmentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i911d92d35253426b83463f7da0d61d1f_I20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i844ad1946e424f03bb43339adf4bf686_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SecuredDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Real Estate Investments - Mortgage Debt Joint Venture (Details)", "role": "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "shortName": "Real Estate Investments - Mortgage Debt Joint Venture (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i911d92d35253426b83463f7da0d61d1f_I20220630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StraightLineRent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Leases (Details)", "role": "http://dhcreit.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StraightLineRent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410405 - Disclosure - Indebtedness (Details)", "role": "http://dhcreit.com/role/IndebtednessDetails", "shortName": "Indebtedness (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "ic38e3968ce684e4d85c5409da8bba557_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:EquitySecuritiesFvNiRealizedGainLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413406 - Disclosure - Fair Value of Assets and Liabilities - Assets and Liabilities (Details)", "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "shortName": "Fair Value of Assets and Liabilities - Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i9227d5a94b6441e3b9c57761aab776ad_D20220101-20220630", "decimals": null, "lang": "en-US", "name": "dhc:EquitySecuritiesFVNIHoldingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "iffb568d8735e42838a3507571271aa6e_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414407 - Disclosure - Fair Value of Assets and Liabilities - Liabilities (Details)", "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "shortName": "Fair Value of Assets and Liabilities - Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "iffb568d8735e42838a3507571271aa6e_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "ibe4011db24874edda1bb4d3294eff6dd_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "dhc:FairValueMeasurementNumberOfDebtSecurities", "reportCount": 1, "unique": true, "unitRef": "security", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415408 - Disclosure - Fair Value of Assets and Liabilities - Narrative (Details)", "role": "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails", "shortName": "Fair Value of Assets and Liabilities - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "ibe4011db24874edda1bb4d3294eff6dd_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "dhc:FairValueMeasurementNumberOfDebtSecurities", "reportCount": 1, "unique": true, "unitRef": "security", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - Noncontrolling Interest (Details)", "role": "http://dhcreit.com/role/NoncontrollingInterestDetails", "shortName": "Noncontrolling Interest (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i80806bcfd89f427f928b0f786e62270b_D20220601-20220630", "decimals": "2", "lang": "en-US", "name": "dhc:PercentageOfEquityMethodInvestmentSold", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "2", "first": true, "lang": "en-US", "name": "dhc:StockRepurchasedDuringPeriodWeightedAveragePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - Shareholders' Equity - Narrative (Details)", "role": "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails", "shortName": "Shareholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "2", "first": true, "lang": "en-US", "name": "dhc:StockRepurchasedDuringPeriodWeightedAveragePrice", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i02a0b3d7d40d498eb369554d29d7c6f4_D20220519-20220519", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421411 - Disclosure - Shareholders' Equity - Schedule of Dividends Declared and Paid (Details)", "role": "http://dhcreit.com/role/ShareholdersEquityScheduleofDividendsDeclaredandPaidDetails", "shortName": "Shareholders' Equity - Schedule of Dividends Declared and Paid (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DividendsDeclaredTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i02a0b3d7d40d498eb369554d29d7c6f4_D20220519-20220519", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockDividendsPerShareCashPaid", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2424412 - Disclosure - Segment Reporting - Narrative (Details)", "role": "http://dhcreit.com/role/SegmentReportingNarrativeDetails", "shortName": "Segment Reporting - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "ib13083f654f24eeeabcdaaf1dd6be7fb_D20210401-20210630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2425413 - Disclosure - Segment Reporting - Income Statements (Details)", "role": "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "shortName": "Segment Reporting - Income Statements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7ee4ffac41e24dd3812b2aaa8b443ca3_D20220401-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426414 - Disclosure - Segment Reporting - Assets (Details)", "role": "http://dhcreit.com/role/SegmentReportingAssetsDetails", "shortName": "Segment Reporting - Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i20c567e75a4345adaf89800e5155d623_I20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2429415 - Disclosure - Senior Living Community Management Agreements - Narrative (Details)", "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "shortName": "Senior Living Community Management Agreements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i16451c973a9c4ce8a782d390a3b671f5_D20220401-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:LeaseIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430416 - Disclosure - Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details)", "role": "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails", "shortName": "Senior Living Community Management Agreements - Schedule of Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "iaa70214d288142deb45bdcf4a42a520d_D20220401-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "dei:EntityNumberOfEmployees", "reportCount": 1, "unitRef": "employee", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432417 - Disclosure - Business and Property Management Agreements with RMR (Details)", "role": "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "shortName": "Business and Property Management Agreements with RMR (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "lang": "en-US", "name": "dhc:PropertyManagementAndConstructionSupervisionFees", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfRealEstateProperties", "reportCount": 1, "unitRef": "property", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2434418 - Disclosure - Related Person Transactions (Details)", "role": "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "shortName": "Related Person Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i976e5eca53f04d84a1b8449fc16f1d64_I20220630", "decimals": "3", "lang": "en-US", "name": "dhc:InvestmentOwnedPercentageOfTotalSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436419 - Disclosure - Income Taxes (Details)", "role": "http://dhcreit.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438420 - Disclosure - Weighted Average Common Shares (shares amounts in thousands) (Details)", "role": "http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousandsDetails", "shortName": "Weighted Average Common Shares (shares amounts in thousands) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i063cf670eec2441d963b3cc06061a1c1_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "idd9a269db7f64a53a9706b62802505fb_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "ic2cf9e69cd034e9c81cd4a8b27fa80f4_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007008 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Unaudited) (Parenthetical)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Supplemental (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i22298971c3754aa89ef71bb2e5aaffcf_D20220101-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i7f1ad0fd089248628f24f58bbf673f0a_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008009 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Unaudited) (Parenthetical)", "role": "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Cash and Restricted Cash (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "dhc-20220630.htm", "contextRef": "i34547c664f974f02be27e5b2bcca065d_I20210630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 85, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r509" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityNumberOfEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of persons employed by the Entity", "label": "Entity Number of Employees", "terseLabel": "Number of employees" } } }, "localname": "EntityNumberOfEmployees", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "decimalItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Smaller Reporting Company" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title Of Each Class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Name Of Each Exchange On Which Registered" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol(s)" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dhc_AlerisLifeIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AlerisLife Inc", "label": "AlerisLife Inc [Member]", "terseLabel": "AlerisLife Inc" } } }, "localname": "AlerisLifeIncMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "domainItemType" }, "dhc_AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amortization of acquired real estate leases and other intangible assets during the period.", "label": "Amortization of Acquired Real Estate Leases and Other Intangible Assets", "terseLabel": "Amortization of acquired real estate leases" } } }, "localname": "AmortizationOfAcquiredRealEstateLeasesAndOtherIntangibleAssets", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "dhc_BasicHousingAndSupportServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic Housing And Support Services [Member]", "label": "Basic Housing And Support Services [Member]", "terseLabel": "Basic housing and support services" } } }, "localname": "BasicHousingAndSupportServicesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "dhc_BusinessAndPropertyManagementAgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business And Property Management Agreements", "label": "Business And Property Management Agreements [Text Block]", "terseLabel": "Business and Property Management Agreements with RMR LLC" } } }, "localname": "BusinessAndPropertyManagementAgreementsTextBlock", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMR" ], "xbrltype": "textBlockItemType" }, "dhc_BusinessManagementAgreementAnnualIncentiveFeeEstimateIncludedInManagementFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Management Agreement Annual Incentive Fee Estimate Included in Management Fees", "label": "Business Management Agreement Annual Incentive Fee Estimate Included in Management Fees", "terseLabel": "Related party transaction business management agreement, annual incentive fee estimate included in management fees" } } }, "localname": "BusinessManagementAgreementAnnualIncentiveFeeEstimateIncludedInManagementFees", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "monetaryItemType" }, "dhc_BusinessManagementFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the business management fees incurred pursuant to business management agreement with related parties.", "label": "Business Management Fees", "terseLabel": "Business management fees incurred" } } }, "localname": "BusinessManagementFees", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "monetaryItemType" }, "dhc_CapitalExpenditureFundingCapacity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capital Expenditure Funding Capacity", "label": "Capital Expenditure Funding Capacity", "terseLabel": "Capital expenditure" } } }, "localname": "CapitalExpenditureFundingCapacity", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "dhc_ConsolidatedIncomeAvailableToDebtRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consolidated Income Available To Debt Ratio", "label": "Consolidated Income Available To Debt Ratio", "terseLabel": "Debt ratio" } } }, "localname": "ConsolidatedIncomeAvailableToDebtRatio", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "percentItemType" }, "dhc_ContractTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Type", "label": "Contract Type [Axis]", "terseLabel": "Contract Type [Axis]" } } }, "localname": "ContractTypeAxis", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "dhc_ContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Type", "label": "Contract Type [Domain]", "terseLabel": "Contract Type [Domain]" } } }, "localname": "ContractTypeDomain", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "dhc_CumulativeCommonDistributionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents cumulative distributions to common shareholders.", "label": "Cumulative Common Distributions [Member]", "terseLabel": "Cumulative Distributions" } } }, "localname": "CumulativeCommonDistributionsMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "dhc_CumulativeCommonStockDividends": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount as of the balance sheet date representing cumulative distributions to common shareholders.", "label": "Cumulative Common Stock Dividends", "negatedLabel": "Cumulative distributions" } } }, "localname": "CumulativeCommonStockDividends", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "dhc_DebtInstrumentAmountRedeemed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Amount Redeemed", "label": "Debt Instrument, Amount Redeemed", "terseLabel": "Debt instrument, amount redeemed" } } }, "localname": "DebtInstrumentAmountRedeemed", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "dhc_DebtInstrumentExtensionOptionTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Extension Option Term", "label": "Debt Instrument, Extension Option Term", "terseLabel": "Extension term" } } }, "localname": "DebtInstrumentExtensionOptionTerm", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "durationItemType" }, "dhc_DeconsolidationOfPreviouslyConsolidatedInvestmentsRealEstate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deconsolidation Of Previously Consolidated Investments, Real Estate", "label": "Deconsolidation Of Previously Consolidated Investments, Real Estate", "negatedTerseLabel": "Real estate, net" } } }, "localname": "DeconsolidationOfPreviouslyConsolidatedInvestmentsRealEstate", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "dhc_DiversifiedHealthcareTrustsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified Healthcare Trusts", "label": "Diversified Healthcare Trusts [Member]", "terseLabel": "Diversified Healthcare Trusts" } } }, "localname": "DiversifiedHealthcareTrustsMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_EquitySecuritiesFVNIHoldingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Securities, FV-NI, Holding Period", "label": "Equity Securities, FV-NI, Holding Period", "terseLabel": "Holding period" } } }, "localname": "EquitySecuritiesFVNIHoldingPeriod", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "dhc_FairValueMeasurementNumberOfDebtSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value Measurement, Number Of Debt Securities", "label": "Fair Value Measurement, Number Of Debt Securities", "terseLabel": "Fair value measurement, number of debt securities" } } }, "localname": "FairValueMeasurementNumberOfDebtSecurities", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "integerItemType" }, "dhc_FinanceLeasedPropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance Leased Properties", "label": "Finance Leased Properties [Member]", "terseLabel": "Finance Leased Properties" } } }, "localname": "FinanceLeasedPropertiesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "dhc_FiveStarQualityCareIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Five Star Quality Care, Inc.", "label": "Five Star Quality Care Inc [Member]", "terseLabel": "Five Star" } } }, "localname": "FiveStarQualityCareIncMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_FormerEmployeesOfRMRLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Employees Of RMR LLC", "label": "Former Employees Of RMR LLC [Member]", "terseLabel": "Former Employees Of RMR LLC" } } }, "localname": "FormerEmployeesOfRMRLLCMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_GainLossOnEarlyExtinguishmentOfDebt": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain (Loss) On Early Extinguishment Of Debt", "label": "Gain (Loss) On Early Extinguishment Of Debt", "negatedTerseLabel": "Loss on modification or early extinguishment of debt" } } }, "localname": "GainLossOnEarlyExtinguishmentOfDebt", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "dhc_IncreaseDecreaseInInvestmentInJointVenture": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Assets, Net", "label": "Increase (Decrease) In Investment In Joint Venture", "terseLabel": "Other assets, net" } } }, "localname": "IncreaseDecreaseInInvestmentInJointVenture", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "dhc_InvestmentOwnedPercentageOfTotalSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of shares held as a percentage of the total shares outstanding at the end of the period.", "label": "Investment Owned, Percentage of Total Shares Outstanding", "terseLabel": "Investment owned, percentage of total shares outstanding" } } }, "localname": "InvestmentOwnedPercentageOfTotalSharesOutstanding", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "percentItemType" }, "dhc_InvestmentsInUnconsolidatedJointVentures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investments In Unconsolidated Joint Ventures", "label": "Investments In Unconsolidated Joint Ventures", "negatedTerseLabel": "Investments in unconsolidated joint ventures" } } }, "localname": "InvestmentsInUnconsolidatedJointVentures", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "dhc_JointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Joint Venture [Member]", "label": "Joint Venture [Member]", "terseLabel": "Joint Venture" } } }, "localname": "JointVentureMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_LifeScienceBuildingLocatedInCaliforniaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Life Science Building Located In California", "label": "Life Science Building Located In California [Member]", "terseLabel": "Life Science Building Located In California" } } }, "localname": "LifeScienceBuildingLocatedInCaliforniaMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_LifeSciencePropertyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Life Science Property", "label": "Life Science Property [Member]", "terseLabel": "Life Science Property" } } }, "localname": "LifeSciencePropertyMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_MeasurementInputMarketCapitalizationRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Market Capitalization Rate", "label": "Measurement Input, Market Capitalization Rate [Member]", "terseLabel": "Measurement Input, Market Capitalization Rate" } } }, "localname": "MeasurementInputMarketCapitalizationRateMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_MedicalOfficeAndLifeScienceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Office And Life Science", "label": "Medical Office And Life Science [Member]", "terseLabel": "Medical Office And Life Science" } } }, "localname": "MedicalOfficeAndLifeScienceMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "dhc_MedicalOfficeAndLifeSciencePropertiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Office and Life Science Properties", "label": "Medical Office and Life Science Properties [Member]", "terseLabel": "Medical Office and Life Science Properties" } } }, "localname": "MedicalOfficeAndLifeSciencePropertiesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "domainItemType" }, "dhc_MedicalOfficeBuildingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to medical office buildings. The MOBs are office or commercial buildings constructed for use or operated as medical office space for physicians and other health personnel, and other businesses in medical related fields, including clinics and laboratory uses.", "label": "Medical Office Building [Member]", "terseLabel": "Medical Office Building" } } }, "localname": "MedicalOfficeBuildingMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "dhc_MedicalOfficeBuildingandLifeScienceBuildingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medical Office Building and Life Science Building [Member]", "label": "Medical Office Building and Life Science Building [Member]", "terseLabel": "Medical Office Building and Life Science Building" } } }, "localname": "MedicalOfficeBuildingandLifeScienceBuildingMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_MedicareAndMedicaidProgramsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medicare And Medicaid Programs [Member]", "label": "Medicare And Medicaid Programs [Member]", "terseLabel": "Medicare and Medicaid programs" } } }, "localname": "MedicareAndMedicaidProgramsMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "dhc_MinimumLiquidityRequirementAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Minimum Liquidity Requirement Amount", "label": "Minimum Liquidity Requirement Amount", "terseLabel": "Minimum liquidity requirement" } } }, "localname": "MinimumLiquidityRequirementAmount", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "dhc_Mortgages628PercentDueJuly2022Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mortgages 6.28 Percent Due July 2022", "label": "Mortgages 6.28 Percent Due July 2022 [Member]", "terseLabel": "Mortgages 6.28 Percent Due July 2022" } } }, "localname": "Mortgages628PercentDueJuly2022Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "dhc_NoncashInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to the Non cash investing activities.", "label": "Noncash Investing Activities [Abstract]", "terseLabel": "Non-cash investing activities:" } } }, "localname": "NoncashInvestingActivitiesAbstract", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "stringItemType" }, "dhc_NumberJointVentureArrangements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Joint Venture Arrangements", "label": "Number Joint Venture Arrangements", "terseLabel": "Number joint venture arrangements" } } }, "localname": "NumberJointVentureArrangements", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfCommunitiesManagedByRelatedParty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of communities managed by a related party.", "label": "Number of Communities Managed by Related Party", "terseLabel": "Number of communities managed" } } }, "localname": "NumberOfCommunitiesManagedByRelatedParty", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfExtensionOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Extension Options", "label": "Number Of Extension Options", "terseLabel": "Number of extension options" } } }, "localname": "NumberOfExtensionOptions", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfMedicalOfficeAndLifeScienceProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Medical Office And Life Science Properties", "label": "Number Of Medical Office And Life Science Properties", "terseLabel": "Number of medical office and life science properties" } } }, "localname": "NumberOfMedicalOfficeAndLifeScienceProperties", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfOwnedProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Owned Properties", "label": "Number Of Owned Properties", "terseLabel": "Number of owned properties" } } }, "localname": "NumberOfOwnedProperties", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfPropertiesIncludedInJointVentureAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Properties Included In Joint Venture Agreement", "label": "Number Of Properties Included In Joint Venture Agreement", "terseLabel": "Number of properties included in joint venture agreement" } } }, "localname": "NumberOfPropertiesIncludedInJointVentureAgreement", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfRealEstatePropertiesTransitioned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Real Estate Properties Transitioned", "label": "Number Of Real Estate Properties Transitioned", "terseLabel": "Number of properties transitioned" } } }, "localname": "NumberOfRealEstatePropertiesTransitioned", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfStates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of States", "label": "Number Of States", "terseLabel": "Number of states" } } }, "localname": "NumberOfStates", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfThirdPartyInstitutionalInvestors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Third Party Institutional Investors", "label": "Number Of Third Party Institutional Investors", "terseLabel": "Number of third party institutional investors" } } }, "localname": "NumberOfThirdPartyInstitutionalInvestors", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "integerItemType" }, "dhc_NumberOfUnconsolidatedJointVentures": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Unconsolidated Joint Ventures", "label": "Number Of Unconsolidated Joint Ventures", "terseLabel": "Number of unconsolidated joint ventures" } } }, "localname": "NumberOfUnconsolidatedJointVentures", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "dhc_OfficePortfolioSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Office Portfolio Segment", "label": "Office Portfolio Segment [Member]", "terseLabel": "Office Portfolio" } } }, "localname": "OfficePortfolioSegmentMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "domainItemType" }, "dhc_PerCommonShareAmountsBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per Common Share Amounts, Basic and Diluted", "label": "Per Common Share Amounts, Basic and Diluted [Abstract]", "terseLabel": "Per common share amounts (basic and diluted):" } } }, "localname": "PerCommonShareAmountsBasicAndDilutedAbstract", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" ], "xbrltype": "stringItemType" }, "dhc_PercentageOfEquityMethodInvestmentSold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Equity Method Investment Sold", "label": "Percentage Of Equity Method Investment Sold", "terseLabel": "Additional equity joint venture percentage" } } }, "localname": "PercentageOfEquityMethodInvestmentSold", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "dhc_PeriodOfActualAmountOfIncentiveFees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period Of Actual Amount Of Incentive Fees", "label": "Period Of Actual Amount Of Incentive Fees", "terseLabel": "Period of actual amount of incentive fees" } } }, "localname": "PeriodOfActualAmountOfIncentiveFees", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "durationItemType" }, "dhc_PrivatePayAndOtherThirdPartyPayerServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Pay And Other Third Party Payer Services [Member]", "label": "Private Pay And Other Third Party Payer Services [Member]", "terseLabel": "Private pay and other third party payer SNF services" } } }, "localname": "PrivatePayAndOtherThirdPartyPayerServicesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "dhc_ProceedsFromDivestitureOfInterestInJointVentureNet": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Divestiture Of Interest In Joint Venture, Net", "label": "Proceeds from Divestiture Of Interest In Joint Venture, Net", "terseLabel": "Proceeds from sale of interest in joint venture, net" } } }, "localname": "ProceedsFromDivestitureOfInterestInJointVentureNet", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "dhc_PropertyManagementAndConstructionSupervisionFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the property management and construction supervision fees incurred pursuant to business and property management agreements with related parties.", "label": "Property Management and Construction Supervision Fees", "terseLabel": "Property management and construction supervision fees" } } }, "localname": "PropertyManagementAndConstructionSupervisionFees", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "monetaryItemType" }, "dhc_PropertyManagementAndConstructionSupervisionFeesCapitalized": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Property Management And Construction Supervision Fees, Capitalized", "label": "Property Management And Construction Supervision Fees, Capitalized", "terseLabel": "Party transaction property management and construction supervision fees capitalized" } } }, "localname": "PropertyManagementAndConstructionSupervisionFeesCapitalized", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "monetaryItemType" }, "dhc_PropertyManagementAndConstructionSupervisionFeesPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the property management and construction supervision fees paid to related parties.", "label": "Property Management And Construction Supervision Fees Paid", "terseLabel": "Property management and construction supervision fees paid" } } }, "localname": "PropertyManagementAndConstructionSupervisionFeesPaid", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "monetaryItemType" }, "dhc_PropertyManagementFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property Management Fee", "label": "Property Management Fee", "terseLabel": "Property management fee" } } }, "localname": "PropertyManagementFee", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "percentItemType" }, "dhc_RealEstateAggregatePurchasePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Real Estate Aggregate Purchase Price", "label": "Real Estate Aggregate Purchase Price", "terseLabel": "Purchase price" } } }, "localname": "RealEstateAggregatePurchasePrice", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhc_RealEstatePropertyFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Real Estate Property Fair Value", "label": "Real Estate Property Fair Value", "terseLabel": "Real estate property fair value" } } }, "localname": "RealEstatePropertyFairValue", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhc_RehabilitationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rehabilitation Services [Member]", "label": "Rehabilitation Services [Member]", "terseLabel": "Rehabilitation Services" } } }, "localname": "RehabilitationServicesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_ReimbursementRevenueLease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reimbursement Revenue Lease", "label": "Reimbursement Revenue Lease", "terseLabel": "Reimbursement revenue lease" } } }, "localname": "ReimbursementRevenueLease", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "dhc_ReitManagementAndResearchMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents details pertaining to Reit Management and Research LLC, or RMR.", "label": "Reit Management And Research [Member]", "terseLabel": "RMR" } } }, "localname": "ReitManagementAndResearchMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_RelatedPartyManagementAgreements": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party, Management Agreements", "label": "Related Party, Management Agreements", "terseLabel": "Number of management agreements" } } }, "localname": "RelatedPartyManagementAgreements", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "integerItemType" }, "dhc_RelatedPartyTransactionCapitalizedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction Capitalized Amount", "label": "Related Party Transaction Capitalized Amount", "terseLabel": "Related party transaction capitalized amount" } } }, "localname": "RelatedPartyTransactionCapitalizedAmount", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhc_RelatedPartyTransactionClosingCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Closing Cost", "label": "Related Party Transaction, Closing Cost", "terseLabel": "Related party transaction, closing cost" } } }, "localname": "RelatedPartyTransactionClosingCost", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "dhc_RelatedPartyTransactionExpensesFromPropertyManagementAgreementTransactionsWithRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized during the period resulting from property management transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.", "label": "Related Party Transaction, Expenses from Property Management Agreement Transactions with Related Party", "terseLabel": "Property management agreement expense" } } }, "localname": "RelatedPartyTransactionExpensesFromPropertyManagementAgreementTransactionsWithRelatedParty", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "dhc_RelatedPartyTransactionPercentageTargetEBITDAOfNewManagementAgreementNotEarned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transaction, Percentage Target EBITDA Of New Management Agreement Not Earned", "label": "Related Party Transaction, Percentage Target EBITDA Of New Management Agreement Not Earned", "terseLabel": "Percentage target EBITDA of new management agreement not earned" } } }, "localname": "RelatedPartyTransactionPercentageTargetEBITDAOfNewManagementAgreementNotEarned", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "dhc_RelatedPartyTransactionPropertyManagementAgreementNumberOfConsecutiveRenewalTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of consecutive renewal terms of agreement that the entity has the option to renew.", "label": "Related Party Transaction, Property Management Agreement, Number of Consecutive Renewal Terms", "terseLabel": "Number of consecutive renewal terms of agreement" } } }, "localname": "RelatedPartyTransactionPropertyManagementAgreementNumberOfConsecutiveRenewalTerms", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails" ], "xbrltype": "integerItemType" }, "dhc_RelatedPartyTransactionsTerminationPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Related Party Transactions, Termination Percentage", "label": "Related Party Transactions, Termination Percentage", "terseLabel": "Related party transactions, termination percentage" } } }, "localname": "RelatedPartyTransactionsTerminationPercentage", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "dhc_RentalIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rental Income [Member]", "label": "Rental Income [Member]", "terseLabel": "Rental income" } } }, "localname": "RentalIncomeMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "domainItemType" }, "dhc_ResidentFeesAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Resident Fees And Services [Member]", "label": "Resident Fees And Services [Member]", "terseLabel": "Residents fees and services" } } }, "localname": "ResidentFeesAndServicesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "dhc_SeaportInnovationLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Seaport Innovation LLC", "label": "Seaport Innovation LLC [Member]", "terseLabel": "Seaport Innovation LLC" } } }, "localname": "SeaportInnovationLLCMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_SecuredDebtAndFinanceLeaseObligations": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower and amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.", "label": "Secured Debt And Finance Lease Obligations", "terseLabel": "Secured debt and finance leases, net" } } }, "localname": "SecuredDebtAndFinanceLeaseObligations", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "dhc_SeniorHousingOperatingPortfolioSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Housing Operating Portfolio [Member]", "label": "Senior Housing Operating Portfolio Segment [Member]", "terseLabel": "SHOP" } } }, "localname": "SeniorHousingOperatingPortfolioSegmentMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorLivingCommunitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Living Communities", "label": "Senior Living Communities [Member]", "terseLabel": "Senior Living Communities" } } }, "localname": "SeniorLivingCommunitiesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorLivingCommunityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to senior living properties. Senior apartments are marketed to residents who are generally capable of caring for themselves. Residence is usually restricted on the basis of age. Purpose built properties may have special function rooms, concierge services, high levels of security and assistance call systems for emergency use.", "label": "Senior Living Community [Member]", "terseLabel": "Senior Living Communities" } } }, "localname": "SeniorLivingCommunityMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorNotesDue2042Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2042 [Member]", "label": "Senior Notes Due 2042 [Member]", "terseLabel": "5.625% Senior Notes due 2042" } } }, "localname": "SeniorNotesDue2042Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "domainItemType" }, "dhc_SeniorNotesDue2046Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Notes Due 2046 [Member]", "label": "Senior Notes Due 2046 [Member]", "terseLabel": "6.25% Senior Notes due 2046" } } }, "localname": "SeniorNotesDue2046Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/Cover" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNoteDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Note Due 2025", "label": "Senior Unsecured Note Due 2025 [Member]", "terseLabel": "Senior Unsecured Note Due 2022" } } }, "localname": "SeniorUnsecuredNoteDue2025Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotes4.75PercentDue2024Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes 4.75 Percent Due 2024", "label": "Senior Unsecured Notes 4.75 Percent Due 2024 [Member]", "terseLabel": "Senior unsecured notes, 4.750% coupon rate, due 2024" } } }, "localname": "SeniorUnsecuredNotes4.75PercentDue2024Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotes4.75PercentDue2028Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes 4.75 Percent Due 2028 [Member]", "label": "Senior Unsecured Notes 4.75 Percent Due 2028 [Member]", "terseLabel": "Senior unsecured notes, 4.750% coupon rate, due 2028" } } }, "localname": "SeniorUnsecuredNotes4.75PercentDue2028Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotes4375PercentDue2031Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes 4.375 Percent Due 2031", "label": "Senior Unsecured Notes 4.375 Percent Due 2031 [Member]", "terseLabel": "Senior unsecured notes, 4.375% coupon rate, due 2031" } } }, "localname": "SeniorUnsecuredNotes4375PercentDue2031Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotes5625PercentDue2042Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes 5.625 Percent Due 2042", "label": "Senior Unsecured Notes 5.625 Percent Due 2042 [Member]", "terseLabel": "Senior unsecured notes, 5.625% coupon rate, due 2042" } } }, "localname": "SeniorUnsecuredNotes5625PercentDue2042Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotes625PercentDue2046Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes 6.25 Percent Due 2046", "label": "Senior Unsecured Notes 6.25 Percent Due 2046 [Member]", "terseLabel": "Senior unsecured notes, 6.250% coupon rate, due 2046" } } }, "localname": "SeniorUnsecuredNotes625PercentDue2046Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotes975PercentDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes 9.75 Percent Due 2025", "label": "Senior Unsecured Notes 9.75 Percent Due 2025 [Member]", "terseLabel": "Senior unsecured notes, 9.750% coupon rate, due 2025" } } }, "localname": "SeniorUnsecuredNotes975PercentDue2025Member", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_SeniorUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Unsecured Notes [Member]", "label": "Senior Unsecured Notes [Member]", "terseLabel": "Senior Unsecured Notes" } } }, "localname": "SeniorUnsecuredNotesMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "dhc_ShareAwardPlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Award Plans", "label": "Share Award Plans [Member]", "terseLabel": "Share Award Plans" } } }, "localname": "ShareAwardPlansMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_SkilledNursingBedLicenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "skilled nursing bed license", "label": "skilled nursing bed license [Member]", "terseLabel": "Skilled nursing bed license" } } }, "localname": "SkilledNursingBedLicenseMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_StockRepurchasedDuringPeriodWeightedAveragePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Repurchased During Period, Weighted Average Price", "label": "Stock Repurchased During Period, Weighted Average Price", "terseLabel": "Weighted average share price (in dollars per share)" } } }, "localname": "StockRepurchasedDuringPeriodWeightedAveragePrice", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "dhc_StraightLineRentExcludingPropertiesHeldforSale": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Straight Line Rent, Excluding Properties Held-for-Sale", "label": "Straight Line Rent, Excluding Properties Held-for-Sale", "terseLabel": "Straight line rental income, excluding properties held-for-sale" } } }, "localname": "StraightLineRentExcludingPropertiesHeldforSale", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "dhc_TheLSMDFundREITLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The LSMD Fund REIT LLC", "label": "The LSMD Fund REIT LLC [Member]", "terseLabel": "The LSMD Fund REIT LLC" } } }, "localname": "TheLSMDFundREITLLCMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "dhc_ThirdPartyInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third Party Investor", "label": "Third Party Investor [Member]", "terseLabel": "Investor", "verboseLabel": "Third Party Investor" } } }, "localname": "ThirdPartyInvestorMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_TrusteeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trustee", "label": "Trustee [Member]", "terseLabel": "Trustee" } } }, "localname": "TrusteeMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_UnrelatedInvestorOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unrelated Investor One", "label": "Unrelated Investor One [Member]", "terseLabel": "Unrelated Investor One" } } }, "localname": "UnrelatedInvestorOneMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "dhc_UnrelatedInvestorTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unrelated Investor Two", "label": "Unrelated Investor Two [Member]", "terseLabel": "Unrelated Investor Two" } } }, "localname": "UnrelatedInvestorTwoMember", "nsuri": "http://dhcreit.com/20220630", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_AffiliatedEntityMember": { "auth_ref": [ "r276", "r398", "r399", "r402", "r495" ], "lang": { "en-us": { "role": { "label": "Affiliated Entity [Member]", "terseLabel": "Affiliated Entity" } } }, "localname": "AffiliatedEntityMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r77", "r116", "r129", "r130", "r131", "r132", "r134", "r136", "r140", "r188", "r189", "r190", "r191", "r192", "r193", "r195", "r196", "r198", "r200", "r201" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r77", "r116", "r129", "r130", "r131", "r132", "r134", "r136", "r140", "r188", "r189", "r190", "r191", "r192", "r193", "r195", "r196", "r198", "r200", "r201" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r27", "r29", "r75", "r76", "r207", "r240" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]", "terseLabel": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r183", "r184", "r185", "r186", "r206", "r239", "r278", "r280", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r473", "r476", "r500", "r502" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r183", "r184", "r185", "r186", "r206", "r239", "r278", "r280", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r473", "r476", "r500", "r502" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": { "auth_ref": [ "r484", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494" ], "lang": { "en-us": { "role": { "label": "Real Estate, Type of Property [Axis]", "terseLabel": "Real Estate, Type of Property [Axis]" } } }, "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": { "auth_ref": [ "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494" ], "lang": { "en-us": { "role": { "label": "Real Estate [Domain]", "terseLabel": "Real Estate [Domain]" } } }, "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_OwnershipAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Axis]", "terseLabel": "Ownership [Axis]" } } }, "localname": "OwnershipAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_OwnershipDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ownership [Domain]", "terseLabel": "Ownership [Domain]" } } }, "localname": "OwnershipDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r143", "r184", "r185", "r260", "r261", "r420", "r472", "r474" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r143", "r184", "r185", "r260", "r261", "r420", "r472", "r474" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r178", "r183", "r184", "r185", "r186", "r206", "r239", "r268", "r278", "r280", "r305", "r306", "r307", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r473", "r476", "r500", "r502" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r178", "r183", "r184", "r185", "r186", "r206", "r239", "r268", "r278", "r280", "r305", "r306", "r307", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r473", "r476", "r500", "r502" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": { "auth_ref": [ "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r496" ], "lang": { "en-us": { "role": { "label": "Name of Property [Axis]", "terseLabel": "Name of Property [Axis]" } } }, "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": { "auth_ref": [ "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r496" ], "lang": { "en-us": { "role": { "label": "Name of Property [Domain]", "terseLabel": "Name of Property [Domain]" } } }, "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r28", "r29", "r75", "r76", "r207", "r240" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r86", "r279" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r86", "r91", "r182", "r279" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]", "terseLabel": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r144", "r145", "r260", "r262", "r475", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r144", "r145", "r260", "r262", "r475", "r484", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r86", "r91", "r182", "r279", "r409" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r149", "r401" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]", "terseLabel": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "stpr_CA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CALIFORNIA", "terseLabel": "California" } } }, "localname": "CA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "stpr_MA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MASSACHUSETTS", "terseLabel": "Massachusetts" } } }, "localname": "MA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r16" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r78", "r79", "r80", "r311", "r312", "r313", "r351" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to cash (used in) provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r61", "r226", "r233", "r234", "r383" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Net amortization of debt premiums, discounts and issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousandsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AreaOfRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of a real estate property.", "label": "Area of Real Estate Property", "terseLabel": "Area of real estate property" } } }, "localname": "AreaOfRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "areaItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r61", "r169" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment of assets" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r10", "r72", "r124", "r131", "r138", "r153", "r188", "r189", "r190", "r192", "r193", "r194", "r195", "r197", "r199", "r201", "r202", "r331", "r337", "r371", "r405", "r407", "r437", "r456" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/SegmentReportingAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_BuildingsAndImprovementsGross": { "auth_ref": [ "r172" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 2.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Buildings and Improvements, Gross", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingsAndImprovementsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r327" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition\u00a0and certain other transaction related\u00a0costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CarryingReportedAmountFairValueDisclosureMember": { "auth_ref": [ "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "Measured as reported on the statement of financial position (balance sheet).", "label": "Reported Value Measurement [Member]", "terseLabel": "Carrying Amount" } } }, "localname": "CarryingReportedAmountFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r6", "r7", "r63" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r55", "r63", "r68" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period", "totalLabel": "Total cash and cash equivalents and restricted cash shown in our condensed consolidated statements of cash flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r55", "r372" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "(Decrease) increase in cash and cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r24", "r444", "r461" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Cash Paid", "verboseLabel": "Distribution per share (in dollars per share)" } } }, "localname": "CommonStockDividendsPerShareCashPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityScheduleofDividendsDeclaredandPaidDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r257" ], "lang": { "en-us": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Distributions to common shareholders declared (in dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r78", "r79", "r351" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Shares" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common shares of beneficial interest, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common shares of beneficial interest, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common shares of beneficial interest, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r15", "r252" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)", "terseLabel": "Beginning balance (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnauditedParenthetical", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r15", "r407" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common shares of beneficial interest, $.01 par value: 300,000,000 shares authorized, 239,123,496 and 238,994,894 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "Senior Living Community Management Agreements" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreements" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r106", "r107", "r108", "r109", "r369", "r370", "r485" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConstructionInProgressExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r65", "r66", "r67" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for construction in progress expenditures that have occurred.", "label": "Construction in Progress Expenditures Incurred but Not yet Paid", "terseLabel": "Real estate improvements accrued, not paid" } } }, "localname": "ConstructionInProgressExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateJointVentureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporation owned and operated by a small group of ventures to accomplish a mutually beneficial venture or project.", "label": "Corporate Joint Venture [Member]", "terseLabel": "Corporate Joint Venture" } } }, "localname": "CorporateJointVentureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r129", "r130", "r131", "r132", "r134", "r140", "r142" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Non-Segment" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r40" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Expenses:", "verboseLabel": "Expenses:" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r69", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r220", "r227", "r228", "r230", "r237" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Indebtedness" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/Indebtedness" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r11", "r12", "r13", "r71", "r77", "r203", "r204", "r205", "r206", "r207", "r208", "r210", "r216", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r231", "r232", "r233", "r234", "r384", "r438", "r439", "r454" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/Cover", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Basis points per annum (as a percent)" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r203", "r231", "r232", "r382", "r384", "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r218", "r231", "r232", "r366" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value disclosure" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r21", "r223", "r382" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Debt Instrument, Interest Rate During Period", "terseLabel": "Weighted average interest rate on debt (as a percent)" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r21", "r204" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Coupon rate (percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Indebtedness" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r22", "r71", "r77", "r203", "r204", "r205", "r206", "r207", "r208", "r210", "r216", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r231", "r232", "r233", "r234", "r384" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/Cover", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption price (as a percent)" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r22", "r71", "r77", "r203", "r204", "r205", "r206", "r207", "r208", "r210", "r216", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r229", "r231", "r232", "r233", "r234", "r253", "r254", "r255", "r256", "r381", "r382", "r384", "r385", "r453" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r61", "r171" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and amortization" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r61", "r119" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r29", "r343", "r344", "r345", "r348" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r168", "r170" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that is disposed of other than by sale. For example, but not limited to, abandonment, in an exchange measured based on the recorded amount of the nonmonetary asset relinquished, or in a distribution to owners in a spinoff. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Disposed of by Means Other than Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupDisposedOfByMeansOtherThanSaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r3", "r167", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]", "terseLabel": "Closed" } } }, "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r257", "r451" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedTerseLabel": "Distributions" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsDeclaredTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to dividends declared, including paid and unpaid dividends.", "label": "Dividends Declared [Table Text Block]", "terseLabel": "Schedule of Dividends Declared and Paid" } } }, "localname": "DividendsDeclaredTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r39", "r83", "r84", "r85", "r86", "r87", "r92", "r94", "r96", "r97", "r98", "r102", "r103", "r352", "r353", "r448", "r468" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net (loss) income attributable to common shareholders - basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r39", "r83", "r84", "r85", "r86", "r87", "r94", "r96", "r97", "r98", "r102", "r103", "r352", "r353", "r448", "r468" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net (loss) income attributable to common shareholders - diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r99", "r100", "r101", "r104" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Weighted Average Common Shares (shares amounts in thousands)" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/WeightedAverageCommonSharessharesamountsinthousands" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r32", "r33", "r34", "r78", "r79", "r80", "r82", "r88", "r90", "r105", "r155", "r252", "r257", "r311", "r312", "r313", "r318", "r319", "r351", "r373", "r374", "r375", "r376", "r377", "r378", "r395", "r477", "r478", "r479" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentDividendsOrDistributions": { "auth_ref": [ "r37", "r54", "r61", "r466" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.", "label": "Proceeds from Equity Method Investment, Distribution", "terseLabel": "Unconsolidated joint venture distributions" } } }, "localname": "EquityMethodInvestmentDividendsOrDistributions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment ownership percentage", "verboseLabel": "Equity method investment ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestmentsTextBlock": { "auth_ref": [ "r154" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.", "label": "Equity Method Investments [Table Text Block]", "terseLabel": "Schedule of Equity Method Investments" } } }, "localname": "EquityMethodInvestmentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesFvNiGainLoss": { "auth_ref": [ "r150" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Gain (Loss)", "negatedLabel": "Losses on equity securities, net" } } }, "localname": "EquitySecuritiesFvNiGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquitySecuritiesFvNiMeasurementInput": { "auth_ref": [ "r359" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Measurement Input", "terseLabel": "Measurement input" } } }, "localname": "EquitySecuritiesFvNiMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": { "auth_ref": [ "r150", "r469" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).", "label": "Equity Securities, FV-NI, Realized Gain (Loss)", "terseLabel": "Losses on equity securities, net" } } }, "localname": "EquitySecuritiesFvNiRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EstimateOfFairValueFairValueDisclosureMember": { "auth_ref": [ "r218", "r231", "r232", "r366" ], "lang": { "en-us": { "role": { "documentation": "Measured as an estimate of fair value.", "label": "Estimate of Fair Value Measurement [Member]", "terseLabel": "Estimated Fair Value" } } }, "localname": "EstimateOfFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r354", "r355", "r362" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r354", "r355", "r356", "r361", "r362" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Schedule of Assets and Liabilities Recurring and Nonrecurring Measured at Fair Value" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r218", "r231", "r232", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r355", "r410", "r411", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementBasisAxis": { "auth_ref": [ "r218", "r231", "r232", "r354", "r363" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement basis.", "label": "Measurement Basis [Axis]", "terseLabel": "Measurement Basis [Axis]" } } }, "localname": "FairValueByMeasurementBasisAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r354", "r355", "r358", "r359", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosureItemAmountsDomain": { "auth_ref": [ "r218", "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.", "label": "Fair Value Measurement [Domain]", "terseLabel": "Fair Value Measurement [Domain]" } } }, "localname": "FairValueDisclosureItemAmountsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r360" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Assets and Liabilities" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r218", "r269", "r270", "r275", "r277", "r355", "r410" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1", "verboseLabel": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r218", "r231", "r232", "r269", "r270", "r275", "r277", "r355", "r411" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "verboseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r218", "r231", "r232", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r355", "r412" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r218", "r231", "r232", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r277", "r410", "r411", "r412" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r360", "r364" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r387", "r392" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "terseLabel": "Finance lease obligations" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "auth_ref": [ "r389", "r391" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "terseLabel": "Finance leased asset, accumulated depreciation" } } }, "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "auth_ref": [ "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "terseLabel": "Finance leased asset, gross" } } }, "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r166", "r421" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Acquired real estate leases and other intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfOtherAssets": { "auth_ref": [ "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of other assets.", "label": "Gain (Loss) on Disposition of Other Assets", "verboseLabel": "Gain (loss) on sales of beds" } } }, "localname": "GainLossOnSaleOfOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfProperties": { "auth_ref": [ "r61", "r170", "r174" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the carrying value and the sale price of real estate or properties that were intended to be sold or held for capital appreciation or rental income. This element refers to the gain (loss) included in earnings and not to the cash proceeds of the sale. This element is a noncash adjustment to net income when calculating net cash generated by operating activities using the indirect method.", "label": "Gain (Loss) on Sale of Properties", "negatedLabel": "Gain on sale of properties", "verboseLabel": "(Loss) gain on sale of properties" } } }, "localname": "GainLossOnSaleOfProperties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r61", "r235", "r236" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "netLabel": "Gain (loss) on extinguishment of debt", "terseLabel": "Loss on modification or early extinguishment of debt", "verboseLabel": "Gain (loss) on modification or early extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative", "verboseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r36", "r124", "r130", "r134", "r137", "r140", "r434", "r446", "r450", "r470" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Income (loss) from continuing operations before income tax benefit (expense) and equity in earnings of investees", "totalLabel": "(Loss) income from continuing operations before income tax benefit (expense) and equity in earnings of investees" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r37", "r61", "r121", "r151", "r445", "r466" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedTerseLabel": "Equity in earnings of investees", "terseLabel": "Equity in earnings of investees" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r175", "r179" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r179" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r73", "r315", "r316", "r317", "r320", "r322", "r324", "r325", "r326" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r74", "r89", "r90", "r122", "r314", "r321", "r323", "r471" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Income Tax Expense (Benefit)", "terseLabel": "Income tax benefit (expense)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/IncomeTaxesDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaid": { "auth_ref": [ "r58", "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.", "label": "Income Taxes Paid", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLeasingFees": { "auth_ref": [ "r60" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the book value of deferred leasing fees. Amortization of these fees over the terms of the leases reduces deferred leasing fees. Originating new leases increases the balance of deferred leasing fees.", "label": "Increase (Decrease) in Deferred Leasing Fees", "negatedTerseLabel": "Deferred leasing costs, net" } } }, "localname": "IncreaseDecreaseInDeferredLeasingFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r60" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Accrued interest" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Change in assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r60" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r60" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "terseLabel": "Interest and other income", "verboseLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r35", "r118", "r380", "r383", "r449" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense (including net amortization of debt premiums, discounts and issuance costs of $2,318, $3,017, $4,790 and $5,829, respectively)", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidCapitalized": { "auth_ref": [ "r46", "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest capitalized, classified as investing activity.", "label": "Interest Paid, Capitalized, Investing Activities", "terseLabel": "Capitalized interest" } } }, "localname": "InterestPaidCapitalized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r52", "r57", "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r441", "r464" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateCapMember": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.", "label": "Interest Rate Cap [Member]", "terseLabel": "Interest Rate Cap" } } }, "localname": "InterestRateCapMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Equity securities investment (in shares)" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure": { "auth_ref": [ "r354" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investments in an entity not consolidated. Includes, but is not limited to, investments in an entity that is affiliated with the reporting entity by means of direct or indirect ownership, an entity in which the reporting entity shares control of the entity with another party or group, an entity which the company has significant influence, but does not have control and subsidiaries that are not required to be consolidated and are accounted for using the equity or cost method.", "label": "Investments in Affiliates, Subsidiaries, Associates, and Joint Ventures, Fair Value Disclosure", "terseLabel": "Investments in affiliates, fair value" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVenturesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Land": { "auth_ref": [ "r8" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 1.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.", "label": "Land", "terseLabel": "Land" } } }, "localname": "Land", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseIncome": { "auth_ref": [ "r393" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lease income from operating, direct financing, and sales-type leases. Includes, but is not limited to, variable lease payments, interest income, profit (loss) recognized at commencement, and lease payments paid and payable to lessor.", "label": "Lease Income", "terseLabel": "Lease income" } } }, "localname": "LeaseIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r72", "r132", "r153", "r188", "r189", "r190", "r193", "r194", "r195", "r197", "r199", "r201", "r202", "r332", "r337", "r338", "r371", "r405", "r406" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r18", "r72", "r153", "r371", "r407", "r440", "r460" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r13", "r439", "r454" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Revolving credit facility" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.", "label": "Line of Credit Facility, Commitment Fee Percentage", "terseLabel": "Debt instrument, facility fee (as a percent)" } } }, "localname": "LineOfCreditFacilityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The effective interest rate at the end of the reporting period.", "label": "Line of Credit Facility, Interest Rate at Period End", "terseLabel": "Revolving credit facility, interest rate payable (as a percent)" } } }, "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r19" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Unsecured revolving credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Unsecured Revolving Credit Facility" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r22", "r187" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]", "terseLabel": "Measurement Input, Discount Rate" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "auth_ref": [ "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "negatedTerseLabel": "Distributions to noncontrolling interest", "terseLabel": "Distributions to noncontrolling interest" } } }, "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/NoncontrollingInterestDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDisclosureTextBlock": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest Disclosure [Text Block]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "MinorityInterestDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/NoncontrollingInterest" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterestLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncontrolling Interest [Line Items]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "MinorityInterestLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/NoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Noncontrolling interest, ownership percentage by parent" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestTable": { "auth_ref": [ "r26", "r41", "r329", "r336" ], "lang": { "en-us": { "role": { "documentation": "Schedule of noncontrolling interest disclosure which includes the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.", "label": "Noncontrolling Interest [Table]", "terseLabel": "Noncontrolling Interest [Table]" } } }, "localname": "MinorityInterestTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/NoncontrollingInterestDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgages" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "verboseLabel": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r55" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "verboseLabel": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r55", "r59", "r62" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r4", "r30", "r31", "r34", "r38", "r62", "r72", "r81", "r83", "r84", "r85", "r86", "r89", "r90", "r95", "r124", "r130", "r134", "r137", "r140", "r153", "r188", "r189", "r190", "r193", "r194", "r195", "r197", "r199", "r201", "r202", "r353", "r371", "r447", "r467" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net (loss) income attributable to common shareholders" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r30", "r31", "r34", "r89", "r90", "r334", "r340" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net income attributable to noncontrolling interest", "terseLabel": "Net income attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncontrolling Interest [Abstract]" } } }, "localname": "NoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r78", "r79", "r80", "r257", "r328" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Total Equity Attributable to Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r112" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfRealEstateProperties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of real estate properties owned as of the balance sheet date.", "label": "Number of Real Estate Properties", "terseLabel": "Number of properties (property)", "verboseLabel": "Number of real estate properties" } } }, "localname": "NumberOfRealEstateProperties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfStatesInWhichEntityOperates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of states the entity operates in as of the balance sheet date.", "label": "Number of States in which Entity Operates", "terseLabel": "Number of states in which properties are located" } } }, "localname": "NumberOfStatesInWhichEntityOperates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfUnitsInRealEstateProperty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of units in a real estate property owned as of the balance sheet date.", "label": "Number of Units in Real Estate Property", "terseLabel": "Number of property units (units)" } } }, "localname": "NumberOfUnitsInRealEstateProperty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OffMarketLeaseUnfavorable": { "auth_ref": [ "r23" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents a liability associated with the acquisition of an off-market lease when the terms of the lease are unfavorable to the market terms for the lease at the date of acquisition.", "label": "Off-Market Lease, Unfavorable", "terseLabel": "Assumed real estate lease obligations, net" } } }, "localname": "OffMarketLeaseUnfavorable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingCostsAndExpenses": { "auth_ref": [], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.", "label": "Operating Costs and Expenses", "terseLabel": "Property operating expenses", "verboseLabel": "Property operating expenses" } } }, "localname": "OperatingCostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenseMember": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.", "label": "Operating Expense [Member]", "terseLabel": "Operating Expense" } } }, "localname": "OperatingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r387" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease, liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease liability.", "label": "Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Statement of Financial Position" } } }, "localname": "OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r386" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease, right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.", "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position" } } }, "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessor's operating leases.", "label": "Lessor, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "OperatingLeasesOfLessorDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r129", "r130", "r131", "r132", "r134", "r140" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r5", "r342" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/BasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r9", "r436", "r455" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "terseLabel": "Other assets, net" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilities": { "auth_ref": [ "r442" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other.", "label": "Other Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other non-cash adjustments, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Equity Attributable to Common Shareholders" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForCapitalImprovements": { "auth_ref": [ "r46" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.", "label": "Payments for Capital Improvements", "negatedLabel": "Real estate improvements" } } }, "localname": "PaymentsForCapitalImprovements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r48" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Repurchase of common shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r50" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedTerseLabel": "Loss on early extinguishment of debt settled in cash" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsCommonStock": { "auth_ref": [ "r48" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Common Stock", "negatedLabel": "Distributions to shareholders", "terseLabel": "Total Distributions", "verboseLabel": "Distributions to shareholders" } } }, "localname": "PaymentsOfDividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityScheduleofDividendsDeclaredandPaidDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r51" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "negatedLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToMinorityShareholders": { "auth_ref": [ "r51" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.", "label": "Payments to Noncontrolling Interests", "negatedTerseLabel": "Distributions to noncontrolling interest" } } }, "localname": "PaymentsToMinorityShareholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PortionAtFairValueFairValueDisclosureMember": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Measured at fair value for financial reporting purposes.", "label": "Portion at Fair Value Measurement [Member]", "terseLabel": "Portion at Fair Value Measurement" } } }, "localname": "PortionAtFairValueFairValueDisclosureMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": { "auth_ref": [ "r43" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.", "label": "Proceeds from Divestiture of Interest in Joint Venture", "terseLabel": "Proceeds from sale of interest in joint venture, net" } } }, "localname": "ProceedsFromDivestitureOfInterestInJointVenture", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "auth_ref": [ "r47" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.", "label": "Proceeds from Issuance of Unsecured Debt", "terseLabel": "Proceeds from issuance of senior unsecured notes, net" } } }, "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r47", "r71" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "verboseLabel": "Proceeds from borrowings on revolving credit facility" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRealEstateAndRealEstateJointVentures": { "auth_ref": [ "r45" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of real estate held-for-investment and real estate joint ventures.", "label": "Proceeds from Real Estate and Real Estate Joint Ventures", "terseLabel": "Proceeds from sale of properties to joint venture, net" } } }, "localname": "ProceedsFromRealEstateAndRealEstateJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherAssets1": { "auth_ref": [ "r56" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale of other assets as part of operating activities.", "label": "Proceeds from Sale of Other Assets", "terseLabel": "Proceeds from sale of other assets" } } }, "localname": "ProceedsFromSaleOfOtherAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": { "auth_ref": [ "r44" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.", "label": "Proceeds from Sale of Real Estate Held-for-investment", "terseLabel": "Proceeds from sale of properties, net" } } }, "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r4", "r30", "r31", "r34", "r53", "r72", "r81", "r89", "r90", "r124", "r130", "r134", "r137", "r140", "r153", "r188", "r189", "r190", "r193", "r194", "r195", "r197", "r199", "r201", "r202", "r330", "r333", "r335", "r340", "r341", "r353", "r371", "r450" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net (loss) income", "verboseLabel": "Net (loss) income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Real Estate Properties" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate [Abstract]", "terseLabel": "Real Estate [Abstract]" } } }, "localname": "RealEstateAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RealEstateDisclosureTextBlock": { "auth_ref": [ "r497", "r498", "r499", "r501", "r503" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for certain real estate investment financial statements, real estate investment trust operating support agreements, real estate owned, retail land sales, time share transactions, as well as other real estate related disclosures.", "label": "Real Estate Disclosure [Text Block]", "terseLabel": "Real Estate Investments" } } }, "localname": "RealEstateDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestments" ], "xbrltype": "textBlockItemType" }, "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": { "auth_ref": [ "r462" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 2.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes.", "label": "Real Estate Investment Property, Accumulated Depreciation", "negatedLabel": "Accumulated depreciation" } } }, "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyAtCost": { "auth_ref": [ "r463" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 1.0, "parentTag": "us-gaap_RealEstateInvestmentPropertyNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, at Cost", "terseLabel": "Total real estate properties, gross", "totalLabel": "Total real estate properties, gross" } } }, "localname": "RealEstateInvestmentPropertyAtCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyNet": { "auth_ref": [ "r463" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.", "label": "Real Estate Investment Property, Net", "totalLabel": "Total real estate properties, net" } } }, "localname": "RealEstateInvestmentPropertyNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateInvestmentPropertyNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Real Estate Investment Property, Net [Abstract]", "terseLabel": "Real estate properties:" } } }, "localname": "RealEstateInvestmentPropertyNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures": { "auth_ref": [ "r463" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of investments in unconsolidated real estate and other joint ventures not separately presented. This includes direct and indirect investments.", "label": "Real Estate Investments, Unconsolidated Real Estate and Other Joint Ventures", "terseLabel": "Investments in unconsolidated joint ventures" } } }, "localname": "RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealEstateLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Real Estate [Line Items]", "terseLabel": "Real Estate" } } }, "localname": "RealEstateLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RealEstateTable": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions.", "label": "Real Estate [Table]", "terseLabel": "Real Estate [Table]" } } }, "localname": "RealEstateTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r276", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r398", "r402" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Amounts of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r276", "r398", "r399", "r402" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r398" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Expenses from transactions with related party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related person transactions" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]", "terseLabel": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r276", "r398", "r402", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesAssetsandLiabilitiesDetails", "http://dhcreit.com/role/NoncontrollingInterestDetails", "http://dhcreit.com/role/RealEstateInvestmentsEquityInvestmentInJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r396", "r397", "r399", "r403", "r404" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Person Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RelatedPersonTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "terseLabel": "Repayments of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLinesOfCredit": { "auth_ref": [ "r49", "r71" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Repayments of Lines of Credit", "negatedLabel": "Repayments of borrowings on revolving credit facility", "terseLabel": "Repayments of lines of credit" } } }, "localname": "RepaymentsOfLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfOtherDebt": { "auth_ref": [ "r49" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the payment of debt classified as other.", "label": "Repayments of Other Debt", "negatedLabel": "Repayment of other debt" } } }, "localname": "RepaymentsOfOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfSeniorDebt": { "auth_ref": [ "r49" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.", "label": "Repayments of Senior Debt", "negatedTerseLabel": "Redemption of senior unsecured notes" } } }, "localname": "RepaymentsOfSeniorDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfUnsecuredDebt": { "auth_ref": [ "r49" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.", "label": "Repayments of Unsecured Debt", "negatedTerseLabel": "Repayment of term loan" } } }, "localname": "RepaymentsOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r7", "r68", "r435", "r458" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSCashandRestrictedCashUnauditedParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r17", "r257", "r407", "r459", "r480", "r481" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Cumulative net income" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r78", "r79", "r80", "r82", "r88", "r90", "r155", "r311", "r312", "r313", "r318", "r319", "r351", "r477", "r479" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Cumulative Net\u00a0Income" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r115", "r116", "r129", "r135", "r136", "r143", "r144", "r147", "r259", "r260", "r420" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues", "verboseLabel": "Total revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues:", "verboseLabel": "Revenues:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]", "terseLabel": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.", "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Carrying Value and Fair Value of the Financial Instruments" } } }, "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r400", "r402" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]", "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/BusinessandPropertyManagementAgreementswithRMRDetails", "http://dhcreit.com/role/RelatedPersonTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r124", "r127", "r133", "r164" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r124", "r127", "r133", "r164" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of segment reporting information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r13", "r439", "r457" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "terseLabel": "Aggregate principal amount of mortgage debt" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "verboseLabel": "Secured Debts" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/FairValueofAssetsandLiabilitiesLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.", "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]", "terseLabel": "SOFR" } } }, "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r111", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r129", "r130", "r131", "r132", "r134", "r135", "r136", "r137", "r138", "r140", "r147", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r180", "r181", "r472" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r111", "r113", "r114", "r124", "r128", "r134", "r138", "r139", "r140", "r141", "r143", "r146", "r147", "r148" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment reporting" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SeniorNotes": { "auth_ref": [ "r443", "r465" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.", "label": "Senior Notes", "terseLabel": "Senior unsecured notes, net" } } }, "localname": "SeniorNotes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Share forfeitures (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Net number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures", "terseLabel": "Share grants (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Common shares awarded (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r2", "r111", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r129", "r130", "r131", "r132", "r134", "r135", "r136", "r137", "r138", "r140", "r147", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r176", "r180", "r181", "r472" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/SegmentReportingAssetsDetails", "http://dhcreit.com/role/SegmentReportingIncomeStatementsDetails", "http://dhcreit.com/role/SegmentReportingNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r25", "r32", "r33", "r34", "r78", "r79", "r80", "r82", "r88", "r90", "r105", "r155", "r252", "r257", "r311", "r312", "r313", "r318", "r319", "r351", "r373", "r374", "r375", "r376", "r377", "r378", "r395", "r477", "r478", "r479" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement", "verboseLabel": "Summarized financial information of significant tenant" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/SeniorLivingCommunityManagementAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r78", "r79", "r80", "r105", "r420" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture", "terseLabel": "Share grants" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r309" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited", "negatedTerseLabel": "Share forfeitures" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r14", "r15", "r252", "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Share repurchases (in shares)", "terseLabel": "Number of shares (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r14", "r15", "r252", "r257" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Share repurchases" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r33", "r72", "r78", "r79", "r80", "r82", "r88", "r153", "r155", "r257", "r311", "r312", "r313", "r318", "r319", "r328", "r329", "r339", "r351", "r371", "r373", "r374", "r378", "r395", "r478", "r479" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited", "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Shareholders' equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r70", "r238", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r257", "r258", "r350" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StraightLineRent": { "auth_ref": [ "r60" ], "calculation": { "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between actual rental income due and rental income recognized on a straight-line basis.", "label": "Straight Line Rent", "negatedLabel": "Straight line rental income", "terseLabel": "Straight line rental income" } } }, "localname": "StraightLineRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited", "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r379", "r408" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r379", "r408" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r379", "r408" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsNarrativeDetails", "http://dhcreit.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSSupplementalUnauditedParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_UnsecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.", "label": "Unsecured Debt [Member]", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableLeasePayment": { "auth_ref": [ "r390" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for variable lease payment excluded from lease liability.", "label": "Variable Lease, Payment", "terseLabel": "Variable lease, payment" } } }, "localname": "VariableLeasePayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/IndebtednessDetails", "http://dhcreit.com/role/RealEstateInvestmentsMortgageDebtJointVentureDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r93", "r98" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average common shares outstanding (diluted) (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r92", "r98" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Weighted average common shares outstanding (basic) (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://dhcreit.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 18 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r104": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r148": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r237": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r258": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r326": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r342": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r394": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888252" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r404": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.16)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(d))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(d))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 5))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r497": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "970", "URI": "https://asc.fasb.org/topic&trid=2156125" }, "r498": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "972", "URI": "https://asc.fasb.org/topic&trid=2134617" }, "r499": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "974", "URI": "https://asc.fasb.org/topic&trid=2156429" }, "r5": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r501": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "976", "URI": "https://asc.fasb.org/topic&trid=2134846" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r503": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "978", "URI": "https://asc.fasb.org/topic&trid=2134977" }, "r504": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r505": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r506": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r507": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r508": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r509": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "21D", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" } }, "version": "2.1" } ZIP 65 0001075415-22-000025-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001075415-22-000025-xbrl.zip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�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end